<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Neurosci</journal-id>
<journal-id journal-id-type="publisher-id">Front. Neurosci.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Neuroscience</journal-title>
</journal-title-group>
<issn pub-type="ppub">1662-4548</issn>
<issn pub-type="epub">1662-453X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31178679</article-id>
<article-id pub-id-type="pmc">6537480</article-id>
<article-id pub-id-type="doi">10.3389/fnins.2019.00454</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Therapeutic Potential of Oxytocin in Atherosclerotic Cardiovascular Disease: Mechanisms and Signaling Pathways</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Ping</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>†</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/403178/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Stephani C.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>†</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/403177/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yang</surname>
<given-names>Haipeng</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lv</surname>
<given-names>Chunmei</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jia</surname>
<given-names>Shuwei</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/485924/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Xiaoyu</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Xiaoran</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/485873/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Meng</surname>
<given-names>Dexin</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Qin</surname>
<given-names>Danian</given-names>
</name>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhu</surname>
<given-names>Hui</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="corresp" rid="c001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/534112/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Yu-Feng</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="corresp" rid="c001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/319898/overview" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Genetics, School of Basic Medical Sciences, Harbin Medical University</institution>, <addr-line>Harbin</addr-line>, <country>China</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Medicine, Albany Medical Center</institution>, <addr-line>Albany, NY</addr-line>, <country>United States</country></aff>
<aff id="aff3"><sup>3</sup><institution>Department of Pediatrics, The Forth Affiliated Hospital, Harbin Medical University</institution>, <addr-line>Harbin</addr-line>, <country>China</country></aff>
<aff id="aff4"><sup>4</sup><institution>Department of Physiology, School of Basic Medical Sciences, Harbin Medical University</institution>, <addr-line>Harbin</addr-line>, <country>China</country></aff>
<aff id="aff5"><sup>5</sup><institution>Department of Physiology, Jiamusi University</institution>, <addr-line>Jiamusi</addr-line>, <country>China</country></aff>
<aff id="aff6"><sup>6</sup><institution>Department of Physiology, Shantou University of Medical College</institution>, <addr-line>Shantou</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Pierrette Gaudreau, Université de Montréal, Canada</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Marta Busnelli, Italian National Research Council (CNR), Italy; Philip M. McCabe, University of Miami, United States</p>
</fn>
<corresp id="c001">*Correspondence: Yu-Feng Wang, <email>yufengwang@ems.hrbmu.edu.cn</email> Hui Zhu, <email>dzhuhui@aliyun.com</email></corresp>
<fn fn-type="other" id="fn001">
<p><sup>†</sup>These authors have contributed equally to this work</p>
</fn>
<fn fn-type="other" id="fn002">
<p>This article was submitted to Neuroendocrine Science, a section of the journal Frontiers in Neuroscience</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>21</day>
<month>5</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<year>2019</year>
</pub-date>
<volume>13</volume>
<elocation-id>454</elocation-id>
<history>
<date date-type="received">
<day>14</day>
<month>12</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>23</day>
<month>4</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2019 Wang, Wang, Yang, Lv, Jia, Liu, Wang, Meng, Qin, Zhu and Wang.</copyright-statement>
<copyright-year>2019</copyright-year>
<copyright-holder>Wang, Wang, Yang, Lv, Jia, Liu, Wang, Meng, Qin, Zhu and Wang</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>Coronary artery disease (CAD) is a major cardiovascular disease responsible for high morbidity and mortality worldwide. The major pathophysiological basis of CAD is atherosclerosis in association with varieties of immunometabolic disorders that can suppress oxytocin (OT) receptor (OTR) signaling in the cardiovascular system (CVS). By contrast, OT not only maintains cardiovascular integrity but also has the potential to suppress and even reverse atherosclerotic alterations and CAD. These protective effects of OT are associated with its protection of the heart and blood vessels from immunometabolic injuries and the resultant inflammation and apoptosis through both peripheral and central approaches. As a result, OT can decelerate the progression of atherosclerosis and facilitate the recovery of CVS from these injuries. At the cellular level, the protective effect of OT on CVS involves a broad array of OTR signaling events. These signals mainly belong to the reperfusion injury salvage kinase pathway that is composed of phosphatidylinositol 3-kinase-Akt-endothelial nitric oxide synthase cascades and extracellular signal-regulated protein kinase 1/2. Additionally, AMP-activated protein kinase, Ca<sup>2+</sup>/calmodulin-dependent protein kinase signaling and many others are also implicated in OTR signaling in the CVS protection. These signaling events interact coordinately at many levels to suppress the production of inflammatory cytokines and the activation of apoptotic pathways. A particular target of these signaling events is endoplasmic reticulum (ER) stress and mitochondrial oxidative stress that interact through mitochondria-associated ER membrane. In contrast to these protective effects and machineries, rare but serious cardiovascular disturbances were also reported in labor induction and animal studies including hypotension, reflexive tachycardia, coronary spasm or thrombosis and allergy. Here, we review our current understanding of the protective effect of OT against varieties of atherosclerotic etiologies as well as the approaches and underlying mechanisms of these effects. Moreover, potential cardiovascular disturbances following OT application are also discussed to avoid unwanted effects in clinical trials of OT usages.</p>
</abstract>
<kwd-group>
<kwd>atherosclerosis</kwd>
<kwd>coronary artery disease</kwd>
<kwd>etiology</kwd>
<kwd>oxytocin</kwd>
<kwd>signaling pathways</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source id="cn001">National Natural Science Foundation of China<named-content content-type="fundref-id">10.13039/501100001809</named-content></funding-source>
</award-group>
</funding-group>
<counts>
<fig-count count="3"></fig-count>
<table-count count="0"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="231"></ref-count>
<page-count count="21"></page-count>
<word-count count="0"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec>
<title>Introduction</title>
<p>Cardiovascular disease (CVD) is responsible for both high morbidity and mortality worldwide with coronary artery disease (CAD) being the leading cause of death (45.1%) (<xref ref-type="bibr" rid="B21">Cassar et al., 2009</xref>). In the United States, the prevalence of CVD comprising chronic heart disease, heart failure, and hypertension in adults (≥20 years of age) was 121.5 million in 2016 and increases with advancing age in both males and females (<xref ref-type="bibr" rid="B12">Benjamin et al., 2019</xref>). The major pathological basis of CAD is atherosclerosis that affects various components of the cardiovascular system (CVS), particularly the coronary artery. Over the past decades, identifying and reversing the pathogenesis of CAD and preventing myocardial infarction (MI) remain a major challenge for clinical management of CAD (<xref ref-type="bibr" rid="B99">Koton et al., 2014</xref>).</p>
<p>Oxytocin (OT), a nonapeptide synthesized in hypothalamic magnocellular neuroendocrine cells in the supraoptic and paraventricular nuclei (SON and PVN) (<xref ref-type="bibr" rid="B215">Yang et al., 2013</xref>; <xref ref-type="bibr" rid="B88">Johnson and Young, 2017</xref>), has emerged as an efficient cardioprotective agent in animal studies (<xref ref-type="bibr" rid="B82">Jankowski et al., 2016</xref>). However, due to the lack of deep knowledge of its involvement in the pathogenesis of atherosclerosis, therapeutic potential of OT in treating CAD is largely unexplored in clinical studies. In this review, we summarize our current understanding of the pathogenetic involvement of OT in atherosclerosis, the cellular/molecular mechanisms underlying OT suppression of atherosclerosis development and current challenges in clinical trials of OT.</p>
</sec>
<sec>
<title>Atherosclerosis and Cardioprotective Effect of OT</title>
<p>Atherosclerosis can occur in the coronary artery, renal and cerebral circulation, and peripheral and mesenteric vasculature, largely due to metabolic disorders and immunological injuries (<xref ref-type="bibr" rid="B159">Rahman and Woollard, 2017</xref>). CVDs are often accompanied by disruption of OT/OT receptor (OTR) signaling. For instance, particulate matter 2.5 exposure resulted in global adult cardiac dysfunction (<xref ref-type="bibr" rid="B186">Tanwar et al., 2017</xref>) while reduced OTR mRNA expression (<xref ref-type="bibr" rid="B73">Iobst et al., 2019</xref>). Moreover, endoplasmic reticulum (ER) stress, a common cause of cardiovascular disorders (<xref ref-type="bibr" rid="B194">Wang S.C. et al., 2018</xref>), significantly reduced the levels of OT mRNA (<xref ref-type="bibr" rid="B128">Morishita et al., 2011</xref>); in ischemia/reperfusion (I/R) injury in C57B6 mice, OTR expression decreased in the heart by 40% (<xref ref-type="bibr" rid="B72">Indrambarya et al., 2009</xref>). By contrast, OT can exert cardiovascular protective function through suppressing the development of atherosclerosis and repairing the injured heart following myocardial infarction as shown in mice (<xref ref-type="bibr" rid="B148">Plante et al., 2015</xref>).</p>
<sec>
<title>Atherosclerosis and Its Etiology</title>
<p>Cardiovascular health is largely determined by mechanisms of vascular endothelial defenses. This defense involves oxygen utilization, tension on the wall and flow resistance, local regulation of vascular tone and contractility, control of inflammatory cell adhesion, and anti-thrombotic nature of the endothelial surfaces. These factors together support normal circulatory function and its adaptive response to adverse environmental challenges, disturbance of which can predispose to atherosclerosis (<xref ref-type="bibr" rid="B94">Kim et al., 2013</xref>; <xref ref-type="bibr" rid="B104">Lee et al., 2013</xref>). Factors leading to atherosclerosis include consumption of high-fat and cholesterol diet (<xref ref-type="bibr" rid="B118">Marir et al., 2013</xref>), dyslipidemia (<xref ref-type="bibr" rid="B169">Sanin et al., 2017</xref>), diabetes (<xref ref-type="bibr" rid="B105">Lehrke and Marx, 2017</xref>), chronic inflammation (<xref ref-type="bibr" rid="B103">Lee et al., 2018</xref>), genetic risk (<xref ref-type="bibr" rid="B206">Whayne, and Saha, 2019</xref>), lack of exercise (<xref ref-type="bibr" rid="B214">Yang J. et al., 2017</xref>), hypertension (<xref ref-type="bibr" rid="B70">Hurtubise et al., 2016</xref>), social stress (<xref ref-type="bibr" rid="B121">Meng et al., 2019</xref>), smoking and other unhealthy life-styles or environmental factors (<xref ref-type="bibr" rid="B133">Niemann et al., 2017</xref>). As shown in a cohort study in Mexico, the coronary risk factors observed were dyslipidemia (100%), hypertension (86%), obesity/overweight (75%), metabolic syndrome (71%), smoking (68%), and diabetes (58%) (<xref ref-type="bibr" rid="B163">Rettori et al., 2014</xref>). Moreover, coronary artery spasm and embolism could be evoked by emotional or physical stress due to increased sympathetic output (<xref ref-type="bibr" rid="B91">Kc and Dick, 2010</xref>; <xref ref-type="bibr" rid="B127">Mori et al., 2012</xref>). Thus, immunometabolic disorders and abnormal cerebral-cardiovascular communication are the major etiology of CAD in association with atherosclerosis.</p>
<p>In general, the development of atherosclerosis begins with the attachment and invasion of leukocytes to the endothelium of the artery under the drive of oxidized lipoprotein particles within the wall or injuries of epithelial cells. The ensuing inflammation causes adhesion of platelets, leading to formation of atheromatous plaques in the arterial tunica intima. This process involves precipitation and oxidization of cholesterol released from circulating low density lipoprotein, inflammation-stimulated proliferation and migration of smooth muscle from the tunica media into the intima, followed by the formation of fibrous capsule and calcification of the arterial walls. As the plaques grow, wall thickening and narrowing can affect any arteries, particularly the coronary artery, resulting in a shortage of blood and oxygen delivery to various tissues. Pieces of plaque can also break off, and lead to MI, stroke, or heart failure if left untreated (<xref ref-type="bibr" rid="B33">Crea and Libby, 2017</xref>).</p>
<p>In the pathogenesis of atherosclerosis, different etiologies work through different mechanisms. For example, high blood cholesterol and fat can deposit in the wall of arteries, which reduces the flexibility of blood vessels, stimulates inflammation and restricts, even blocks blood circulation to the heart and other organs (<xref ref-type="bibr" rid="B52">Garrott et al., 2017</xref>). Hypertension can damage the endothelium of blood vessels in heart, increase shear and tear forces on vessel walls that change cell osmotic stability (<xref ref-type="bibr" rid="B86">Jiao et al., 2017</xref>) and fasten lipid deposition in arteries (<xref ref-type="bibr" rid="B100">Lawes et al., 2008</xref>). Cigarette smoking can damage the endothelium of arteries, stimulate inflammation (<xref ref-type="bibr" rid="B71">Hussien and Mousa, 2016</xref>), increase blood pressure (BP) and cause cardiac hypertrophy (<xref ref-type="bibr" rid="B60">Guasch and Gilsanz, 2016</xref>). People with diabetes have a much higher incidence of CAD because of dyslipidemia and metabolic disorders, particularly the formation of glycated proteins that cause inflammation, stiffening arteries, trapping other macromolecules, and disrupting enzyme activities, hormone regulation, immune function and activities of dendritic cells (<xref ref-type="bibr" rid="B152">Price and Knight, 2007</xref>). Furthermore, lack of social support or mental stress is etiologically related to coronary artery lesion through sympathetic-adrenomedullary influences on platelet function, heart rate, and BP in the initial endothelial injury, and the hypothalamic-pituitary-adrenocortical (HPA) axis that is involved in smooth muscle cell proliferation during progression of vascular lesion (<xref ref-type="bibr" rid="B43">Dupont et al., 2014</xref>). With increase in age, arteries become less elastic and are more susceptible to plaque buildup (<xref ref-type="bibr" rid="B159">Rahman and Woollard, 2017</xref>; <xref ref-type="bibr" rid="B169">Sanin et al., 2017</xref>). Correspondingly, prevention of CAD involves changing lifestyle to limit the amount of fat and cholesterol intake and increase their utilization through exercise. In the treatment, cholesterol-lowering medication statins, antiplatelet and anticoagulants, β-blockers, calcium channel blockers, diuretics, or angiotensin converting enzyme inhibitors can be recommended. In some cases, interventions may be necessary such as percutaneous coronary intervention, bypass surgery, thrombolytic therapy, angioplasty, and endarterectomy (<xref ref-type="bibr" rid="B104">Lee et al., 2013</xref>; <xref ref-type="bibr" rid="B111">Lindahl et al., 2017</xref>). These measures could slow down injuries to the arteries but with various side effects and complications. Thus, agents targeting multiple aspects of atherosclerotic pathogenesis or CAD but having minimal side-effects are especially critical, and OT is one potential agent with such properties.</p>
</sec>
<sec>
<title>Cardiovascular Protective Effect of OT</title>
<p>Oxytocin has multiple cardiovascular protective functions, which are achieved through both central and peripheral approaches (<xref ref-type="bibr" rid="B191">Viero et al., 2010</xref>). OT terminals were found on large intracerebral (<xref ref-type="bibr" rid="B231">Zimmerman et al., 1984</xref>) and other large blood vessels (<xref ref-type="bibr" rid="B84">Jankowski et al., 2000</xref>) as well as neural structures regulating cardiac activity (<xref ref-type="bibr" rid="B215">Yang et al., 2013</xref>). OTR was localized in microvessels expressing CD31 marker and co-localized with endothelial NO synthase (eNOS) (<xref ref-type="bibr" rid="B81">Jankowski et al., 2010b</xref>). OTR mRNA was found in the vena cava, pulmonary veins, and pulmonary artery with lower levels in the aorta in the rats (<xref ref-type="bibr" rid="B84">Jankowski et al., 2000</xref>; <xref ref-type="bibr" rid="B209">Wsol et al., 2016</xref>). Thus, OT may modulate cardiac activity by activating OTRs on CVS.</p>
<sec>
<title>OT and Ischemic Cardiomyopathy</title>
<p>Ischemic cardiomyopathy involves poor perfusion and oxygenation to the myocardium, mainly due to CAD. OTR signaling is closely associated with the development of CAD and its complications. As previously reviewed (<xref ref-type="bibr" rid="B107">Li et al., 2017</xref>), plasma OT levels or hypothalamic OT neuronal activities were significantly increased at the early stage of sepsis, advanced cancer patients, adjuvant arthritis and pancreatic injury, which in turn changed the activity of immune system to initiate immune defense, thereby playing the role of immune surveillance. In CVS, OT plasma levels and the activity of the intracardiac OT system significantly increased at 4 weeks after MI in the rats survived from the coronary artery ligation (<xref ref-type="bibr" rid="B29">Ciosek and Drobnik, 2012</xref>); post-infarction heart failure was associated with an increased activity of the intracardiac OTergic system (<xref ref-type="bibr" rid="B209">Wsol et al., 2016</xref>). Moreover, MI activates parvocellular OT neurons projecting to the rostral ventral lateral medulla (<xref ref-type="bibr" rid="B166">Roy et al., 2018</xref>). Thus, changes in the activity of the OT-secreting system in the brain and the heart can be a biomarker of immune disturbance in CVD while exerting the function of adaptive cardioprotection (<xref ref-type="bibr" rid="B80">Jankowski et al., 2010a</xref>).</p>
<p>The cardioprotective effect of OT has been proven by many experimental observations. OT administration significantly inhibited myocardial injury in rats (<xref ref-type="bibr" rid="B124">Moghimian et al., 2012</xref>; <xref ref-type="bibr" rid="B150">Polshekan et al., 2016</xref>); however, blocking OTRs with atosiban increased infarct size and levels of creatine kinase MB isoenzyme and lactate dehydrogenase (<xref ref-type="bibr" rid="B124">Moghimian et al., 2012</xref>; <xref ref-type="bibr" rid="B67">Houshmand et al., 2015</xref>). In rabbits with I/R of the left coronary artery, OT pretreatment significantly decreased infarct size and yielded antiarrhythmic effects including ventricular tachycardia and fibrillation (<xref ref-type="bibr" rid="B48">Faghihi et al., 2012</xref>); however, atosiban abolished the beneficial effects of this ischemic preconditioning of OT (<xref ref-type="bibr" rid="B36">Das and Sarkar, 2012</xref>). Lastly, in the post-ischemia repair of a rabbit model, post-infarction group treated with OT had reduced infarct size and improved left ventricular function by enhancing anti-fibrotic and angiogenic effects via activating OTRs (<xref ref-type="bibr" rid="B98">Kobayashi et al., 2009</xref>). Importantly, the cardioprotective effect of OT can be achieved in doses of 8 × 10<sup>-12</sup> to 2 × 10<sup>-11</sup>M as shown in rat I/R heart (<xref ref-type="bibr" rid="B7">Anvari et al., 2012</xref>), a physiological level in the plasma (<xref ref-type="bibr" rid="B65">Hirst et al., 1991</xref>), indicating that the protective role can be physiological.</p>
<p>The protective effect of OT is first attributable to its negative chronotropic and inotropic roles in cardiac activity following the activation of cardiac OTR (<xref ref-type="bibr" rid="B32">Costa E Sousa et al., 2005</xref>) in association with the release of protective atrial natriuretic peptide (ANP) and nitric oxide (NO) (<xref ref-type="bibr" rid="B67">Houshmand et al., 2015</xref>) and increase in parasympathetic output (<xref ref-type="bibr" rid="B179">Sun et al., 2015</xref>), decrease in the activity of renin-angiotensin-aldosterone system (<xref ref-type="bibr" rid="B132">Nielsen et al., 1997</xref>) and reduction of sympathetic outflow (<xref ref-type="bibr" rid="B137">Olszewski et al., 2010</xref>). In addition, OT also decreased cardiac preload and afterload through its diuresis and natriuretic effect (<xref ref-type="bibr" rid="B132">Nielsen et al., 1997</xref>). As a result, OT can reduce oxygen consumption while increasing the cardiac output during I/R injury.</p>
</sec>
<sec>
<title>Vascular Protection</title>
<p>Oxytocin is synthesized and released in the heart and vasculature that express OTRs, and is important in normal homeostatic regulation of cardiac and vascular systems (<xref ref-type="bibr" rid="B85">Japundzic-Zigon, 2013</xref>). It is well-known that OT preconditioning increased expression of genes associated with angiogenic, antiapoptotic, and cardiac antiremodeling properties (<xref ref-type="bibr" rid="B134">Noiseux et al., 2012</xref>). OT promoted angiogenic behaviors of human umbilical vein endothelial cells through activating OTRs (<xref ref-type="bibr" rid="B22">Cattaneo et al., 2008</xref>) by increasing hypoxia-inducible factor-1α mRNA and protein expression (<xref ref-type="bibr" rid="B230">Zhu et al., 2017</xref>). In rats of sinoaortic denervation, intravenous application of OT induced an enhanced initial pressor effect with much reduced reflex bradycardia and fall in cardiac output. A larger and more prolonged delayed fall in mean arterial pressure was apparent with both OT and its specific agonist [Thr4,Gly7]OT (<xref ref-type="bibr" rid="B17">Busnelli et al., 2013</xref>) although supraphysiological doses of OT caused transient pressor reaction by activating vasopressin (VP) receptors (<xref ref-type="bibr" rid="B145">Petty et al., 1985</xref>). Moreover, OT could antagonize the pressor effect of VP through reflexively activating cholinergic neurons (<xref ref-type="bibr" rid="B129">Mukaddam-Daher et al., 2001</xref>). These effects allow OT to reduce the pre- and after-load of CVS.</p>
<p>The protective effect of OT is closely associated with its suppression of immunological disorders. In rat heart, angiogenic and antiapototic effects of OT were mediated by upregulating vascular endothelial growth factor (VEGF) and prosurvival B-cell lymphoma-2 protein (<xref ref-type="bibr" rid="B98">Kobayashi et al., 2009</xref>), with decreasing apoptosis caused by neutrophils (<xref ref-type="bibr" rid="B2">Al-Amran and Shahkolahi, 2013</xref>). Moreover, incubation of cells at physiological levels of OT significantly decreased basal and stimulated NADPH-dependent superoxide activity in vascular cells, monocytes, and macrophages that express OTR protein and mRNA. OT can decrease NADPH-dependent superoxide production and pro-inflammatory cytokine release from vascular endothelial cells and macrophages, and thus, inhibit inflammation and atherosclerotic lesion development (<xref ref-type="bibr" rid="B196">Wang P. et al., 2015</xref>). In Watanabe Heritable Hyperlipidemic rabbit, a model of dyslipidemia and atherosclerosis, chronic OT-treatment significantly reduced plasma C-reactive protein levels, atherosclerosis formation in the thoracic aorta and cytokine gene expression in visceral adipose tissues; however, body weight, serum lipids, plasma/urinary measures of oxidative stress, plasma cortisol, or urinary catecholamines did not change (<xref ref-type="bibr" rid="B184">Szeto et al., 2013</xref>). Thus, attenuating vascular oxidative stress and inflammation are important mechanisms for OT to antagonize the pathogenesis of atherosclerosis.</p>
</sec>
<sec>
<title>Cardioprotection in Post-menopausal Women</title>
<p>Coronary artery disease is generally considered the pathology of aging and gender with strong correlation with the activity of OT neurons. Between age 45 to 65, approximately 10% women developed CAD, while the incidence increased to 33% after age 65 (<xref ref-type="bibr" rid="B12">Benjamin et al., 2019</xref>). Correspondingly, heart disease was the leading cause of death for women in the United States, killing 289,758 women in 2013 (<xref ref-type="bibr" rid="B212">Xu et al., 2016</xref>). CAD-associated hypertension increased dramatically in women after menopause due to reduction in ovarian hormone in older women (<xref ref-type="bibr" rid="B119">McLeod et al., 2010</xref>), which could impair baroreflex and autonomic balance by negatively impacting OTergic drive and OT levels in pre-autonomic neurons in rats (<xref ref-type="bibr" rid="B37">De Melo et al., 2016</xref>). Declines in OT and OTRs were related to aging-associated acceleration of inflammation and oxidative injuries in the CVS, particularly after menopause (<xref ref-type="bibr" rid="B109">Light et al., 2005</xref>). Consistently, plasma OT level experienced a threefold decline in aged mice compared with young, and this decline was accompanied by similar decrease in levels of OTRs in muscle stem cells (<xref ref-type="bibr" rid="B45">Elabd et al., 2014</xref>). Exogenous estrogen application was found to increase OT secretion in both rodents (<xref ref-type="bibr" rid="B155">Quinones-Jenab et al., 1997</xref>) and women (<xref ref-type="bibr" rid="B27">Chiodera et al., 1991</xref>), and increase in OTR mRNA expression in mouse brain (<xref ref-type="bibr" rid="B155">Quinones-Jenab et al., 1997</xref>) as well as intracardiac OTR signaling (<xref ref-type="bibr" rid="B81">Jankowski et al., 2010b</xref>). The pro-synthetic function of estrogen in OT expression may also explain the lower CAD prevalence among women before menopause. Hence, OT has special potential in treating female patients with CAD.</p>
</sec>
</sec>
</sec>
<sec>
<title>Mechanisms Underlying the Protective Effects of OT</title>
<p>Oxytocin exerts much protective functions on the CVS through suppressing atherosclerosis-evoking factors and reducing the injury following MI. These protective effects of OT are based on its direct CVS effects and its modulation of the regulatory system of CVS activity (<xref ref-type="fig" rid="F1">Figure 1</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Approaches mediating cardiovascular protective effect of OT. There are three pathways affecting cardiovascular activity. Neuronal activation of SON and PVN can counteract stress, hypertension, and brain-heart syndrome. Release of OT from MNCs and CMs inhibits atherosclerotic injuries of heart and artery by inhibiting immunological injuries and metabolic disorders through immune protection, paracrine function, and CM regeneration. Finally, activation of OT in pPVN regulates autonomic and vasomotor center activity, leading to inhibition of cardiac arrhythmia, ischemia-reperfusion injury, oxygen demand, and vasoconstriction. Ach, acetylcholine; CM, cardiomyocyte; MNCs, magnocellular neuroendocrine cells; OT, oxytocin; OTR, oxytocin receptor; pPVN, parvocellular division of the PVN; PVN, paraventricular nucleus; SON, supraoptic nucleus.</p>
</caption>
<graphic xlink:href="fnins-13-00454-g001"></graphic>
</fig>
<sec>
<title>Peripheral Effect</title>
<p>In response to environmetal challenges, OT in the hypothalamus can be released into the blood stream in various amounts and patterns (<xref ref-type="bibr" rid="B63">Hatton and Wang, 2008</xref>; <xref ref-type="bibr" rid="B66">Hou et al., 2016</xref>) and modulate activities of the heart and blood vessels by activating OTRs along with intracardiac OT (<xref ref-type="bibr" rid="B209">Wsol et al., 2016</xref>). OT has both chronotropic and inotropic effects on cardiac activity, which can protect the heart from I/R-induced myocardial injury by reducing oxygen consumption. OT also regulates lipid metabolism, and exerts the effect of anti-diabetes, anti-inflammation, and anti-apoptosis while promotes angiogenesis and regeneration of cardiomyocytes as further stated below.</p>
<sec>
<title>Regulation of Lipid Metabolism</title>
<p>Among many factors contributing to atherosclerosis, disorders in the regulation of lipid metabolism and obesity are major etiologies (<xref ref-type="bibr" rid="B170">Schinzari et al., 2017</xref>) and thus the target of cardioprotective effect of OT. As reported that hyperlipidemia disrupted OTR signaling (<xref ref-type="bibr" rid="B138">Padol et al., 2017</xref>), that serum OT levels were decreased in obese group (<xref ref-type="bibr" rid="B153">Qian et al., 2014</xref>), and that mice with OT- or OTR-deficiency developed late-onset obesity (<xref ref-type="bibr" rid="B185">Takayanagi et al., 2008</xref>) which was associated with type 2 diabetes and CAD (<xref ref-type="bibr" rid="B6">Amri and Pisani, 2016</xref>). Consistently, blood OT concentration was inversely correlated to serum triglyceride, low-density lipoprotein and total cholesterol levels (<xref ref-type="bibr" rid="B153">Qian et al., 2014</xref>). It was also found that cholesterol levels in rats displayed a tendency to fall in response to subcutaneous injection of OT (<xref ref-type="bibr" rid="B181">Suva et al., 1980</xref>); chronic systemic treatment with OT largely reproduced the effects of central administration of OT by reducing weight gain in obese rodents; chronic subcutaneous or intranasal OT treatment was sufficient to elicit body weight loss in obese subjects (<xref ref-type="bibr" rid="B13">Blevins and Baskin, 2015</xref>). Thus, increasing OTR signaling is an important step in prevention of atherosclerosis and OT has therapeutic potential in reducing obesity, atherosclerosis, and the incidence of CAD through regulating lipid metabolism.</p>
</sec>
<sec>
<title>Anti-diabetic Effects</title>
<p>Population with diabetes mellitus has high prevalence of CAD, peripheral vascular disease and heart failure (<xref ref-type="bibr" rid="B105">Lehrke and Marx, 2017</xref>). In type 2 diabetes mellitus, serum OT levels were decreased (<xref ref-type="bibr" rid="B153">Qian et al., 2014</xref>). Similarly, in a mouse model of type 2 diabetes mellitus, there was a significant down-regulation of OT, OTRs, ANP, and eNOS gene expressions in the heart, and chronic OT treatment prevented the development of diabetic cardiomyopathy in these animals (<xref ref-type="bibr" rid="B148">Plante et al., 2015</xref>). Consistently, OT administered to fasted male subjects via intranasal approach attenuated the peak excursion of plasma glucose (<xref ref-type="bibr" rid="B97">Klement et al., 2017</xref>). These findings support that disruption of OTR signaling is closely related to the occurrence of diabetes mellitus.</p>
<p>Further studies revealed that the anti-diabetic effect of OT is closely related to its regulation of glucose metabolism. OT could promote glucose metabolism in cultured cardiomyocytes from newborn and adult rats (<xref ref-type="bibr" rid="B50">Florian et al., 2010</xref>), in myocardial cells during hypoxia and other physiological stressors (<xref ref-type="bibr" rid="B174">Shioi et al., 2000</xref>) and in mesenchymal stem cells (<xref ref-type="bibr" rid="B134">Noiseux et al., 2012</xref>). These findings are consistent with the report that OT stimulated glucose oxidation in myometrial tissue (<xref ref-type="bibr" rid="B136">Okabe et al., 1985</xref>) and glucose oxidation and lipogenesis in rat epididymal adipocytes (<xref ref-type="bibr" rid="B56">Goren et al., 1986</xref>). This effect was mediated through tricarboxylic acid cycle (<xref ref-type="bibr" rid="B136">Okabe et al., 1985</xref>) in an extracellular Ca<sup>2+</sup>-dependent manner (<xref ref-type="bibr" rid="B14">Bonne et al., 1978</xref>). On the other hand, OT contributes to metabolic control of glucose by directly improving pancreatic functions. In mice, OTR signaling reduced the death of pancreatic β-cells in islets exposed to cytotoxic stresses, which was diminished in islets isolated from OTR knockout mice (<xref ref-type="bibr" rid="B204">Watanabe et al., 2016</xref>). In fasted male subjects, OT was also found to augment the early increases in insulin and C-peptide concentrations in response to glucose challenge due to a pronounced increase in β-cell sensitivity (<xref ref-type="bibr" rid="B97">Klement et al., 2017</xref>). These facts indicate that OT exerts anti-diabetic effect by regulating glucose metabolism and protecting pancreatic β-cells in islets, thereby rendering the OT system a potential target of anti-diabetic treatment and prevention of CAD.</p>
</sec>
<sec>
<title>Anti-inflammation</title>
<p>One of the critical factors involved in the development of CAD is chronic inflammation in association with oxidative stress and the release of pro-inflammatory cytokines (<xref ref-type="bibr" rid="B130">Mullenix et al., 2005</xref>). Early atherosclerosis formation is based on leukocyte accumulation and atheroma-activating cells, such as macrophages, dendritic cells, and T- and B-lymphocytes. Pro-inflammatory cytokines enhance leukocyte adhesion molecule expression, leading to leukocyte penetration into the endothelial layer and accumulation in intima. Other molecules, such as interleukin-6, that affect lipid metabolism (<xref ref-type="bibr" rid="B221">Yudkin, 2003</xref>) are associated with increased level of C-reactive protein production, which changes inversely to serum OT levels (<xref ref-type="bibr" rid="B153">Qian et al., 2014</xref>). OT was also identified as an agent that suppresses the production of inflammatory cytokines (<xref ref-type="bibr" rid="B200">Wang, 2016</xref>), including smooth muscle and vascular endothelial cells (<xref ref-type="bibr" rid="B184">Szeto et al., 2013</xref>). Moreover, OT could down-regulate neutrophil chemotactic molecules and myocardial neutrophil infiltration, and prevent myocardial injury by reducing inflammatory reaction and reactive oxygen species (ROS) produced by neutrophils (<xref ref-type="bibr" rid="B2">Al-Amran and Shahkolahi, 2013</xref>). Thus, along with the general immunological regulatory functions (<xref ref-type="bibr" rid="B196">Wang P. et al., 2015</xref>; <xref ref-type="bibr" rid="B200">Wang, 2016</xref>), OT could be a potentially preventative agent in those at high-risk for atherosclerosis development and further limit the progression in those with existing disease.</p>
</sec>
<sec>
<title>Regeneration of Cardiomyocytes</title>
<p>In MI, an initial ischemic event can lead to either reversible or irreversible myocardial injury based on the duration and size of ischemia, and subsequent damages by reperfusion. Prolonged ischemia caused dysfunction in ATPase-dependent ion transport, cellular swelling and rupture, intracellular ion dysregulation and cellular apoptosis; reperfusion caused transient elevation in levels of ROS and inflammatory neutrophils, leading to exacerbation of initial ischemic event; following an ischemic attack, up to 1-billion cardiac cells died but humans had a limited ability to regenerate myocardial cells and injured cells were often replaced by fibrotic scars, leading to conduction abnormalities and heart failure (<xref ref-type="bibr" rid="B159">Rahman and Woollard, 2017</xref>; <xref ref-type="bibr" rid="B169">Sanin et al., 2017</xref>). For this reason, regeneration of cardiomyocytes is extremely important in long-term prognosis.</p>
<p>Along with the anti-inflammatory and anti-apoptotic effects of OT on the CVS (<xref ref-type="bibr" rid="B98">Kobayashi et al., 2009</xref>; <xref ref-type="bibr" rid="B134">Noiseux et al., 2012</xref>; <xref ref-type="bibr" rid="B2">Al-Amran and Shahkolahi, 2013</xref>), OTR signaling can exert cardioprotective function by promoting regeneration of injured cardiomyocytes. OT stimulated <italic>in situ</italic> differentiation of cardiac stem cells into functionally matured cardiomyocytes by replacing lost cells from ischemic events. When OT-treated mesenchymal stem cells were co-cultured with I/R rat cardiomyocytes, there were decreased cardiac fibrosis, macrophage infiltration, restoration of connexin 43, and increased overall cardiac ejection fraction (<xref ref-type="bibr" rid="B93">Kim et al., 2012</xref>). OT preconditioning was also known to increase expression of genes involved in angiogenesis, anti-apoptosis, and anti-cardiac remodeling, such as HSP 27, HSP 32, and VEGF (<xref ref-type="bibr" rid="B61">Gutkowska et al., 2009</xref>). Thus, OT treatment can evoke mesenchymal stem cell differentiation to replace the lost cardiac cells, which endows OT the potential of reversing injuries from atherosclerotic CVD.</p>
</sec>
<sec>
<title>Effects of Intracardiac OT via ANP</title>
<p>In rat heart (<xref ref-type="bibr" rid="B209">Wsol et al., 2016</xref>), the right atrium has the highest OT concentration (∼2.128 ng/mg protein) (<xref ref-type="bibr" rid="B83">Jankowski et al., 1998</xref>), comparable with OT content in the hypothalamus wherein different regions have OT concentrations varying from &gt;0.1∼228 ng/mg protein (<xref ref-type="bibr" rid="B51">Gainer, 2011</xref>). Thus, when OT is released from the atrium, dramatic changes in the cardiac activity can be elicited through paracrine functions, in which ANP serves as cardioprotective mediators of OT in the heart. Upon activation of OTRs, intracellular Ca<sup>2+</sup> mobilization occurred in the right atrium, which caused ANP release from cardiomyocytes (<xref ref-type="bibr" rid="B62">Gutkowska et al., 2014</xref>) whereas, application of OT antagonist blocked basal ANP release (<xref ref-type="bibr" rid="B139">Paquin et al., 2002</xref>) and caused a significant decline in ejection fraction and increased cardiac fibrosis (<xref ref-type="bibr" rid="B81">Jankowski et al., 2010b</xref>).</p>
<p>Similarly, OTR signaling also increased NO production (<xref ref-type="bibr" rid="B151">Polshekan et al., 2019</xref>) that exerted cardiovascular protective effect (<xref ref-type="bibr" rid="B76">Jackson et al., 2017</xref>). This action is likely mediated by ANP (<xref ref-type="bibr" rid="B120">Menaouar et al., 2014</xref>). Moreover, OT-evoked release of ANP into the blood during expansion of blood volume could also reduce BP through its diuresis and natriuresis effects (<xref ref-type="bibr" rid="B175">Soares et al., 1999</xref>). The natriuretic effect helps to remove excess volume and thus reduces BP. These features allow OT to modulate cardiovascular activity through changing ANP secretion.</p>
</sec>
</sec>
<sec>
<title>Central Effect</title>
<p>Cardiovascular activity is under intense regulation of the central nervous system. CVDs can be caused by disorders in the cardiovascular regulation involving disrupting normal neuroendocrine, autonomic, and behavioral responses. By antagonizing these responses, OT can counteract the deleterious effects of stress, hypertension, unhealthy life-style, and brain-heart syndrome on the CVS.</p>
<sec>
<title>Neural Regulation of Cardiovascular Activity</title>
<p>Vasomotor center(s) in the brainstem are the key structure in neural regulation of cardiovascular activity and are also the target of OT protection of cardiovascular activity. In response to physiological challenges, OT in the hypothalamus can change vasotone through autonomic nerves and in turn modulate cardiovascular activity.</p>
<p>The pumping effectiveness of the heart and contractility of blood vessels are primarily regulated by the autonomic nervous system including excitatory sympathetic and inhibitory parasympathetic nerves. As evidenced in trained rats, there were an increased gain of baroreflex control of heart rate, markedly elevated OT mRNA expression and OT peptide density in PVN neurons, which were blocked with sinoaortic denervation (<xref ref-type="bibr" rid="B23">Cavalleri et al., 2011</xref>). OT neurons and their terminals are present in both intra- and extra-hypothalamic sites (<xref ref-type="bibr" rid="B66">Hou et al., 2016</xref>), through which OT can change the activity of the neural centers controlling CVS at different levels. The descending fibers from hypothalamic OT cells were found to innervate the locus coeruleus and dorsal vagal complex in the brainstem of the rat (<xref ref-type="bibr" rid="B183">Swanson and Hartman, 1980</xref>; <xref ref-type="bibr" rid="B114">Llewellyn-Smith et al., 2012</xref>). Through them, OT increased parasympathetic cardiac control and decreased sympathetic cardiac control by activating brainstem vagal neurons (<xref ref-type="bibr" rid="B137">Olszewski et al., 2010</xref>), resulting in the slowing down of the heart rate (<xref ref-type="bibr" rid="B64">Higa et al., 2002</xref>).</p>
<p>It is worth noting that acute MI could activate microglial P2X7R in the PVN that mediates sympatho-excitatory responses and the production of proinflammatory cytokines in rats. In addition, pro-inflammatory cytokines subsequently increased OT release (<xref ref-type="bibr" rid="B42">Du et al., 2015</xref>), thereby limiting the damaging effect of sympathetic outflows (<xref ref-type="bibr" rid="B132">Nielsen et al., 1997</xref>; <xref ref-type="bibr" rid="B166">Roy et al., 2018</xref>).</p>
</sec>
<sec>
<title>OT and Hypertension</title>
<p>Hypertension was one of the most significant risk factors for atherosclerosis and the development of CVD, and responsible for 54% of all strokes and 47% of ischemic cardiomyopathy (<xref ref-type="bibr" rid="B100">Lawes et al., 2008</xref>). In a cohort study on patients without baseline CVD, about 63% of those with baseline hypertension developed CVD while only 46% in those with normal baseline BP developed CVD (<xref ref-type="bibr" rid="B161">Rapsomaniki et al., 2014</xref>).</p>
<p>Oxytocin is deeply involved in body defense against hypertension. As reported, intrauterine growth restriction, caused by excessive glucocorticoid exposure to the fetus, produced hypertension later in life due to damages to OTR signaling (<xref ref-type="bibr" rid="B189">Vargas-Martinez et al., 2017</xref>). In hypertensive rats, a decreased expression of OT mRNA and protein was found in hypothalamus. This is consistent with an earlier finding that when OT was injected subcutaneously or intracerebroventricularly for 5 day, BP decreased in rats (<xref ref-type="bibr" rid="B144">Petersson and Uvnas-Moberg, 2008</xref>). Moreover, centrally released OT was also found to reduce the cardiovascular responses in BP and heart rate to the acute stressor significantly, which were reversed by OTR antagonist applied through brain ventricular system (<xref ref-type="bibr" rid="B208">Wsol et al., 2009</xref>).</p>
<p>The central anti-hypertensive effect of OT is mediated by PVN-brainstem-autonomic nervous system. It has been known for long that OT could reduce overall sympathetic activation of vessel contraction (<xref ref-type="bibr" rid="B137">Olszewski et al., 2010</xref>), and selectively dilate blood vessels that were innervated by parasympathetic nerves (<xref ref-type="bibr" rid="B132">Nielsen et al., 1997</xref>). Chronic activation of OT neurons restored the release of OT from PVN fibers in the dorsal motor nucleus of the vagus, and prevented the hypertension that occurred with 3 weeks of chronic intermittent hypoxia-hypercapnia exposure (<xref ref-type="bibr" rid="B79">Jameson et al., 2016</xref>). Thus, promoting OTergic drive from PVN to brainstem could improve autonomic control of the circulation to maintain stability of the BP.</p>
<p>Lastly, disorder of the immune system in the pathogenesis of hypertension has been firmly established by a large number of investigations (<xref ref-type="bibr" rid="B165">Rodriguez-Iturbe et al., 2017</xref>); hence, OT could also reduce hypertension through its immune homeostatic functions (<xref ref-type="bibr" rid="B196">Wang P. et al., 2015</xref>; <xref ref-type="bibr" rid="B200">Wang, 2016</xref>). Thus, OT can exert anti-hypertensive effects through multiple approaches.</p>
</sec>
<sec>
<title>Cardiovascular Protection Through Anti-stress Effects</title>
<p>Both positive and negative social stimuli can modify the activity of HPA axis and thus, affect body recovery from acute illnesses including stress, wounds, stroke, and cardiovascular complications (<xref ref-type="bibr" rid="B43">Dupont et al., 2014</xref>). OT can exert cardiovascular protection through its anti-stress effects. It has been demonstrated that Watanabe Heritable Hyperlipidemic rabbits exposed to a consistent, stable social experience in association with higher blood OT levels exhibited more affiliative social behavior and less aortic atherosclerosis (<xref ref-type="bibr" rid="B184">Szeto et al., 2013</xref>). Social stress promoted the progression of atherosclerosis in these rabbits in association with increased urinary norepinephrine, plasma cortisol and splenic weight as well as less affiliative behavior and more stressful physiological and tissue responses (<xref ref-type="bibr" rid="B135">Noller et al., 2013</xref>). In human being, OT was positively associated with diminished stress among securely attached participants and had an attenuating effect on perceived stress due to adverse life events in old age (<xref ref-type="bibr" rid="B46">Emeny et al., 2015</xref>). Moreover, in adult mice grouped into isolated or paired environment, social pairing enhanced hypothalamic OT gene expression and that was associated with smaller infarct size, and reduced neuroinflammation and oxidative stress following stroke. In contrast, administration of OT to socially isolated mice reproduced the neuroprotection conferred by social housing, and this effect was associated with the suppressive action of OT on microglia, a source of brain inflammatory cytokines (<xref ref-type="bibr" rid="B90">Karelina et al., 2011</xref>). By acting on many brain sites, OT could reduce stress-elicited neuroendocrine, autonomic, and behavioral responses (<xref ref-type="bibr" rid="B107">Li et al., 2017</xref>) wherein OT reduced stress-associated release of epinephrine (<xref ref-type="bibr" rid="B207">Wronska et al., 2017</xref>), which can reduce cardiac consumption of oxygen and thus endow OT the ability to oppose the injury from stress on the CVS.</p>
</sec>
<sec>
<title>Suppression of Smoking and Alcohol Craving</title>
<p>Healthy behaviors including moderate alcohol consumption, smoking abstinence, lack of abdominal adiposity, decreased sedentarism, and adherence to Alternate Mediterranean Dietary Index that is characterized by high intakes of fruit, vegetables, fish, and whole grains, moderate amounts of alcohol and dairy products, and low amounts of red or processed meats and sweets, could significantly reduce the presence of coronary artery calcium and plaques in femoral and carotid arteries; adoption of multiple healthy lifestyle behaviors early in life could be a key strategy in tackling the onset of atherosclerosis and reducing the burden of CVD (<xref ref-type="bibr" rid="B39">Dennis and Gerstman, 2014</xref>). However, cigarette smoking and alcoholism remain significant problems among population that is at high-risk for atherogenesis.</p>
<p>In a well-characterized, multi-ethnic United States cohort, it has been found that coronary artery calcium was predictive of atherosclerotic CVD in 6.7% of all smokers and in 14.2% of lung cancer screening eligible smokers (<xref ref-type="bibr" rid="B92">Kenkel et al., 2014</xref>). Cigarette smoking decreased OT secretion while worsening CAD (<xref ref-type="bibr" rid="B188">Vardavas and Panagiotakos, 2009</xref>). Smoking in men inhibited OT release by the mediation of endogenous opioids (<xref ref-type="bibr" rid="B172">Seckl et al., 1988</xref>) and GABA (<xref ref-type="bibr" rid="B26">Chiodera et al., 1993</xref>). In contrast, nasal application of OT significantly reduced levels of cue-induced smoking craving that often led to smoking relapse (<xref ref-type="bibr" rid="B123">Miller et al., 2016</xref>). In addition, OT could decrease withdrawal signs in rats and somatic component of the nicotine withdrawal syndrome (<xref ref-type="bibr" rid="B116">Manbeck et al., 2014</xref>). Thus, OT is helpful in reducing these detrimental behaviors.</p>
<p>Similar to the effect on smoking, OT can also inhibit craving for alcohol. The primary metabolite of alcohol, acetaldehyde, stimulated vascular smooth muscle cell Notch signaling and muscle growth, and mediated the ultimate effects of drinking on CVD (<xref ref-type="bibr" rid="B141">Patrick and Ames, 2014</xref>). Animal studies support OT as a potential treatment in reducing alcohol consumption. For example, intraperitoneal application of OT (3.0 mg/kg) significantly reduced alcohol (15%) consumption in the first-hour after treatment (<xref ref-type="bibr" rid="B177">Stevenson et al., 2017</xref>). Moreover, acute intracerebroventricular infusion of OT attenuated voluntary alcohol self-administration (20%) in male rats. Furthermore, intracerebroventricular application of OT completely blocked alcohol-induced dopamine release within the nucleus accumbens (<xref ref-type="bibr" rid="B143">Peters et al., 2017</xref>) that is a well-known nucleus of rewarding. Mechanistically, OT was considered to act by inhibiting the effects of the corticotropin-releasing factor on GABAergic interneurons in the amygdala and PVN, which suppressed the mechanisms of relapse and craving by reducing anxiety, stress vulnerability, and social withdrawal in abstinent alcohol-dependent patients (<xref ref-type="bibr" rid="B47">Faehrmann et al., 2018</xref>). By improving these life-styles, OT may also help to suppress the development of atherosclerotic CVD.</p>
</sec>
<sec>
<title>Protection From Brain-Heart Syndrome</title>
<p>Brain-heart syndrome is reversible acute heart diseases caused by acute encephalopathy involving the regulatory centers of the CVS. Many autonomic brain regions, including insula cortex, amygdala complex, anterior cingulate cortex, ventral medial prefrontal cortex, hypothalamus, and pineal gland are involved in the regulation of cardiovascular activity. At the cellular level, the disturbance of autonomic regulation resulted in catecholamine excitotoxicity, oxidative stress, and free radical myocardium injury (<xref ref-type="bibr" rid="B57">Gotovina et al., 2018</xref>). The damage of these structures leads to arrhythmia in previously intact myocardium, systolic and diastolic dysfunction, and ischemic changes. Although it does not cause CAD directly, it often occurs on the basis of atherosclerosis and worsens the CAD.</p>
<p>In association with the stress-relieving effect, OT could also alleviate brain-heart syndrome through its neuroprotective functions. As reported that in a rat model of transient middle cerebral artery occlusion, OT significantly reduced the infarct volume of the cerebral cortex and striatum (<xref ref-type="bibr" rid="B162">Reed et al., 2019</xref>). Moreover, intracerebroventricular infusion of OT and centrally released OT induced a preconditioning effect in I/R rat heart via brain receptors (<xref ref-type="bibr" rid="B125">Moghimian et al., 2013</xref>). Thus, while OT system dysfunction serves as one common mechanism underlying metabolic syndrome and psychotic disorders (<xref ref-type="bibr" rid="B156">Quintana et al., 2017</xref>), brain OT can exert cardiovascular protective effect by suppressing the brain-heart syndrome in cerebrovascular accidents.</p>
</sec>
</sec>
</sec>
<sec>
<title>Signaling Pathways Mediating the Cardiovascular Protective Effect of OT</title>
<p>Oxytocin is known to exert its biological functions through both OTR and VP receptors (<xref ref-type="bibr" rid="B176">Song and Albers, 2017</xref>). Although supraphysiological doses of OT could also activate VP receptors, OTR is the mediator of OT effects in terms of cardiovascular protection (<xref ref-type="bibr" rid="B210">Wsol et al., 2014</xref>). Understanding of the signaling pathway through OTR signaling is crucial in understanding of its cardiovascular protection and identifying novel targets of treatment.</p>
<sec>
<title>OTR and G Proteins</title>
<p>Oxytocin receptors are typical class I G protein-coupled receptors (GPCRs). The binding of OT to OTRs activates its primary downstream effector Gq protein via RVSSVKL segment in the COOH-terminal region of the third intracellular domain of OTR (<xref ref-type="bibr" rid="B227">Zhong et al., 2007</xref>); however, Gi/o family members can also mediate the cardioprotective effects of OT directly as stated below.</p>
<p>In general, the effect of OTR activation is mediated by phospholipase C (PLC)-β downstream to the α-subunit of both Gq and Gi/o proteins (<xref ref-type="bibr" rid="B17">Busnelli et al., 2013</xref>; <xref ref-type="bibr" rid="B89">Jurek and Neumann, 2018</xref>). In the early stage of cardiac injury, the activity of PLC-β1b was elevated selectively, which caused de-phosphorylation of phospholamban and depletion of the Ca<sup>2+</sup> stores in the sarcoplasmic reticulum (SR), leading to cytosolic Ca<sup>2+</sup> oscillation, mitochondrial Ca<sup>2+</sup>overload, and oxidative stress (<xref ref-type="bibr" rid="B1">Abdallah et al., 2011</xref>). Thus, it is not likely for OTR to activate PLC-β1 signaling to exert the cardioprotective function. Instead, PLC-β3 could be a mediator of OTR signaling (<xref ref-type="bibr" rid="B222">Yue and Sanborn, 2001</xref>). The differential effects of downstream signals to OTR are in agreement with the findings that biological effects of OT depended on OTR localization in caveolin-1 enriched domains (<xref ref-type="bibr" rid="B164">Rimoldi et al., 2003</xref>) and that angiotensin and OT respectively caused injury and protective effects by activating different signaling pathways downstream to their corresponding Gq proteins (<xref ref-type="bibr" rid="B131">Natochin et al., 2018</xref>).</p>
<p>The activation of OTRs can also protect cardiomyocytes through Gβγ subunits of OTR-coupled G proteins and the crosstalk between this GPCR and receptor tyrosine kinase signaling pathways, which has been identified in myometrial cells (<xref ref-type="bibr" rid="B228">Zhong et al., 2003</xref>) and HEK293 cells (<xref ref-type="bibr" rid="B164">Rimoldi et al., 2003</xref>) wherein Gβγ subunits could increase phosphorylation of extracellular signal-regulated protein kinase (ERK) 1/2, the critical component of cardioprotective reperfusion injury salvage kinase (RISK) pathway (<xref ref-type="bibr" rid="B150">Polshekan et al., 2016</xref>). The RISK pathway involves phosphatidylinositol 3-kinase (PI3K)-protein kinase B (Akt)-eNOS cascades and ERK 1/2. In addition, AMP-activated protein kinase (AMPK), Ca<sup>2+</sup>/calmodulin-dependent protein kinase (CaMK) signaling and others are also implicated, disruption of which has been implicated in immunometabolic dysregulation-associated pathogenesis of cardiac arrhythmias as recently reviewed (<xref ref-type="bibr" rid="B194">Wang S.C. et al., 2018</xref>). The activation of OTR-Gq and Gi/o proteins could regulate these and other signaling pathways to suppress immunometabolic dysregulation-associated CAD.</p>
<p>Between the signaling events downstream to α-subunit and Gβγ subunits of OTR-coupled G proteins, there is also crosstalk. Indeed, the activation of PLC could be generated by the βγ complexes released by Gαi of the OTR/Gi coupled receptor and by transactivating tyrosine kinase receptor EGFR via MAPK cascade (<xref ref-type="bibr" rid="B164">Rimoldi et al., 2003</xref>).</p>
<p>It is important to note that there are rapid and extensive internalization and desensitization of the OTR upon agonist exposure, which is determined by several signaling molecules in a cascade. For example, stable OTR/beta-arrestin2 interaction played an important role in determining the rate of recycling of human OTRs; OTRs were localized in vesicles containing Rab5 and Rab4 small GTPases, the markers for direct receptor recycling without decomposition (<xref ref-type="bibr" rid="B31">Conti et al., 2009</xref>). In human embryonic kidney cells, OTR internalization was unaffected by inhibitors of protein kinase C (PKC) or CaMK-II but was significantly reduced after transfection with dominant-negative mutant cDNAs of GPCR kinase (GRK)2, β-arrestin 2, dynamin, and Eps15 (a component of clathrin-coated pits) (<xref ref-type="bibr" rid="B140">Patel and Radeos, 2018</xref>); GRK-evoked OTR phosphorylation was a prerequisite for β-arrestin-mediated internalization and OTR desensitization (<xref ref-type="bibr" rid="B193">Wang C. et al., 2018</xref>). In uterus, knockdown of GRK6 largely prevented OT-induced OTR desensitization; in contrast, selective depletion of GRKs 2, 3, or 5 was without effect (<xref ref-type="bibr" rid="B40">Denson et al., 2018</xref>; <xref ref-type="bibr" rid="B113">Liu et al., 2018</xref>). This signaling feature highlights a potentially beneficial effect of using intermittent OT application pattern in treating CVDs, the power of which has been well-discussed about studies on the milk-letdown reflex (<xref ref-type="bibr" rid="B63">Hatton and Wang, 2008</xref>; <xref ref-type="bibr" rid="B66">Hou et al., 2016</xref>).</p>
</sec>
<sec>
<title>PI3K/Akt Cascades</title>
<p>Disruption of PI3K/Akt cascade is a major pathological event for CAD occurrence, which has been observed in smoking interference of the cardioprotective signaling by post-conditioning (<xref ref-type="bibr" rid="B60">Guasch and Gilsanz, 2016</xref>) and many other etiologies as recently reviewed (<xref ref-type="bibr" rid="B194">Wang S.C. et al., 2018</xref>). The protective effect of this pathway is supported by the findings of myocardial protection through hydrogen sulfate (H<sub>2</sub>S) (<xref ref-type="bibr" rid="B87">Jin et al., 2017</xref>), isoflurane-induced myocardial post-conditioning under acute hyperglycemia (<xref ref-type="bibr" rid="B160">Raphael et al., 2015</xref>), the protection of the heart against I/R injury by limb remote ischemia preconditioning through the opioid system (<xref ref-type="bibr" rid="B226">Zhang et al., 2017</xref>), post-reperfusion administration of granulocyte colony-stimulating factor (<xref ref-type="bibr" rid="B178">Sumi et al., 2010</xref>) and others (<xref ref-type="bibr" rid="B229">Zhou et al., 2015</xref>; <xref ref-type="bibr" rid="B223">Zafirovic et al., 2017</xref>). The protective effect of this pathway is likely associated with its critical roles in cellular proliferation, migration, and protection against apoptotic and cytotoxic effects due to hypoxia (<xref ref-type="bibr" rid="B194">Wang S.C. et al., 2018</xref>). Consistently, PI3K/Akt cascade is also implicated in the cardioprotective effect of OT. For example, activating PI3K/Akt signaling was responsible for the post-conditioning and the anti-apoptotic effect of OT (<xref ref-type="bibr" rid="B55">Gonzalez-Reyes et al., 2015</xref>) whereas, PI3K/Akt inhibitors and OTR blocker atosiban blocked the protective effect in rats (<xref ref-type="bibr" rid="B150">Polshekan et al., 2016</xref>).</p>
<p>Oxytocin activation of PI3K/Akt signaling could be achieved through a crosstalk between Gq protein and epidermal growth factor receptor (<xref ref-type="bibr" rid="B228">Zhong et al., 2003</xref>) that is an upstream signal of PI3K/Akt as demonstrated in the action of protease-activated receptor 2 (<xref ref-type="bibr" rid="B197">Wang and DeFea, 2006</xref>; <xref ref-type="bibr" rid="B198">Wang et al., 2010</xref>). In OTR signaling, PI3K/Akt signaling-mediated protection is achieved through eNOS that subsequently activates mitochondrial ATP-dependent potassium (mKATP) channels (<xref ref-type="bibr" rid="B36">Das and Sarkar, 2012</xref>) to reduce mitochondrial oxidative stress (MOS) as discussed in previous review in detail (<xref ref-type="bibr" rid="B194">Wang S.C. et al., 2018</xref>).</p>
<p>Between NO and mKATP channels, the involvement of NO-soluble guanylyl cyclase has been found in OT-evoked differentiation of porcine bone marrow stem cells into cardiomyocytes and cell proliferation (<xref ref-type="bibr" rid="B217">Ybarra et al., 2011</xref>). In cells treated with OT, activated Akt and eNOS were translocated into the nuclear and perinuclear area to protect heart from I/R injury, which was abrogated by inhibition of OTR signaling, PI3K, cGMP-dependent protein kinase as well as soluble guanylate cyclase (<xref ref-type="bibr" rid="B55">Gonzalez-Reyes et al., 2015</xref>). Downstream to the eNOS-cGMP-dependent protein kinase is the mKATP channels, inhibition of which is a pivotal mechanism in immunometabolic disorder-evoked CVDs (<xref ref-type="bibr" rid="B194">Wang S.C. et al., 2018</xref>). In addition, cyclic AMP response element-binding protein (CREB) signaling could also be a mediator of PI3K/Akt signaling, which has been shown in the nervous system (<xref ref-type="bibr" rid="B34">Da Silva et al., 2013</xref>).</p>
</sec>
<sec>
<title>ERK 1/2 Pathway</title>
<p>Following the activation of OTRs, the release of Gβγ subunits from OTR-associated Gq protein can activate ERK 1/2 as shown in myometrial cells (<xref ref-type="bibr" rid="B228">Zhong et al., 2003</xref>) and in OT neurons (<xref ref-type="bibr" rid="B202">Wang and Hatton, 2007a</xref>,<xref ref-type="bibr" rid="B203">b</xref>). As a major component of the RISK pathway, ERK 1/2 signaling is also implicated in OT-mediated cardiovascular protection. For example, the cardioprotective effect of OT post-conditioning on isolated ischemic rat heart depended on the activation of ERK1/2 signaling (<xref ref-type="bibr" rid="B55">Gonzalez-Reyes et al., 2015</xref>) since that was blocked by ERK1/2 inhibitors and atosiban (<xref ref-type="bibr" rid="B150">Polshekan et al., 2016</xref>).</p>
<p>Studies further revealed that the protective effect of ERK1/2 signaling is mediated through CREB signaling. Reduced expression of genes regulated by the transcription factor CREB is linked to atrial fibrillation susceptibility in patients, which has been verified in transgenic mouse model recently (<xref ref-type="bibr" rid="B173">Seidl et al., 2017</xref>). CREB is responsible for the expression of potassium channel Kv1.5 that was impaired in diet-induced obese in mice (<xref ref-type="bibr" rid="B68">Huang et al., 2013</xref>). Thus, this signaling cascade is critical in pathophysiology of atrial fibrillation, ventricular ectopy, insulin secretion, hypoxic pulmonary vasoconstriction and sudden cardiac death. Moreover, CREB is also associated with peroxisome proliferator-activated receptor signaling known to regulate lipid metabolism and insulin sensitivity, integrity of sarcomeres and mitochondria, and the deposition of collagen and glycogen in the heart (<xref ref-type="bibr" rid="B173">Seidl et al., 2017</xref>). In addition, GRK2 may participate in OT regulation of CVS activity although the expression level of GRK2 was dependent on the tissues and their functional status (<xref ref-type="bibr" rid="B126">Montgomery et al., 2018</xref>). Importantly, high fat-diet caused marked intracellular lipid accumulation and significantly increased cardiac GRK2 levels in mice, which promoted obesity-induced cardiac remodeling and steatosis. In contrast, low GRK2 protein levels were able to keep the PKA/CREB pathway active and prevented a high fat diet-induced down-regulation of key fatty acid metabolism modulators such as peroxisome proliferator-activated receptor gamma co-activators, thus preserving the expression of cardioprotective proteins such as mitochondrial fusion markers mitofusin (<xref ref-type="bibr" rid="B118">Marir et al., 2013</xref>).</p>
<p>Mitofusin was known as an inhibitor of mitochondrial membrane depolarization and ROS production by acting on the mitochondria-associated ER membrane (MAM) to inhibit mitochondrial Ca<sup>2+</sup> overloading, a function opposite to glycogen synthase kinase-3β (GSK-3β) (<xref ref-type="bibr" rid="B81">Jankowski et al., 2010b</xref>). Thus, by activating CREB signaling, OT-activated ERK 1/2 can suppress ER stress response (<xref ref-type="bibr" rid="B204">Watanabe et al., 2016</xref>) and the associated MOS (<xref ref-type="bibr" rid="B194">Wang S.C. et al., 2018</xref>), thereby exerting cardiovascular protective effects. Interestingly, the protective effect of CREB signaling might not work in low potassium diet since elevated autophagy and CREB signaling were found to promote calcification of arteries from low potassium diet-fed mice as well as aortic arteries exposed to low potassium <italic>ex vivo</italic> (<xref ref-type="bibr" rid="B16">Brown et al., 2013</xref>).</p>
</sec>
<sec>
<title>CaMK Signaling</title>
<p>Another important signaling molecule in OT protective effect is CaMK-II. CaMK II is important for Ca<sup>2+</sup> homeostasis of cardiomyocytes. In infarcted heart, cardiac SR Ca<sup>2+</sup> uptake and release activities were depressed significantly due to a decrease in SR CaMK-II phosphorylation of the SR proteins, ryanodine receptor, Ca<sup>2+</sup> pump ATPase/ER Ca<sup>2+</sup> ATPase, and phospholamban (<xref ref-type="bibr" rid="B8">Araujo et al., 2013</xref>), leading to ER stress and MOS. Thus, CaMK could be an important mediator of the cardiovascular protection of OT.</p>
<p>Following the activation of OTRs, mobilization of Gαq or Gβγ caused intracellular Ca<sup>2+</sup> release and subsequent activation of CaMK-II (<xref ref-type="bibr" rid="B222">Yue and Sanborn, 2001</xref>), likely mediated by PLC-β3 signaling pathway. The intracellular Ca<sup>2+</sup> could also come from other sources. For instance, L-type Ca<sup>2+</sup> channels, IP3-RyR-gated, and store-operated Ca<sup>2+</sup> channels including transient receptor potential channel pathways played significant roles in OT-induced contractions of myometrium of buffaloes (<xref ref-type="bibr" rid="B15">Borrow et al., 2018</xref>). CaMK-II can further phosphorylate PLC-β3 but not PLC-β1 (<xref ref-type="bibr" rid="B222">Yue and Sanborn, 2001</xref>) that was a known as a deteriorating signal in heart (<xref ref-type="bibr" rid="B1">Abdallah et al., 2011</xref>). The activation of CaMK-II was associated with OT-elicited activation of AMPK (<xref ref-type="bibr" rid="B101">Lee et al., 2008</xref>), release of ANP (<xref ref-type="bibr" rid="B62">Gutkowska et al., 2014</xref>) and NO (<xref ref-type="bibr" rid="B101">Lee et al., 2008</xref>; <xref ref-type="bibr" rid="B120">Menaouar et al., 2014</xref>), and they are all known to play important roles in OT protection of CVS.</p>
<p>It has been demonstrated that OT could antagonize endothelin-1 or angiotensin II-evoked cardiomyocyte hypertrophy though ANP and NO release in the developing rat heart, which was mediated by CaMK-II and AMPK pathways and by normalization of the reduced Akt phosphorylation (<xref ref-type="bibr" rid="B120">Menaouar et al., 2014</xref>). Moreover, CaMK II was involved in NO-elicited relaxation of endothelium-intact rat aortic rings as a result of Ca<sup>2+</sup>-dependent activation of eNOS in cultured porcine aortic endothelial cells (<xref ref-type="bibr" rid="B5">Alizadeh and Mirzabeglo, 2013</xref>). Thus, CaMK signaling is an important approach for OT protection of arteries.</p>
</sec>
<sec>
<title>AMPK Pathway</title>
<p>In parallel with the RISK pathway, AMPK signaling pathway is also involved in OT function in anti-inflammation and promotion of metabolic homeostasis (<xref ref-type="bibr" rid="B117">Mancini et al., 2017</xref>) through multiple approaches. As reported that OT stimulated and activated AMPK in C2C12 myoblast cells in a time/dose-dependent manner. This process also depends on the activation of CaMK since it was blocked by inhibition of either CaMK or AMPK (<xref ref-type="bibr" rid="B101">Lee et al., 2008</xref>). In db/db mice, OT treatment normalized cardiac structure and function, cardiac OTRs, ANP, and AMPK while reducing body fat accumulation, fasting blood glucose levels and improving glucose tolerance and insulin sensitivity (<xref ref-type="bibr" rid="B148">Plante et al., 2015</xref>). Moreover, AMPK could inhibit HMG-CoA reductase to reduce cholesterol synthesis and inflammation (<xref ref-type="bibr" rid="B192">Vilahur et al., 2014</xref>). Thus, inhibition of multiple pro-inflammatory signaling pathways and metabolic disorders by AMPK should be an important mechanism of the cardiovascular protective functions by OT.</p>
</sec>
<sec>
<title>Other Signals</title>
<p>Oxytocin protection of the CVS was associated with its activation of PKC (<xref ref-type="bibr" rid="B48">Faghihi et al., 2012</xref>), likely PKC-ε signaling in the mitochondria. In cardioprotection, PKC-ε, a downstream effector of PLC-β and NO generated by eNOS, increased the stability of gap junctions and suppressed ventricular fibrillation by antioxidant-increased connexin-43 in rats (<xref ref-type="bibr" rid="B10">Bacova et al., 2017</xref>; <xref ref-type="bibr" rid="B102">Lee et al., 2017</xref>). In contrast, activation of PKC-α, a downstream event of PLC-β1b that is a heart-specific signaling, led to cardiac injury by increasing inducible NOS (iNOS) expression, concomitant to enhanced apoptotic cell percentage, and molecular interaction between apoptotic protease activating factor-1 and cytochrome C (<xref ref-type="bibr" rid="B154">Qiu et al., 2012</xref>). These findings indicate that PLC-β1b-PKC-α-iNOS signaling pathway activates mitochondrial apoptotic pathways while PKC-ε is protective. In contrast to the effect of OT, norepinephrine, angiotensin II, and endothelin 1 and phorbol ester could activate and translocate protein kinase D1 to the Z-disks in rat cardiomyocytes in a PKC-ε-dependent manner, which process was essential to induce hypertrophic responses (<xref ref-type="bibr" rid="B75">Iwata et al., 2005</xref>). Thus, protein kinase D1 and PKC-ε interaction may also induce cardiac hypertrophy. Moreover, ERK1/2 activation by metabotropic glutamate receptor 1 induced melanoma development and was also PKC-ε-dependent, but cAMP and PKA-independent. Thus, the proliferating effect of PKC-ε downstream to OTRs either functions during regeneration of injured cardiomyocytes or is linked to different signaling events from those that are used by the GPCRs of “stress hormones.” Nevertheless, experimental evidence remains to be collected.</p>
<p>In parallel with NO, H<sub>2</sub>S is also a well-known cardioprotective gaseous signal (<xref ref-type="bibr" rid="B160">Raphael et al., 2015</xref>; <xref ref-type="bibr" rid="B87">Jin et al., 2017</xref>). H<sub>2</sub>S is mainly converted from cysteine catalyzed by cystathionine-γ-lyase (CSE) that was present in OTR-expressing supraoptic neurons (<xref ref-type="bibr" rid="B30">Coletti et al., 2019</xref>) and could be activated by CaMK, PI3K and NO. H<sub>2</sub>S could also suppress inflammation by activating KATP channel, PI3K, and pERK1/2 signaling (<xref ref-type="bibr" rid="B220">You et al., 2017</xref>). Importantly, CSE can regulate OTR expression in tissue- and function-dependent manner. In isolated human uterine smooth muscle cells, CSE had negative correlation with the expression of OTR in pregnant myometrial tissues (<xref ref-type="bibr" rid="B220">You et al., 2017</xref>). By contrast, myocardial injury evoked by contusion of the thorax in mice was found to reduce myocardial OTR expression, and that was aggravated in CSE(-/-) mice; exogenous H<sub>2</sub>S administration restored myocardial OTR protein expression to wild-type levels (<xref ref-type="bibr" rid="B122">Merz et al., 2018</xref>). This study suggests that cardiac CSE can exert cardioprotective function by activating RISK pathway and up-regulating cardiac OTR expression.</p>
<p>In addition, OT-evoked protection was also related to increases in VEGF, B-cell lymphoma 2 and matrix metalloproteinase-1 (<xref ref-type="bibr" rid="B98">Kobayashi et al., 2009</xref>) along with aforementioned signals that opened mKATP channels (<xref ref-type="bibr" rid="B4">Alizadeh et al., 2010</xref>). Among them, serum levels of VEGF had negative association with atrial fibrillation episode duration (<xref ref-type="bibr" rid="B142">Peller et al., 2017</xref>) and exerted antifibrotic and angiogenic effects, which were associated with the activation of matrix metalloproteinase-1 and eNOS (<xref ref-type="bibr" rid="B98">Kobayashi et al., 2009</xref>).</p>
</sec>
<sec>
<title>Signaling Network</title>
<p>In cardiovascular protection, different signaling pathways function interactively and coordinately to suppress immunometabolic disorders. For instance, exercise in mice reduced infarct size by 60% while increasing phosphorylation of Akt, ERK1/2, and AMPK; however, the level of corresponding phosphatases PTEN, MKP-3, and PP2C were decreased in both wild-type and obese mice (<xref ref-type="bibr" rid="B35">Danalache et al., 2014</xref>). Moreover, different signaling pathways have close interactions as shown in the following studies. In vascular endothelial cells in mice (<xref ref-type="bibr" rid="B25">Chen et al., 2009</xref>) and human umbilical vein endothelial cells (<xref ref-type="bibr" rid="B69">Huang et al., 2017</xref>), AMPK served as an upstream enzyme of the Akt-NO pathway. These signals are known to activate mKATP channels via activation of eNOS-NO-protein kinase G pathway and CREB, thereby protecting the CVS from the damaging effect of ER stress and MOS as previously discussed (<xref ref-type="bibr" rid="B194">Wang S.C. et al., 2018</xref>). Another example is that H<sub>2</sub>S-evoked activation of ERK 1/2 PI3K depended on mKATP channel activation (<xref ref-type="bibr" rid="B220">You et al., 2017</xref>).</p>
<p>Together with other evidence, such as the mediation of statin protection by the phosphorylated Akt, GSK-3β (inhibition), and CREB and the functions of OT at other tissues (<xref ref-type="bibr" rid="B95">Klein et al., 2014</xref>; <xref ref-type="bibr" rid="B204">Watanabe et al., 2016</xref>), we propose the presence of an OTR signaling network that protects the CVS from atherosclerotic injury and CAD (<xref ref-type="fig" rid="F2">Figure 2</xref>).</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Signaling pathway mediating cardiovascular protection of OT. Activation of OTR-Gq and Gi/o proteins can directly increase Gqα subunit and Gβγ subunit signaling. These signals can cross-activate EGFR while activating their downstream signaling molecules, resulting in the activation of CaMK-AMPK, PKC-ε, PI3K/Akt-eNOS, H<sub>2</sub>S, and ERK1/2-CREB signaling cascades. These signaling cascades lead to the activation of a variety of cardioprotective functions including electrical stability, metabolic arrangement, inhibition of inflammation or oxidative stress, and others. AF, atrial fibrillation; Akt, protein kinase B; AMPK, AMP-activated protein kinase; Ang, angiotensin; CaMK, Ca<sup>2+</sup>/calmodulin-dependent protein kinase; CREB, cyclic AMP response element-binding protein; CSE, cystathionine-γ-lyase; Cx-43, connexin-43; EGFR, epidermal growth factor receptor; eNOS, endothelial nitric oxide synthase; ER, endoplasmic reticulum; ERK1/2, extracellular signal-regulated protein kinase 1/2; ET-1, endothelin-1; GRK, G protein-coupled receptor kinase; HMG-CoA reductase, 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase; HPV, hypoxic pulmonary vasoconstriction; H<sub>2</sub>S, hydrogen sulfate; Kv1.5, voltage-gated potassium channel Kv1.5; MFN-2, mitofusin-2; mKATP C, mitochondrial ATP-dependent potassium channels; MOS, mitochondrial oxidative stress; PI3K, phosphatidylinositol 3-kinases; PKC, protein kinase C; PKG, protein kinase G; PLC-β3, phospholipase C-β3; PPAR, peroxisome proliferator-activated receptor; SR, sarcoplasmic reticulum; TCA cycle, tricarboxylic acid cycle; VSM, vascular smooth muscle; VE, ventricular ectopy. Other annotations refer to <xref ref-type="fig" rid="F1">Figure 1</xref>.</p>
</caption>
<graphic xlink:href="fnins-13-00454-g002"></graphic>
</fig>
</sec>
</sec>
<sec>
<title>Protection by Alleviating ER Stress and MOS</title>
<p>Coronary atherosclerosis and CAD are largely caused by immunometabolic disorders and the resultant ER stress and MOS (<xref ref-type="bibr" rid="B194">Wang S.C. et al., 2018</xref>). In agreement with the common machinery of immunometabolic regulation, the cardioprotective effect of OT is also dependent on its suppression of immunometabolic disorders involving “ER-mitochondrial syncytium.”</p>
<sec>
<title>Reducing ER Stress</title>
<p>The ER is an essential organelle for protein synthesis, folding, translocation, calcium homoeostasis, and lipid biosynthesis. Stimuli that disrupt ER homoeostasis and functions can cause the accumulation of misfolded and unfolded proteins that disrupt ER membrane structure and functions. As an adaptive strategy to restore ER homoeostasis, an unfolded protein response (UPR) occurs following ER stress through activating transcriptional and translational pathways. Maladapted ER stress could worsen ER functions, trigger inflammatory reaction and damage membrane structure, leading to cell dysfunction and apoptosis (<xref ref-type="bibr" rid="B199">Wang et al., 2017</xref>). In the CVS, ER stress causes the development and progression of various CVDs. Suppression of ER stress has been shown to promote angiogenesis (<xref ref-type="bibr" rid="B149">Pohl et al., 2018</xref>), reduce cardiomyocyte apoptosis, improve heart function in diabetic rats (<xref ref-type="bibr" rid="B158">Rabow et al., 2018</xref>) and decrease cell death in ER stress models of cultured neonatal rat cardiomyocytes and in acute MI in mice (<xref ref-type="bibr" rid="B41">Ding et al., 2019</xref>). In OT-elicited cardiovascular protection, suppression of ER stress is also an important mechanism.</p>
<p>It has been reported that OT in the colostrum attenuated the impact of inflammation on postnatal gut villi and enhanced autophagy to protect against amino acid insufficiency-induced ER stress during the interval between birth and the first feeding (<xref ref-type="bibr" rid="B96">Klein et al., 2017</xref>). OT reduced ER stress by reducing the burden of protein synthesis and processes in the ER through rapamycin complex 1 (mTORC1) signaling that was up-regulated in CVDs (<xref ref-type="bibr" rid="B216">Yano et al., 2016</xref>). In gut cells, OT was found to downregulate anabolic effects induced by fresh growth medium catalyzed by mTORC1 through regulation of PI3K/Akt/mTORC1 pathway, which has been identified in mice with malignant arrhythmias, heart failure, and premature death (<xref ref-type="bibr" rid="B20">Cao et al., 2013</xref>). Consistently, through activating inositol requiring enzyme (IRE), OT increased the UPR and a chaperone protein, immunoglobulin binding protein while decreased translation initiation factors (<xref ref-type="bibr" rid="B96">Klein et al., 2017</xref>). Through this chaperone approach, OT could inhibit lipopolysaccharide-evoked ER stress (<xref ref-type="bibr" rid="B96">Klein et al., 2017</xref>). Mechanistic studies revealed that the enhancement of IRE1α (IRE1α)/X box-binding protein-1 (XBP1) activity in turn increased ER-associated degradation-mediated clearance of misfolded proteins and autophagy (<xref ref-type="bibr" rid="B41">Ding et al., 2019</xref>). Another line of evidence showed that following the activation of OTRs, IRE1α activation was mediated by OT-elicited VEGF release, which together with sliced XBP1 could carry out the protective functions of OT in a PI3K/Akt/GSK-3β/β-catenin/E2F2-dependent manner (<xref ref-type="bibr" rid="B149">Pohl et al., 2018</xref>). Thus, OT can reduce translation of proteins, increase their export and clearance of misfolded proteins during ER stress and thus protect cardiomyocytes from injuries of immunometabolic stress.</p>
</sec>
<sec>
<title>Inhibition of the MOS</title>
<p>The mKATP channel is a key carrier in the cardioprotective effect of OT and a downstream signal in the RISK pathway (<xref ref-type="bibr" rid="B160">Raphael et al., 2015</xref>; <xref ref-type="bibr" rid="B87">Jin et al., 2017</xref>; <xref ref-type="bibr" rid="B220">You et al., 2017</xref>) and AMPK signaling (<xref ref-type="bibr" rid="B25">Chen et al., 2009</xref>; <xref ref-type="bibr" rid="B69">Huang et al., 2017</xref>). In OT-stimulated cells, activated Akt accumulated intracellularly close to mitochondria in mesenchymal stem cells that have therapeutic potential in I/R heart, and allowed NO-dependent activation of protein kinase G to open mKATP channels (<xref ref-type="bibr" rid="B48">Faghihi et al., 2012</xref>). Moreover, OT could activate mKATP channels in the heart of anesthetized rats that were subject to I/R injury and thus significantly decreased infarct size, creatine kinase-MB isoenzyme plasma level, severity and incidence of ventricular arrhythmia. These effects were blocked by atosiban (<xref ref-type="bibr" rid="B4">Alizadeh et al., 2010</xref>). These findings are consistent with the cardioprotective effect of activating mKATP channels under other conditions (<xref ref-type="bibr" rid="B36">Das and Sarkar, 2012</xref>).</p>
<p>What needs to be note is that the protective effect of OT in mitochondria is achieved in an “oxidative preconditioning” manner. In a simulated I/R experiment using heart-derived H9c2 cells, OT was shown to trigger a short-lived burst in ROS production but reduced I/R-evoked remarkable ROS production (<xref ref-type="bibr" rid="B55">Gonzalez-Reyes et al., 2015</xref>). This “oxidative preconditioning” blocks I/R-evoked MOS, thereby exerting the protective effect. By suppressing the MOS, OT also restores tricarboxylic acid cycle and normal ATP production that are critical in cardiac protection (<xref ref-type="bibr" rid="B194">Wang S.C. et al., 2018</xref>).</p>
</sec>
<sec>
<title>OT Suppression of Ca<sup>2+</sup> Overload Through SR/ER-Mitochondrial Network</title>
<p>It is of interest to note that ER stress and MOS do not occur independently in CAD-associated immunometabolic disorders. The two organelles are interconnected through MAM in the heart, which was responsible for Ca<sup>2+</sup> signaling between ER and mitochondria following the activation of inositol 1,4,5-trisphosphate receptor (IP<sub>3</sub>R) (<xref ref-type="bibr" rid="B211">Wu et al., 2017</xref>), thereby forming an ER-mitochondrial channel.</p>
<p>This Ca<sup>2+</sup> signaling in the heart is regulated by GSK-3β protein in the ER. Dephosphorylation/activation of GSK-3β occurs following the activation of JNK which could be induced by advanced glycation end-products in diverse pathological settings including diabetes, inflammation and acute I/R injury in the heart (<xref ref-type="bibr" rid="B194">Wang S.C. et al., 2018</xref>). During I/R, increased GSK-3β activity leads to enhanced transfer of Ca<sup>2+</sup> from ER to mitochondria by interacting with the IP<sub>3</sub>R Ca<sup>2+</sup> channeling complex in MAM, leading to cytosolic and mitochondrial Ca<sup>2+</sup> overload and the resultant cell death. Inhibition of GSK-3β reduced both IP<sub>3</sub>R phosphorylation and ER Ca<sup>2+</sup> release, which consequently diminished both cytosolic and mitochondrial Ca<sup>2+</sup>concentrations as well as mitochondrial sensitivity to apoptosis (<xref ref-type="bibr" rid="B54">Gomez et al., 2016</xref>). Activation of the mKATP channels reversely induced inhibitory phosphorylation of GSK-3β and suppressed substantial ROS production, lactate dehydrogenase release and apoptosis after antimycin washout (<xref ref-type="bibr" rid="B180">Sunaga et al., 2014</xref>). Another key molecule regulating the interaction between mitochondria and ER is mitofusin-2. Mitofusin-2 has been identified to suppress the interaction between the ER and mitochondrial apoptotic pathway (<xref ref-type="bibr" rid="B59">Guan et al., 2016</xref>; <xref ref-type="bibr" rid="B213">Yang F. et al., 2017</xref>), a function opposite to GSK-β.</p>
<p>In addition to the ER, SR is also an important source of mitochondrial Ca<sup>2+</sup> overload in myocardiac pathogenesis. Ca<sup>2+</sup> transient from SR could also contribute to the MOS. For example, fructose-rich diet induced decrease in SR-mitochondrial distance, SR Ca<sup>2+</sup> leak, and Ca<sup>2+</sup> transit between the two organelles, which resulted in mitochondrial membrane depolarization and oxidative stress, thereby activating the apoptotic pathway and diabetic heart injury (<xref ref-type="bibr" rid="B49">Federico et al., 2017</xref>).</p>
<p>Oxytocin could protect the heart by blocking the activity of malfunctioned ER-mitochondrial syncytium through the following approaches. (1) OT can increase cardiac expression of connexin 43 (<xref ref-type="bibr" rid="B53">Gassanov et al., 2008</xref>; <xref ref-type="bibr" rid="B93">Kim et al., 2012</xref>), which was known to inhibit GSK-3β signaling in cardiomyocytes (<xref ref-type="bibr" rid="B74">Ishikawa et al., 2012</xref>). (2) OT can activate PI3K/Akt pathway (<xref ref-type="bibr" rid="B55">Gonzalez-Reyes et al., 2015</xref>) that is known to exert antiapoptosis in association with upregulation of mitofusin 2 (<xref ref-type="bibr" rid="B225">Zhang et al., 2014</xref>). (3) By activating AMPK, OT can decrease the Ca<sup>2+</sup> oscillation through increasing mitofusin 2 expression (<xref ref-type="bibr" rid="B195">Wang F. et al., 2015</xref>) and suppressing GSK-3β by activation of insulin receptor (<xref ref-type="bibr" rid="B28">Chopra et al., 2012</xref>) that was known to increase mitofusin 2 and decrease GSK-3β (<xref ref-type="bibr" rid="B112">Litwiniuk et al., 2016</xref>). This possibility is supported by the fact that OT stimulated PKC activity in adipocyte plasma membranes, an effect similar to that of insulin (<xref ref-type="bibr" rid="B44">Egan et al., 1990</xref>); however, direct evidence remains to be collected. <xref ref-type="fig" rid="F3">Figure 3</xref> presents a working model of OT suppression of the malfunctioned ER-mitochondrial communication.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Working model of OT suppression of the malfunctioned ER-mitochondrial communication. OTR activation can inhibit inflammation, ER stress, restore UPR and chaperone functions, reduce the production of cholesterol and VLDL, inhibit ER-mitochondrial Ca<sup>2+</sup> oscillation and overload through MAM, precondition MOS, restore TCA cycle, and suppress inflammatory and apoptotic pathways, leading to regeneration and repair of injured cardiomyocytes. These processes are signaling through activating AMPK, pERK1/2, PI3K/Akt, VEGF, and CX43 while inhibiting mTORC1, HMG-CoA reductase, GSK-3β, and calcium oscillation. As a result, lipotoxicity and formation of atherosclerosis are inhibited. GSK-3β, glycogen synthase kinase-3β; IRE1α, inositol-requiring enzyme 1α; pERK1/2, extracellular signal-regulated protein kinase 1/2; MAM, mitochondria-associated ER membrane; ROS, reactive oxygen species; mTORC1, rapamycin complex 1; UPR, unfolded protein response; VEGF, vascular endothelial growth factor; VLDL, low-density lipoproteins; XBP1, X box-binding protein-1. Other annotations refer to <xref ref-type="fig" rid="F2">Figure 2</xref>.</p>
</caption>
<graphic xlink:href="fnins-13-00454-g003"></graphic>
</fig>
</sec>
</sec>
<sec>
<title>Limitation for Therapeutic Use of OT</title>
<p>Oxytocin was generally considered a safe agent in clinical usage (<xref ref-type="bibr" rid="B3">Alfirevic et al., 2016</xref>). A daily treatment with 40 IU intranasal OT for 4 months did not impact on OT and VP plasma levels nor on cardiovascular, body fluids and food intake parameters in healthy humans (<xref ref-type="bibr" rid="B18">Busnelli et al., 2015</xref>). Similarly, intranasal OT strengthened the bonding between male resident and its female partner in rats without changing cardiovascular activity (<xref ref-type="bibr" rid="B19">Calcagnoli et al., 2015</xref>). Moreover, OT has the beneficial effects of insulin, antioxidants, and corticosteroids but not their side effects (<xref ref-type="bibr" rid="B66">Hou et al., 2016</xref>). Thus, its clinical trial is tempting.</p>
<p>It is important to note that some animal studies administer supraphysiological levels of OT (e.g., micromolar concentrations rather than picomolar levels) and at that dosage, OT has affinity for VP receptors and VP-like effect, such as pressor effect of OT at its initial actions (<xref ref-type="bibr" rid="B145">Petty et al., 1985</xref>). Moreover, cardiovascular side effects and allergy to OT have been found in gynecological practice although quite rare. Thus, it is necessary to address these negative sides in clinical trials of OT in prevention and treatment of the CVD.</p>
<sec>
<title>Exogenous OT Application</title>
<p>Since chronic CVDs are associated with declines in OT/OTR signaling, restoring OTR signaling with OT becomes a natural selection. To simulate physiological and natural labor, pulsatile application of intravenous OT was commonly used (<xref ref-type="bibr" rid="B167">Saccone et al., 2017</xref>). Pulsatile application was associated with lower total dose of OT and less incidence of tachy-systole; however, cardiovascular disturbances like hypotension and reflexive tachycardia were sometimes observed when 5∼10 IU OT was given as a rapid intravenous bolus (<xref ref-type="bibr" rid="B110">Lin et al., 2007</xref>; <xref ref-type="bibr" rid="B167">Saccone et al., 2017</xref>). In pregnant women with MI, coronary spasm or thrombosis could occur in response to the intravenous bolus of OT. By contrast, there were only modest cardiovascular disturbances during slow infusion (<xref ref-type="bibr" rid="B182">Svanstrom et al., 2008</xref>). This fact highlights the necessity to reconsider the optimal drug, dose, and administration route in clinical trials of OT.</p>
<p>It is known that the beneficial effect of OT on cardioprotection is correlated with the basal levels of endogenous OT (<xref ref-type="bibr" rid="B65">Hirst et al., 1991</xref>). OT administration to individuals with a low pretreatment OT levels could be beneficial whereas, individuals with an elevated basal OT levels would be prone to adverse effects, which has been shown in swine (<xref ref-type="bibr" rid="B77">Jacquenod et al., 2015</xref>). It is likely that during parturition the basal OT levels are already very high, a bolus injection of OT in large amount may reversely decrease OTR signaling by reducing OTR protein expression (<xref ref-type="bibr" rid="B9">Authier et al., 2010</xref>). Moreover, high doses of OT also activated VP receptors (<xref ref-type="bibr" rid="B201">Wang and Hatton, 2006</xref>), thereby evoking MI (<xref ref-type="bibr" rid="B219">Ying et al., 2015</xref>). These facts highlight the necessity to assay the basal levels of blood OT in the induction of labor, particularly in those with CAD, and use drugs like prostaglandins (<xref ref-type="bibr" rid="B115">Mahomed et al., 2018</xref>) and misoprostol (<xref ref-type="bibr" rid="B147">Pimentel et al., 2018</xref>) to replace OT in those who have higher basal OT levels.</p>
<p>In using exogenous OT to treat CAD, pre-existing neuroendocrine conditions of the patients should also be considered. It has been observed that chronic application of OT and angiotensin-II together increased mean arterial pressure, and caused left ventricular hypertrophy and renal damage in male rats (<xref ref-type="bibr" rid="B146">Phie et al., 2015</xref>). It is likely that prolonged administration of OT in CAD patients with elevated basal angiotensin-II levels accelerated angiotensin-II-induced hypertension and renal damage (<xref ref-type="bibr" rid="B58">Gu et al., 2016</xref>). Since elevated basal levels of angiotensin-II is common among patients with CAD complications (<xref ref-type="bibr" rid="B171">Schuh et al., 2017</xref>), alternative approaches of OT application should be considered.</p>
<p>In addition, anaphylaxis to OT was occasionally observed in delivering women with latex allergy and bronchial asthma (<xref ref-type="bibr" rid="B108">Liccardi et al., 2013</xref>). Thus, special attention in exogenous OT application should be paid to patients who have the history of latex allergy as well as history of hypotension, reflexive tachycardia, and high angiotensin levels in delivering women.</p>
</sec>
<sec>
<title>Intranasal OT Delivery</title>
<p>Circulating OT could modulate cardiovascular activity directly (<xref ref-type="bibr" rid="B3">Alfirevic et al., 2016</xref>); however, intravenous application of OT is inaccessible to the brain sites that are involved in neural regulation of CVS activity. Thus, intranasal OT application had been tested in heart rate variability-an index of autonomic cardiac control (<xref ref-type="bibr" rid="B157">Quintana et al., 2013</xref>). Although intranasally-applied OT usually does not evoke significant change in plasma OT levels (<xref ref-type="bibr" rid="B106">Leng and Ludwig, 2016</xref>), it could exert antiarrhythmic effect in human being as reported (<xref ref-type="bibr" rid="B78">Jain et al., 2017</xref>; <xref ref-type="bibr" rid="B168">Sack et al., 2017</xref>).</p>
<p>Intranasal administration of OT could regulate brain activities including hypothalamic sites (<xref ref-type="bibr" rid="B38">Delorme and Garabedian, 2018</xref>) without side effects of peripheral exposure (<xref ref-type="bibr" rid="B18">Busnelli et al., 2015</xref>; <xref ref-type="bibr" rid="B19">Calcagnoli et al., 2015</xref>). Intranasal delivery of OT had been considered in relieving brain-associated etiologies of CAD, such as obesity, Alzheimer’s disease, depression, anxiety, seizure, and stroke (<xref ref-type="bibr" rid="B24">Chapman et al., 2013</xref>). In CAD patients, intranasal OT also exerted the protective effect (<xref ref-type="bibr" rid="B224">Zhang et al., 2013</xref>) by suppressing the activity of HPA axis and adrenaline secretion (<xref ref-type="bibr" rid="B218">Yee et al., 2016</xref>) and reducing sympathetic output (<xref ref-type="bibr" rid="B187">Tracy et al., 2018</xref>). However, intranasal OT may act on multiple brain sites though different nose-brain routes (<xref ref-type="bibr" rid="B190">Veening and Olivier, 2013</xref>) that may impose additional complications, such as co-activation of VP neurons, thereby compromising the protective effect of OT (<xref ref-type="bibr" rid="B11">Bartekova et al., 2015</xref>). In addition, responsive activation of parvocellular OT neurons during MI could drive cardiac sympathetic nerve activation as observed in rats (<xref ref-type="bibr" rid="B166">Roy et al., 2018</xref>), which could worsen the decompensated heart functions. Although it remains to study if intranasal OT application could activate this sympathetic pathway, caution should be taken in using this approach to deliver OT in acute phase of MI. As a whole, how to let OT activate the descending vagal pathway to minimize cardiac injury remains a puzzle in exploring the therapeutic potential of intranasal OT.</p>
</sec>
</sec>
<sec>
<title>Summary</title>
<p>In varieties of etiologies of atherosclerosis and the resultant CAD, deficits in OTR signaling are an important one. Although the presence of some rare side effects and optimal approaches of OT application remain to be clarified, the perspective to reduce the morbidity and mortality of atherosclerosis and CAD by targeting OTR signaling is highly desirable, which can at least avoid the compromising effect of VP receptor signaling while efficiently blocking the key pathological link in CAD development. To exert the therapeutic potential of OT, questions remain to be answered include but not limit to understandings of the signaling processes from OTR activation to its downstream signals, including CaMK, AMPK, PI3K/Akt, pERK 1/2, PKC-ε, NO and H<sub>2</sub>S, and the details of inter-organelle Ca<sup>2+</sup>transfer and its regulation, and so on. With careful monitoring of both the positive and negative effects of OT, particularly in delivering women (<xref ref-type="bibr" rid="B205">Weissman et al., 2017</xref>), future clinical trials of OT therapies would contribute significantly to the translational study in curbing the development of atherosclerosis and the CAD complications.</p>
</sec>
<sec>
<title>Author Contributions</title>
<p>PW and SW wrote the first draft. HZ and Y-FW conceived the study. Y-FW edited the draft. All authors made critical discussion.</p>
</sec>
<sec>
<title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding.</bold> This work was supported by the National Natural Science Foundation of China (Grant No. 31471113, Y-FW), Fund of “Double-First-Class” Construction of Harbin Medical University (HZ), and the higher education talents funds of Heilongjiang Province (Grant No. 002000154, Y-FW).</p>
</fn>
</fn-group>
<ack>
<p>We thank Drs B. Yang, R. Lyubarova, and C. Xu for advice.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdallah</surname><given-names>Y.</given-names></name><name><surname>Kasseckert</surname><given-names>S. A.</given-names></name><name><surname>Iraqi</surname><given-names>W.</given-names></name><name><surname>Said</surname><given-names>M.</given-names></name><name><surname>Shahzad</surname><given-names>T.</given-names></name><name><surname>Erdogan</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Interplay between Ca2+ cycling and mitochondrial permeability transition pores promotes reperfusion-induced injury of cardiac myocytes.</article-title>
<source/><italic>J. Cell. Mol. Med.</italic>
<volume>15</volume>
<fpage>2478</fpage>–<lpage>2485</lpage>. <pub-id pub-id-type="doi">10.1111/j.1582-4934.2010.01249.x</pub-id>
<pub-id pub-id-type="pmid">21199327</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Amran</surname><given-names>F.</given-names></name><name><surname>Shahkolahi</surname><given-names>M.</given-names></name></person-group> (<year>2013</year>). <article-title>Oxytocin ameliorates the immediate myocardial injury in rat heart transplant through downregulation of neutrophil-dependent myocardial apoptosis.</article-title>
<source/><italic>Transplant. Proc.</italic>
<volume>45</volume>
<fpage>2506</fpage>–<lpage>2512</lpage>. <pub-id pub-id-type="doi">10.1016/j.transproceed.2013.03.022</pub-id>
<pub-id pub-id-type="pmid">23953571</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alfirevic</surname><given-names>Z.</given-names></name><name><surname>Keeney</surname><given-names>E.</given-names></name><name><surname>Dowswell</surname><given-names>T.</given-names></name><name><surname>Welton</surname><given-names>N. J.</given-names></name><name><surname>Medley</surname><given-names>N.</given-names></name><name><surname>Dias</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Which method is best for the induction of labour? A systematic review, network meta-analysis and cost-effectiveness analysis.</article-title>
<source/><italic>Health Technol. Assess.</italic>
<volume>20</volume>
<fpage>1</fpage>–<lpage>584</lpage>. <pub-id pub-id-type="doi">10.3310/hta20650</pub-id>
<pub-id pub-id-type="pmid">27587290</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alizadeh</surname><given-names>A. M.</given-names></name><name><surname>Faghihi</surname><given-names>M.</given-names></name><name><surname>Sadeghipour</surname><given-names>H. R.</given-names></name><name><surname>Mohammadghasemi</surname><given-names>F.</given-names></name><name><surname>Imani</surname><given-names>A.</given-names></name><name><surname>Houshmand</surname><given-names>F.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Oxytocin protects rat heart against ischemia-reperfusion injury via pathway involving mitochondrial ATP-dependent potassium channel.</article-title>
<source/><italic>Peptides</italic>
<volume>31</volume>
<fpage>1341</fpage>–<lpage>1345</lpage>. <pub-id pub-id-type="doi">10.1016/j.peptides.2010.04.012</pub-id>
<pub-id pub-id-type="pmid">20417240</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alizadeh</surname><given-names>A. M.</given-names></name><name><surname>Mirzabeglo</surname><given-names>P.</given-names></name></person-group> (<year>2013</year>). <article-title>Is oxytocin a therapeutic factor for ischemic heart disease?</article-title>
<source/><italic>Peptides</italic>
<volume>45</volume>
<fpage>66</fpage>–<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1016/j.peptides.2013.04.016</pub-id>
<pub-id pub-id-type="pmid">23659864</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amri</surname><given-names>E. Z.</given-names></name><name><surname>Pisani</surname><given-names>D. F.</given-names></name></person-group> (<year>2016</year>). <article-title>Control of bone and fat mass by oxytocin.</article-title>
<source/><italic>Horm. Mol. Biol. Clin. Investig.</italic>
<volume>28</volume>
<fpage>95</fpage>–<lpage>104</lpage>.</mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anvari</surname><given-names>M. A.</given-names></name><name><surname>Imani</surname><given-names>A.</given-names></name><name><surname>Faghihi</surname><given-names>M.</given-names></name><name><surname>Karimian</surname><given-names>S. M.</given-names></name><name><surname>Moghimian</surname><given-names>M.</given-names></name><name><surname>Khansari</surname><given-names>M.</given-names></name></person-group> (<year>2012</year>). <article-title>The administration of oxytocin during early reperfusion, dose-dependently protects the isolated male rat heart against ischemia/reperfusion injury.</article-title>
<source/><italic>Eur. J. Pharmacol.</italic>
<volume>682</volume>
<fpage>137</fpage>–<lpage>141</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejphar.2012.02.029</pub-id>
<pub-id pub-id-type="pmid">22406244</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Araujo</surname><given-names>I. G.</given-names></name><name><surname>Elias</surname><given-names>L. L.</given-names></name><name><surname>Antunes-Rodrigues</surname><given-names>J.</given-names></name><name><surname>Reis</surname><given-names>L. C.</given-names></name><name><surname>Mecawi</surname><given-names>A. S.</given-names></name></person-group> (<year>2013</year>). <article-title>Effects of acute and subchronic AT1 receptor blockade on cardiovascular, hydromineral and neuroendocrine responses in female rats.</article-title>
<source/><italic>Physiol. Behav.</italic>
<volume>122</volume>
<fpage>104</fpage>–<lpage>112</lpage>. <pub-id pub-id-type="doi">10.1016/j.physbeh.2013.08.018</pub-id>
<pub-id pub-id-type="pmid">23978402</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Authier</surname><given-names>S.</given-names></name><name><surname>Tanguay</surname><given-names>J. F.</given-names></name><name><surname>Geoffroy</surname><given-names>P.</given-names></name><name><surname>Gauvin</surname><given-names>D.</given-names></name><name><surname>Bichot</surname><given-names>S.</given-names></name><name><surname>Ybarra</surname><given-names>N.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Cardiovascular effects of oxytocin infusion in a porcine model of myocardial infarct.</article-title>
<source/><italic>J. Cardiovasc. Pharmacol.</italic>
<volume>55</volume>
<fpage>74</fpage>–<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1097/fjc.0b013e3181c5e7d4</pub-id>
<pub-id pub-id-type="pmid">19858734</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bacova</surname><given-names>B. S.</given-names></name><name><surname>Vinczenzova</surname><given-names>C.</given-names></name><name><surname>Zurmanova</surname><given-names>J.</given-names></name><name><surname>Kasparova</surname><given-names>D.</given-names></name><name><surname>Knezl</surname><given-names>V.</given-names></name><name><surname>Benova</surname><given-names>T. E.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Altered thyroid status affects myocardial expression of connexin-43 and susceptibility of rat heart to malignant arrhythmias that can be partially normalized by red palm oil intake.</article-title>
<source/><italic>Histochem. Cell Biol.</italic>
<volume>147</volume>
<fpage>63</fpage>–<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1007/s00418-016-1488-6</pub-id>
<pub-id pub-id-type="pmid">27600718</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bartekova</surname><given-names>M.</given-names></name><name><surname>Barancik</surname><given-names>M.</given-names></name><name><surname>Pokusa</surname><given-names>M.</given-names></name><name><surname>Prokopova</surname><given-names>B.</given-names></name><name><surname>Radosinska</surname><given-names>J.</given-names></name><name><surname>Rusnak</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Molecular changes induced by repeated restraint stress in the heart: the effect of oxytocin receptor antagonist atosiban.</article-title>
<source/><italic>Can. J. Physiol. Pharmacol.</italic>
<volume>93</volume>
<fpage>827</fpage>–<lpage>834</lpage>. <pub-id pub-id-type="doi">10.1139/cjpp-2015-0096</pub-id>
<pub-id pub-id-type="pmid">26323039</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benjamin</surname><given-names>E. J.</given-names></name><name><surname>Muntner</surname><given-names>P.</given-names></name><name><surname>Alonso</surname><given-names>A.</given-names></name><name><surname>Bittencourt</surname><given-names>M. S.</given-names></name><name><surname>Callaway</surname><given-names>C. W.</given-names></name><name><surname>Carson</surname><given-names>A. P.</given-names></name></person-group> (<year>2019</year>). <article-title>Heart disease and stroke statistics-2019 update: a report from the american heart association.</article-title>
<source/><italic>Circulation</italic>
<volume>139</volume>
<fpage>e56</fpage>–<lpage>e66</lpage>. <pub-id pub-id-type="pmid">30700139</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blevins</surname><given-names>J. E.</given-names></name><name><surname>Baskin</surname><given-names>D. G.</given-names></name></person-group> (<year>2015</year>). <article-title>Translational and therapeutic potential of oxytocin as an anti-obesity strategy: insights from rodents, nonhuman primates and humans.</article-title>
<source/><italic>Physiol. Behav.</italic>
<volume>152</volume>(Pt B), <fpage>438</fpage>–<lpage>449</lpage>. <pub-id pub-id-type="pmid">26013577</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonne</surname><given-names>D.</given-names></name><name><surname>Belhadj</surname><given-names>O.</given-names></name><name><surname>Cohen</surname><given-names>P.</given-names></name></person-group> (<year>1978</year>). <article-title>Calcium as modulator of the hormonal-receptors-biological-response coupling system. Effects of Ca2+ ions on the insulin activated 2-deoxyglucose transport in rat fat cells.</article-title>
<source/><italic>Eur. J. Biochem.</italic>
<volume>86</volume>
<fpage>261</fpage>–<lpage>266</lpage>. <pub-id pub-id-type="doi">10.1111/j.1432-1033.1978.tb12307.x</pub-id>
<pub-id pub-id-type="pmid">207516</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borrow</surname><given-names>A. P.</given-names></name><name><surname>Bales</surname><given-names>N. J.</given-names></name><name><surname>Stover</surname><given-names>S. A.</given-names></name><name><surname>Handa</surname><given-names>R. J.</given-names></name></person-group> (<year>2018</year>). <article-title>Chronic variable stress induces sex-specific alterations in social behavior and neuropeptide expression in the mouse.</article-title>
<source/><italic>Endocrinology</italic>
<volume>159</volume>
<fpage>2803</fpage>–<lpage>2814</lpage>. <pub-id pub-id-type="pmid">29788320</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>C. H.</given-names></name><name><surname>Bains</surname><given-names>J. S.</given-names></name><name><surname>Ludwig</surname><given-names>M.</given-names></name><name><surname>Stern</surname><given-names>J. E.</given-names></name></person-group> (<year>2013</year>). <article-title>Physiological regulation of magnocellular neurosecretory cell activity: integration of intrinsic, local and afferent mechanisms.</article-title>
<source/><italic>J. Neuroendocrinol.</italic>
<volume>25</volume>
<fpage>678</fpage>–<lpage>710</lpage>. <pub-id pub-id-type="doi">10.1111/jne.12051</pub-id>
<pub-id pub-id-type="pmid">23701531</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Busnelli</surname><given-names>M.</given-names></name><name><surname>Bulgheroni</surname><given-names>E.</given-names></name><name><surname>Manning</surname><given-names>M.</given-names></name><name><surname>Kleinau</surname><given-names>G.</given-names></name><name><surname>Chini</surname><given-names>B.</given-names></name></person-group> (<year>2013</year>). <article-title>Selective and potent agonists and antagonists for investigating the role of mouse oxytocin receptors.</article-title>
<source/><italic>J. Pharmacol. Exp. Ther.</italic>
<volume>346</volume>
<fpage>318</fpage>–<lpage>327</lpage>. <pub-id pub-id-type="doi">10.1124/jpet.113.202994</pub-id>
<pub-id pub-id-type="pmid">23723434</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Busnelli</surname><given-names>M.</given-names></name><name><surname>Dagani</surname><given-names>J.</given-names></name><name><surname>De Girolamo</surname><given-names>G.</given-names></name><name><surname>Balestrieri</surname><given-names>M.</given-names></name><name><surname>Pini</surname><given-names>S.</given-names></name><name><surname>Saviotti</surname><given-names>F. M.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Unaltered oxytocin and vasopressin plasma levels in patients with schizophrenia after 4 months of daily treatment with intranasal oxytocin.</article-title>
<source/><italic>J. Neuroendocrinol.</italic>
<pub-id pub-id-type="doi">10.1111/jne.12359</pub-id> [Epub ahead of print]. <pub-id pub-id-type="pmid">26715485</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calcagnoli</surname><given-names>F.</given-names></name><name><surname>Kreutzmann</surname><given-names>J. C.</given-names></name><name><surname>De Boer</surname><given-names>S. F.</given-names></name><name><surname>Althaus</surname><given-names>M.</given-names></name><name><surname>Koolhaas</surname><given-names>J. M.</given-names></name></person-group> (<year>2015</year>). <article-title>Acute and repeated intranasal oxytocin administration exerts anti-aggressive and pro-affiliative effects in male rats.</article-title>
<source/><italic>Psychoneuroendocrinology</italic>
<volume>51</volume>
<fpage>112</fpage>–<lpage>121</lpage>. <pub-id pub-id-type="doi">10.1016/j.psyneuen.2014.09.019</pub-id>
<pub-id pub-id-type="pmid">25305547</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>Y.</given-names></name><name><surname>Tao</surname><given-names>L.</given-names></name><name><surname>Shen</surname><given-names>S.</given-names></name><name><surname>Xiao</surname><given-names>J.</given-names></name><name><surname>Wu</surname><given-names>H.</given-names></name><name><surname>Li</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Cardiac ablation of Rheb1 induces impaired heart growth, endoplasmic reticulum-associated apoptosis and heart failure in infant mice.</article-title>
<source/><italic>Int. J. Mol. Sci.</italic>
<volume>14</volume>
<fpage>24380</fpage>–<lpage>24398</lpage>. <pub-id pub-id-type="doi">10.3390/ijms141224380</pub-id>
<pub-id pub-id-type="pmid">24351823</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cassar</surname><given-names>A.</given-names></name><name><surname>Holmes</surname><given-names>D. R.</given-names><suffix>Jr.</suffix></name><name><surname>Rihal</surname><given-names>C. S.</given-names></name><name><surname>Gersh</surname><given-names>B. J.</given-names></name></person-group> (<year>2009</year>). <article-title>Chronic coronary artery disease: diagnosis and management.</article-title>
<source/><italic>Mayo Clin. Proc.</italic>
<volume>84</volume>
<fpage>1130</fpage>–<lpage>1146</lpage>.<pub-id pub-id-type="pmid">19955250</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cattaneo</surname><given-names>M. G.</given-names></name><name><surname>Chini</surname><given-names>B.</given-names></name><name><surname>Vicentini</surname><given-names>L. M.</given-names></name></person-group> (<year>2008</year>). <article-title>Oxytocin stimulates migration and invasion in human endothelial cells.</article-title>
<source/><italic>Br. J. Pharmacol.</italic>
<volume>153</volume>
<fpage>728</fpage>–<lpage>736</lpage>. <pub-id pub-id-type="doi">10.1038/sj.bjp.0707609</pub-id>
<pub-id pub-id-type="pmid">18059319</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cavalleri</surname><given-names>M. T.</given-names></name><name><surname>Burgi</surname><given-names>K.</given-names></name><name><surname>Cruz</surname><given-names>J. C.</given-names></name><name><surname>Jordao</surname><given-names>M. T.</given-names></name><name><surname>Ceroni</surname><given-names>A.</given-names></name><name><surname>Michelini</surname><given-names>L. C.</given-names></name></person-group> (<year>2011</year>). <article-title>Afferent signaling drives oxytocinergic preautonomic neurons and mediates training-induced plasticity.</article-title>
<source/><italic>Am. J. Physiol. Regul. Integr. Comp. Physiol.</italic>
<volume>301</volume>
<fpage>R958</fpage>–<lpage>R966</lpage>. <pub-id pub-id-type="pmid">21795633</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chapman</surname><given-names>C. D.</given-names></name><name><surname>Frey</surname><given-names>W. H.</given-names><suffix>II</suffix></name><name><surname>Craft</surname><given-names>S.</given-names></name><name><surname>Danielyan</surname><given-names>L.</given-names></name><name><surname>Hallschmid</surname><given-names>M.</given-names></name><name><surname>Schioth</surname><given-names>H. B.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Intranasal treatment of central nervous system dysfunction in humans.</article-title>
<source/><italic>Pharm. Res.</italic>
<volume>30</volume>
<fpage>2475</fpage>–<lpage>2484</lpage>. <pub-id pub-id-type="doi">10.1007/s11095-012-0915-1</pub-id>
<pub-id pub-id-type="pmid">23135822</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Z.</given-names></name><name><surname>Peng</surname><given-names>I. C.</given-names></name><name><surname>Sun</surname><given-names>W.</given-names></name><name><surname>Su</surname><given-names>M. I.</given-names></name><name><surname>Hsu</surname><given-names>P. H.</given-names></name><name><surname>Fu</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>AMP-activated protein kinase functionally phosphorylates endothelial nitric oxide synthase Ser633.</article-title>
<source/><italic>Circ. Res.</italic>
<volume>104</volume>
<fpage>496</fpage>–<lpage>505</lpage>. <pub-id pub-id-type="doi">10.1161/circresaha.108.187567</pub-id>
<pub-id pub-id-type="pmid">19131647</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiodera</surname><given-names>P.</given-names></name><name><surname>Volpi</surname><given-names>R.</given-names></name><name><surname>Capretti</surname><given-names>L.</given-names></name><name><surname>Bocchi</surname><given-names>R.</given-names></name><name><surname>Caffarri</surname><given-names>G.</given-names></name><name><surname>Marcato</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>1993</year>). <article-title>Gamma-aminobutyric acid mediation of the inhibitory effect of endogenous opioids on the arginine vasopressin and oxytocin responses to nicotine from cigarette smoking.</article-title>
<source/><italic>Metabolism</italic>
<volume>42</volume>
<fpage>762</fpage>–<lpage>765</lpage>. <pub-id pub-id-type="doi">10.1016/0026-0495(93)90246-k</pub-id>
<pub-id pub-id-type="pmid">8510522</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiodera</surname><given-names>P.</given-names></name><name><surname>Volpi</surname><given-names>R.</given-names></name><name><surname>Capretti</surname><given-names>L.</given-names></name><name><surname>Marchesi</surname><given-names>C.</given-names></name><name><surname>D’amato</surname><given-names>L.</given-names></name><name><surname>De Ferri</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>1991</year>). <article-title>Effect of estrogen or insulin-induced hypoglycemia on plasma oxytocin levels in bulimia and anorexia nervosa.</article-title>
<source/><italic>Metabolism</italic>
<volume>40</volume>
<fpage>1226</fpage>–<lpage>1230</lpage>. <pub-id pub-id-type="doi">10.1016/0026-0495(91)90220-q</pub-id><pub-id pub-id-type="pmid">1943752</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chopra</surname><given-names>I.</given-names></name><name><surname>Li</surname><given-names>H. F.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Webster</surname><given-names>K. A.</given-names></name></person-group> (<year>2012</year>). <article-title>Phosphorylation of the insulin receptor by AMP-activated protein kinase (AMPK) promotes ligand-independent activation of the insulin signalling pathway in rodent muscle.</article-title>
<source/><italic>Diabetologia</italic>
<volume>55</volume>
<fpage>783</fpage>–<lpage>794</lpage>. <pub-id pub-id-type="doi">10.1007/s00125-011-2407-y</pub-id>
<pub-id pub-id-type="pmid">22207502</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ciosek</surname><given-names>J.</given-names></name><name><surname>Drobnik</surname><given-names>J.</given-names></name></person-group> (<year>2012</year>). <article-title>Function of the hypothalamo-neurohypophysial system in rats with myocardial infarction is modified by melatonin.</article-title>
<source/><italic>Pharmacol. Rep.</italic>
<volume>64</volume>
<fpage>1442</fpage>–<lpage>1454</lpage>. <pub-id pub-id-type="doi">10.1016/s1734-1140(12)70942-8</pub-id>
<pub-id pub-id-type="pmid">23406755</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coletti</surname><given-names>R.</given-names></name><name><surname>De Lima</surname><given-names>J. B. M.</given-names></name><name><surname>Maria</surname><given-names>F.</given-names></name><name><surname>Vechiato</surname><given-names>V.</given-names></name><name><surname>De Oliveira</surname><given-names>F. L.</given-names></name><name><surname>Debarba</surname><given-names>L. K.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>Nitric oxide acutely modulates hypothalamic and neurohypophyseal carbon monoxide and hydrogen sulphide production to control vasopressin, oxytocin and atrial natriuretic peptide release in rats.</article-title>
<source/><italic>J. Neuroendocrinol.</italic>
<volume>31</volume>:<issue>e12686</issue>. <pub-id pub-id-type="doi">10.1111/jne.12686</pub-id>
<pub-id pub-id-type="pmid">30633838</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conti</surname><given-names>F.</given-names></name><name><surname>Sertic</surname><given-names>S.</given-names></name><name><surname>Reversi</surname><given-names>A.</given-names></name><name><surname>Chini</surname><given-names>B.</given-names></name></person-group> (<year>2009</year>). <article-title>Intracellular trafficking of the human oxytocin receptor: evidence of receptor recycling via a Rab4/Rab5 “short cycle”.</article-title>
<source/><italic>Am. J. Physiol. Endocrinol. Metab.</italic>
<volume>296</volume>
<fpage>E532</fpage>–<lpage>E542</lpage>. <pub-id pub-id-type="pmid">19126785</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costa E Sousa</surname><given-names>R. H.</given-names></name><name><surname>Pereira-Junior</surname><given-names>P. P.</given-names></name><name><surname>Oliveira</surname><given-names>P. F.</given-names></name><name><surname>Olivares</surname><given-names>E. L.</given-names></name><name><surname>Werneck-De-Castro</surname><given-names>J. P.</given-names></name><name><surname>Mello</surname><given-names>D. B.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>Cardiac effects of oxytocin: is there a role for this peptide in cardiovascular homeostasis?</article-title>
<source/><italic>Regul. Pept.</italic>
<volume>132</volume>
<fpage>107</fpage>–<lpage>112</lpage>. <pub-id pub-id-type="doi">10.1016/j.regpep.2005.09.011</pub-id>
<pub-id pub-id-type="pmid">16213606</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crea</surname><given-names>F.</given-names></name><name><surname>Libby</surname><given-names>P.</given-names></name></person-group> (<year>2017</year>). <article-title>Acute coronary syndromes: the way forward from mechanisms to precision treatment.</article-title>
<source/><italic>Circulation</italic>
<volume>136</volume>
<fpage>1155</fpage>–<lpage>1166</lpage>. <pub-id pub-id-type="doi">10.1161/circulationaha.117.029870</pub-id>
<pub-id pub-id-type="pmid">28923905</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Da Silva</surname><given-names>A. L.</given-names></name><name><surname>Ruginsk</surname><given-names>S. G.</given-names></name><name><surname>Uchoa</surname><given-names>E. T.</given-names></name><name><surname>Crestani</surname><given-names>C. C.</given-names></name><name><surname>Scopinho</surname><given-names>A. A.</given-names></name><name><surname>Correa</surname><given-names>F. M.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Time-course of neuroendocrine changes and its correlation with hypertension induced by ethanol consumption.</article-title>
<source/><italic>Alcohol Alcohol.</italic>
<volume>48</volume>
<fpage>495</fpage>–<lpage>504</lpage>. <pub-id pub-id-type="doi">10.1093/alcalc/agt040</pub-id>
<pub-id pub-id-type="pmid">23733506</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Danalache</surname><given-names>B. A.</given-names></name><name><surname>Yu</surname><given-names>C.</given-names></name><name><surname>Gutkowska</surname><given-names>J.</given-names></name><name><surname>Jankowski</surname><given-names>M.</given-names></name></person-group> (<year>2014</year>). <article-title>Oxytocin-Gly-Lys-Arg stimulates cardiomyogenesis by targeting cardiac side population cells.</article-title>
<source/><italic>J. Endocrinol.</italic>
<volume>220</volume>
<fpage>277</fpage>–<lpage>289</lpage>. <pub-id pub-id-type="doi">10.1530/joe-13-0305</pub-id>
<pub-id pub-id-type="pmid">24403294</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Das</surname><given-names>B.</given-names></name><name><surname>Sarkar</surname><given-names>C.</given-names></name></person-group> (<year>2012</year>). <article-title>Is preconditioning by oxytocin administration mediated by iNOS and/or mitochondrial K(ATP) channel activation in the in vivo anesthetized rabbit heart?</article-title>
<source/><italic>Life Sci.</italic>
<volume>90</volume>
<fpage>763</fpage>–<lpage>769</lpage>. <pub-id pub-id-type="doi">10.1016/j.lfs.2012.03.030</pub-id>
<pub-id pub-id-type="pmid">22525371</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Melo</surname><given-names>V. U.</given-names></name><name><surname>Saldanha</surname><given-names>R. R.</given-names></name><name><surname>Dos Santos</surname><given-names>C. R.</given-names></name><name><surname>De Campos Cruz</surname><given-names>J.</given-names></name><name><surname>Lira</surname><given-names>V. A.</given-names></name><name><surname>Santana-Filho</surname><given-names>V. J.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Ovarian hormone deprivation reduces oxytocin expression in paraventricular nucleus preautonomic neurons and correlates with baroreflex impairment in rats.</article-title>
<source/><italic>Front. Physiol.</italic>
<volume>7</volume>:<issue>461</issue>. <pub-id pub-id-type="doi">10.3389/fphys.2016.00461</pub-id>
<pub-id pub-id-type="pmid">27790154</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delorme</surname><given-names>P.</given-names></name><name><surname>Garabedian</surname><given-names>C.</given-names></name></person-group> (<year>2018</year>). <article-title>[Modalities of birth in case of uncomplicated preterm premature rupture of membranes: CNGOF Preterm Premature Rupture of Membranes Guidelines].</article-title>
<source/><italic>Gynecol. Obstet. Fertil. Senol.</italic>
<volume>46</volume>
<fpage>1068</fpage>–<lpage>1075</lpage>. <pub-id pub-id-type="pmid">30389541</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dennis</surname><given-names>A. T.</given-names></name><name><surname>Gerstman</surname><given-names>M. D.</given-names></name></person-group> (<year>2014</year>). <article-title>Management of labour and delivery in a woman with refractory supraventricular tachycardia.</article-title>
<source/><italic>Int. J. Obstet. Anesth.</italic>
<volume>23</volume>
<fpage>80</fpage>–<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijoa.2013.08.012</pub-id>
<pub-id pub-id-type="pmid">24360330</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Denson</surname><given-names>T. F.</given-names></name><name><surname>O’dean</surname><given-names>S. M.</given-names></name><name><surname>Blake</surname><given-names>K. R.</given-names></name><name><surname>Beames</surname><given-names>J. R.</given-names></name></person-group> (<year>2018</year>). <article-title>Aggression in women: behavior, brain and hormones.</article-title>
<source/><italic>Front. Behav. Neurosci.</italic>
<volume>12</volume>:<issue>81</issue>. <pub-id pub-id-type="doi">10.3389/fnbeh.2018.00081</pub-id>
<pub-id pub-id-type="pmid">29770113</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname><given-names>C.</given-names></name><name><surname>Leow</surname><given-names>M. K.</given-names></name><name><surname>Magkos</surname><given-names>F.</given-names></name></person-group> (<year>2019</year>). <article-title>Oxytocin in metabolic homeostasis: implications for obesity and diabetes management.</article-title>
<source/><italic>Obes. Rev.</italic>
<volume>20</volume>
<fpage>22</fpage>–<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1111/obr.12757</pub-id>
<pub-id pub-id-type="pmid">30253045</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Du</surname><given-names>D.</given-names></name><name><surname>Jiang</surname><given-names>M.</given-names></name><name><surname>Liu</surname><given-names>M.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Xia</surname><given-names>C.</given-names></name><name><surname>Guan</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Microglial P2X(7) receptor in the hypothalamic paraventricular nuclei contributes to sympathoexcitatory responses in acute myocardial infarction rat.</article-title>
<source/><italic>Neurosci. Lett.</italic>
<volume>587</volume>
<fpage>22</fpage>–<lpage>28</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2014.12.026</pub-id>
<pub-id pub-id-type="pmid">25524407</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dupont</surname><given-names>C.</given-names></name><name><surname>Ducloy-Bouthors</surname><given-names>A. S.</given-names></name><name><surname>Huissoud</surname><given-names>C.</given-names></name></person-group> (<year>2014</year>). <article-title>[Clinical and pharmacological procedures for the prevention of postpartum haemorrhage in the third stage of labor].</article-title>
<source/><italic>J. Gynecol. Obstet. Biol. Reprod.</italic>
<volume>43</volume>
<fpage>966</fpage>–<lpage>997</lpage>.</mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Egan</surname><given-names>J. J.</given-names></name><name><surname>Saltis</surname><given-names>J.</given-names></name><name><surname>Wek</surname><given-names>S. A.</given-names></name><name><surname>Simpson</surname><given-names>I. A.</given-names></name><name><surname>Londos</surname><given-names>C.</given-names></name></person-group> (<year>1990</year>). <article-title>Insulin, oxytocin, and vasopressin stimulate protein kinase C activity in adipocyte plasma membranes.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>87</volume>
<fpage>1052</fpage>–<lpage>1056</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.87.3.1052</pub-id>
<pub-id pub-id-type="pmid">2105494</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elabd</surname><given-names>C.</given-names></name><name><surname>Cousin</surname><given-names>W.</given-names></name><name><surname>Upadhyayula</surname><given-names>P.</given-names></name><name><surname>Chen</surname><given-names>R. Y.</given-names></name><name><surname>Chooljian</surname><given-names>M. S.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Oxytocin is an age-specific circulating hormone that is necessary for muscle maintenance and regeneration.</article-title>
<source/><italic>Nat. Commun.</italic>
<volume>5</volume>:<issue>4082</issue>. <pub-id pub-id-type="pmid">24915299</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emeny</surname><given-names>R. T.</given-names></name><name><surname>Huber</surname><given-names>D.</given-names></name><name><surname>Bidlingmaier</surname><given-names>M.</given-names></name><name><surname>Reincke</surname><given-names>M.</given-names></name><name><surname>Klug</surname><given-names>G.</given-names></name><name><surname>Ladwig</surname><given-names>K. H.</given-names></name></person-group> (<year>2015</year>). <article-title>Oxytocin-induced coping with stressful life events in old age depends on attachment: findings from the cross-sectional KORA Age study.</article-title>
<source/><italic>Psychoneuroendocrinology</italic>
<volume>56</volume>
<fpage>132</fpage>–<lpage>142</lpage>. <pub-id pub-id-type="doi">10.1016/j.psyneuen.2015.03.014</pub-id>
<pub-id pub-id-type="pmid">25827957</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faehrmann</surname><given-names>T.</given-names></name><name><surname>Zernig</surname><given-names>G.</given-names></name><name><surname>Mechtcheriakov</surname><given-names>S.</given-names></name></person-group> (<year>2018</year>). <article-title>[Oxytocin and the mechanisms of alcohol dependence].</article-title>
<source/><italic>Neuropsychiatrie</italic>
<volume>32</volume>
<fpage>1</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">28639210</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faghihi</surname><given-names>M.</given-names></name><name><surname>Alizadeh</surname><given-names>A. M.</given-names></name><name><surname>Khori</surname><given-names>V.</given-names></name><name><surname>Latifpour</surname><given-names>M.</given-names></name><name><surname>Khodayari</surname><given-names>S.</given-names></name></person-group> (<year>2012</year>). <article-title>The role of nitric oxide, reactive oxygen species, and protein kinase C in oxytocin-induced cardioprotection in ischemic rat heart.</article-title>
<source/><italic>Peptides</italic>
<volume>37</volume>
<fpage>314</fpage>–<lpage>319</lpage>. <pub-id pub-id-type="doi">10.1016/j.peptides.2012.08.001</pub-id>
<pub-id pub-id-type="pmid">22902709</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Federico</surname><given-names>M.</given-names></name><name><surname>Portiansky</surname><given-names>E. L.</given-names></name><name><surname>Sommese</surname><given-names>L.</given-names></name><name><surname>Alvarado</surname><given-names>F. J.</given-names></name><name><surname>Blanco</surname><given-names>P. G.</given-names></name><name><surname>Zanuzzi</surname><given-names>C. N.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Calcium-calmodulin-dependent protein kinase mediates the intracellular signalling pathways of cardiac apoptosis in mice with impaired glucose tolerance.</article-title>
<source/><italic>J. Physiol.</italic>
<volume>595</volume>
<fpage>4089</fpage>–<lpage>4108</lpage>. <pub-id pub-id-type="doi">10.1113/jp273714</pub-id>
<pub-id pub-id-type="pmid">28105734</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Florian</surname><given-names>M.</given-names></name><name><surname>Jankowski</surname><given-names>M.</given-names></name><name><surname>Gutkowska</surname><given-names>J.</given-names></name></person-group> (<year>2010</year>). <article-title>Oxytocin increases glucose uptake in neonatal rat cardiomyocytes.</article-title>
<source/><italic>Endocrinology</italic>
<volume>151</volume>
<fpage>482</fpage>–<lpage>491</lpage>. <pub-id pub-id-type="doi">10.1210/en.2009-0624</pub-id>
<pub-id pub-id-type="pmid">20008042</pub-id></mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Gainer</surname><given-names>H.</given-names></name></person-group> (<year>2011</year>). <source/><italic>Peptides in Neurobiology.</italic>
<publisher-loc>New York, NY</publisher-loc>: <publisher-name>Springer</publisher-name>.</mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garrott</surname><given-names>K.</given-names></name><name><surname>Dyavanapalli</surname><given-names>J.</given-names></name><name><surname>Cauley</surname><given-names>E.</given-names></name><name><surname>Dwyer</surname><given-names>M. K.</given-names></name><name><surname>Kuzmiak-Glancy</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Chronic activation of hypothalamic oxytocin neurons improves cardiac function during left ventricular hypertrophy-induced heart failure.</article-title>
<source/><italic>Cardiovasc. Res.</italic>
<volume>113</volume>
<fpage>1318</fpage>–<lpage>1328</lpage>. <pub-id pub-id-type="doi">10.1093/cvr/cvx084</pub-id>
<pub-id pub-id-type="pmid">28472396</pub-id></mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gassanov</surname><given-names>N.</given-names></name><name><surname>Devost</surname><given-names>D.</given-names></name><name><surname>Danalache</surname><given-names>B.</given-names></name><name><surname>Noiseux</surname><given-names>N.</given-names></name><name><surname>Jankowski</surname><given-names>M.</given-names></name><name><surname>Zingg</surname><given-names>H. H.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Functional activity of the carboxyl-terminally extended oxytocin precursor Peptide during cardiac differentiation of embryonic stem cells.</article-title>
<source/><italic>Stem Cells</italic>
<volume>26</volume>
<fpage>45</fpage>–<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1634/stemcells.2007-0289</pub-id>
<pub-id pub-id-type="pmid">17951221</pub-id></mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomez</surname><given-names>L.</given-names></name><name><surname>Thiebaut</surname><given-names>P. A.</given-names></name><name><surname>Paillard</surname><given-names>M.</given-names></name><name><surname>Ducreux</surname><given-names>S.</given-names></name><name><surname>Abrial</surname><given-names>M.</given-names></name><name><surname>Crola Da Silva</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>The SR/ER-mitochondria calcium crosstalk is regulated by GSK3beta during reperfusion injury.</article-title>
<source/><italic>Cell Death Differ.</italic>
<volume>23</volume>
<fpage>313</fpage>–<lpage>322</lpage>. <pub-id pub-id-type="doi">10.1038/cdd.2015.101</pub-id>
<pub-id pub-id-type="pmid">26206086</pub-id></mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonzalez-Reyes</surname><given-names>A.</given-names></name><name><surname>Menaouar</surname><given-names>A.</given-names></name><name><surname>Yip</surname><given-names>D.</given-names></name><name><surname>Danalache</surname><given-names>B.</given-names></name><name><surname>Plante</surname><given-names>E.</given-names></name><name><surname>Noiseux</surname><given-names>N.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Molecular mechanisms underlying oxytocin-induced cardiomyocyte protection from simulated ischemia-reperfusion.</article-title>
<source/><italic>Mol. Cell. Endocrinol.</italic>
<volume>412</volume>
<fpage>170</fpage>–<lpage>181</lpage>. <pub-id pub-id-type="doi">10.1016/j.mce.2015.04.028</pub-id>
<pub-id pub-id-type="pmid">25963797</pub-id></mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goren</surname><given-names>H. J.</given-names></name><name><surname>Hanif</surname><given-names>K.</given-names></name><name><surname>Dudley</surname><given-names>R.</given-names></name><name><surname>Hollenberg</surname><given-names>M. D.</given-names></name><name><surname>Lederis</surname><given-names>K.</given-names></name></person-group> (<year>1986</year>). <article-title>Adenosine modulation of fat cell responsiveness to insulin and oxytocin.</article-title>
<source/><italic>Regul. Pept.</italic>
<volume>16</volume>
<fpage>125</fpage>–<lpage>134</lpage>. <pub-id pub-id-type="doi">10.1016/0167-0115(86)90056-x</pub-id>
<pub-id pub-id-type="pmid">3544088</pub-id></mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gotovina</surname><given-names>J.</given-names></name><name><surname>Pranger</surname><given-names>C. L.</given-names></name><name><surname>Jensen</surname><given-names>A. N.</given-names></name><name><surname>Wagner</surname><given-names>S.</given-names></name><name><surname>Kothgassner</surname><given-names>O. D.</given-names></name><name><surname>Mothes-Luksch</surname><given-names>N.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Elevated oxytocin and noradrenaline indicate higher stress levels in allergic rhinitis patients: implications for the skin prick diagnosis in a pilot study.</article-title>
<source/><italic>PLoS One</italic>
<volume>13</volume>:<issue>e0196879</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0196879</pub-id>
<pub-id pub-id-type="pmid">29813071</pub-id></mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>J.</given-names></name><name><surname>Cai</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>B.</given-names></name><name><surname>Lv</surname><given-names>S.</given-names></name></person-group> (<year>2016</year>). <article-title>Anesthetic management for cesarean section in a patient with uncorrected double-outlet right ventricle.</article-title>
<source/><italic>Springerplus</italic>
<volume>5</volume>:<issue>415</issue>. <pub-id pub-id-type="pmid">27069835</pub-id></mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guan</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Liu</surname><given-names>Z.</given-names></name><name><surname>Guo</surname><given-names>X.</given-names></name><name><surname>Jiang</surname><given-names>Y.</given-names></name><name><surname>Lu</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>miR-106a promotes cardiac hypertrophy by targeting mitofusin 2.</article-title>
<source/><italic>J. Mol. Cell. Cardiol.</italic>
<volume>99</volume>
<fpage>207</fpage>–<lpage>217</lpage>. <pub-id pub-id-type="doi">10.1016/j.yjmcc.2016.08.016</pub-id>
<pub-id pub-id-type="pmid">27565029</pub-id></mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guasch</surname><given-names>E.</given-names></name><name><surname>Gilsanz</surname><given-names>F.</given-names></name></person-group> (<year>2016</year>). <article-title>Massive obstetric hemorrhage: current approach to management.</article-title>
<source/><italic>Med. Intensiva</italic>
<volume>40</volume>
<fpage>298</fpage>–<lpage>310</lpage>. <pub-id pub-id-type="doi">10.1016/j.medine.2016.02.003</pub-id><pub-id pub-id-type="pmid">27184441</pub-id></mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gutkowska</surname><given-names>J.</given-names></name><name><surname>Broderick</surname><given-names>T. L.</given-names></name><name><surname>Bogdan</surname><given-names>D.</given-names></name><name><surname>Wang</surname><given-names>D.</given-names></name><name><surname>Lavoie</surname><given-names>J. M.</given-names></name><name><surname>Jankowski</surname><given-names>M.</given-names></name></person-group> (<year>2009</year>). <article-title>Downregulation of oxytocin and natriuretic peptides in diabetes: possible implications in cardiomyopathy.</article-title>
<source/><italic>J. Physiol.</italic>
<volume>587</volume>
<fpage>4725</fpage>–<lpage>4736</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.2009.176461</pub-id>
<pub-id pub-id-type="pmid">19675071</pub-id></mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gutkowska</surname><given-names>J.</given-names></name><name><surname>Jankowski</surname><given-names>M.</given-names></name><name><surname>Antunes-Rodrigues</surname><given-names>J.</given-names></name></person-group> (<year>2014</year>). <article-title>The role of oxytocin in cardiovascular regulation.</article-title>
<source/><italic>Braz. J. Med. Biol. Res.</italic>
<volume>47</volume>
<fpage>206</fpage>–<lpage>214</lpage>. <pub-id pub-id-type="doi">10.1590/1414-431x20133309</pub-id><pub-id pub-id-type="pmid">24676493</pub-id></mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hatton</surname><given-names>G. I.</given-names></name><name><surname>Wang</surname><given-names>Y. F.</given-names></name></person-group> (<year>2008</year>). <article-title>Neural mechanisms underlying the milk ejection burst and reflex.</article-title>
<source/><italic>Prog. Brain Res.</italic>
<volume>170</volume>
<fpage>155</fpage>–<lpage>166</lpage>. <pub-id pub-id-type="doi">10.1016/s0079-6123(08)00414-7</pub-id>
<pub-id pub-id-type="pmid">18655880</pub-id></mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Higa</surname><given-names>K. T.</given-names></name><name><surname>Mori</surname><given-names>E.</given-names></name><name><surname>Viana</surname><given-names>F. F.</given-names></name><name><surname>Morris</surname><given-names>M.</given-names></name><name><surname>Michelini</surname><given-names>L. C.</given-names></name></person-group> (<year>2002</year>). <article-title>Baroreflex control of heart rate by oxytocin in the solitary-vagal complex.</article-title>
<source/><italic>Am. J. Physiol. Regul. Integr. Comp. Physiol.</italic>
<volume>282</volume>
<fpage>R537</fpage>–<lpage>R545</lpage>. <pub-id pub-id-type="pmid">11792664</pub-id></mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirst</surname><given-names>J. J.</given-names></name><name><surname>Haluska</surname><given-names>G. J.</given-names></name><name><surname>Cook</surname><given-names>M. J.</given-names></name><name><surname>Hess</surname><given-names>D. L.</given-names></name><name><surname>Novy</surname><given-names>M. J.</given-names></name></person-group> (<year>1991</year>). <article-title>Comparison of plasma oxytocin and catecholamine concentrations with uterine activity in pregnant rhesus monkeys.</article-title>
<source/><italic>J. Clin. Endocrinol. Metab.</italic>
<volume>73</volume>
<fpage>804</fpage>–<lpage>810</lpage>. <pub-id pub-id-type="doi">10.1210/jcem-73-4-804</pub-id>
<pub-id pub-id-type="pmid">1890153</pub-id></mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hou</surname><given-names>D.</given-names></name><name><surname>Jin</surname><given-names>F.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Lian</surname><given-names>J.</given-names></name><name><surname>Liu</surname><given-names>M.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Model roles of the hypothalamo-neurohypophysial system in neuroscience study.</article-title>
<source/><italic>Biochem. Pharmacol.</italic>
<volume>5</volume>:<issue>211</issue>.</mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Houshmand</surname><given-names>F.</given-names></name><name><surname>Faghihi</surname><given-names>M.</given-names></name><name><surname>Zahediasl</surname><given-names>S.</given-names></name></person-group> (<year>2015</year>). <article-title>Role of atrial natriuretic Peptide in oxytocin induced cardioprotection.</article-title>
<source/><italic>Heart Lung Circ.</italic>
<volume>24</volume>
<fpage>86</fpage>–<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1016/j.hlc.2014.05.023</pub-id>
<pub-id pub-id-type="pmid">25126708</pub-id></mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>H.</given-names></name><name><surname>Amin</surname><given-names>V.</given-names></name><name><surname>Gurin</surname><given-names>M.</given-names></name><name><surname>Wan</surname><given-names>E.</given-names></name><name><surname>Thorp</surname><given-names>E.</given-names></name><name><surname>Homma</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Diet-induced obesity causes long QT and reduces transcription of voltage-gated potassium channels.</article-title>
<source/><italic>J. Mol. Cell. Cardiol.</italic>
<volume>59</volume>
<fpage>151</fpage>–<lpage>158</lpage>. <pub-id pub-id-type="doi">10.1016/j.yjmcc.2013.03.007</pub-id>
<pub-id pub-id-type="pmid">23517696</pub-id></mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>L. Y.</given-names></name><name><surname>Yen</surname><given-names>I. C.</given-names></name><name><surname>Tsai</surname><given-names>W. C.</given-names></name><name><surname>Ahmetaj-Shala</surname><given-names>B.</given-names></name><name><surname>Chang</surname><given-names>T. C.</given-names></name><name><surname>Tsai</surname><given-names>C. S.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Rhodiola crenulata attenuates high glucose induced endothelial dysfunction in human umbilical vein endothelial cells.</article-title>
<source/><italic>Am. J. Chin. Med.</italic>
<volume>45</volume>
<fpage>1201</fpage>–<lpage>1216</lpage>. <pub-id pub-id-type="doi">10.1142/s0192415x17500665</pub-id>
<pub-id pub-id-type="pmid">28830211</pub-id></mixed-citation>
</ref>
<ref id="B70">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hurtubise</surname><given-names>J.</given-names></name><name><surname>Mclellan</surname><given-names>K.</given-names></name><name><surname>Durr</surname><given-names>K.</given-names></name><name><surname>Onasanya</surname><given-names>O.</given-names></name><name><surname>Nwabuko</surname><given-names>D.</given-names></name><name><surname>Ndisang</surname><given-names>J. F.</given-names></name></person-group> (<year>2016</year>). <article-title>The different facets of dyslipidemia and hypertension in atherosclerosis.</article-title>
<source/><italic>Curr. Atheroscler. Rep.</italic>
<volume>18</volume>:<issue>82</issue>.</mixed-citation>
</ref>
<ref id="B71">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hussien</surname><given-names>N. I.</given-names></name><name><surname>Mousa</surname><given-names>A. M.</given-names></name></person-group> (<year>2016</year>). <article-title>Could nitric oxide be a mediator of action of oxytocin on myocardial injury in rats? (Biochemical, histological and immunohistochemical study).</article-title>
<source/><italic>Gen. Physiol. Biophys.</italic>
<volume>35</volume>
<fpage>353</fpage>–<lpage>362</lpage>. <pub-id pub-id-type="doi">10.4149/gpb_2015049</pub-id>
<pub-id pub-id-type="pmid">27226256</pub-id></mixed-citation>
</ref>
<ref id="B72">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Indrambarya</surname><given-names>T.</given-names></name><name><surname>Boyd</surname><given-names>J. H.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Mcconechy</surname><given-names>M.</given-names></name><name><surname>Walley</surname><given-names>K. R.</given-names></name></person-group> (<year>2009</year>). <article-title>Low-dose vasopressin infusion results in increased mortality and cardiac dysfunction following ischemia-reperfusion injury in mice.</article-title>
<source/><italic>Crit. Care</italic>
<volume>13</volume>:<issue>R98</issue>. <pub-id pub-id-type="pmid">19549333</pub-id></mixed-citation>
</ref>
<ref id="B73">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iobst</surname><given-names>S. E.</given-names></name><name><surname>Breman</surname><given-names>R. B.</given-names></name><name><surname>Bingham</surname><given-names>D.</given-names></name><name><surname>Storr</surname><given-names>C. L.</given-names></name><name><surname>Zhu</surname><given-names>S.</given-names></name><name><surname>Johantgen</surname><given-names>M.</given-names></name></person-group> (<year>2019</year>). <article-title>Associations among cervical dilatation at admission, intrapartum care, and birth mode in low-risk, nulliparous women.</article-title>
<source/><italic>Birth</italic> [Epub ahead of print]. <pub-id pub-id-type="pmid">30689220</pub-id></mixed-citation>
</ref>
<ref id="B74">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishikawa</surname><given-names>S.</given-names></name><name><surname>Kuno</surname><given-names>A.</given-names></name><name><surname>Tanno</surname><given-names>M.</given-names></name><name><surname>Miki</surname><given-names>T.</given-names></name><name><surname>Kouzu</surname><given-names>H.</given-names></name><name><surname>Itoh</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Role of connexin-43 in protective PI3K-Akt-GSK-3beta signaling in cardiomyocytes.</article-title>
<source/><italic>Am. J. Physiol. Heart Circ. Physiol.</italic>
<volume>302</volume>
<fpage>H2536</fpage>–<lpage>H2544</lpage>. <pub-id pub-id-type="pmid">22505645</pub-id></mixed-citation>
</ref>
<ref id="B75">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iwata</surname><given-names>M.</given-names></name><name><surname>Maturana</surname><given-names>A.</given-names></name><name><surname>Hoshijima</surname><given-names>M.</given-names></name><name><surname>Tatematsu</surname><given-names>K.</given-names></name><name><surname>Okajima</surname><given-names>T.</given-names></name><name><surname>Vandenheede</surname><given-names>J. R.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>PKCepsilon-PKD1 signaling complex at Z-discs plays a pivotal role in the cardiac hypertrophy induced by G-protein coupling receptor agonists.</article-title>
<source/><italic>Biochem. Biophys. Res. Commun.</italic>
<volume>327</volume>
<fpage>1105</fpage>–<lpage>1113</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2004.12.128</pub-id>
<pub-id pub-id-type="pmid">15652511</pub-id></mixed-citation>
</ref>
<ref id="B76">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jackson</surname><given-names>J.</given-names></name><name><surname>Patterson</surname><given-names>A. J.</given-names></name><name><surname>Macdonald-Wicks</surname><given-names>L.</given-names></name><name><surname>Mcevoy</surname><given-names>M.</given-names></name></person-group> (<year>2017</year>). <article-title>The role of inorganic nitrate and nitrite in CVD.</article-title>
<source/><italic>Nutr. Res. Rev.</italic>
<volume>30</volume>
<fpage>247</fpage>–<lpage>264</lpage>. <pub-id pub-id-type="doi">10.1017/s0954422417000105</pub-id>
<pub-id pub-id-type="pmid">28566109</pub-id></mixed-citation>
</ref>
<ref id="B77">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacquenod</surname><given-names>P.</given-names></name><name><surname>Cattenoz</surname><given-names>M.</given-names></name><name><surname>Canu</surname><given-names>G.</given-names></name><name><surname>Bois</surname><given-names>E.</given-names></name><name><surname>Lieutaud</surname><given-names>T.</given-names></name></person-group> (<year>2015</year>). <article-title>[Acute coronary syndrome following a 100 microg carbetocin injection during an emergency Cesarean delivery].</article-title>
<source/><italic>Can. J. Anaesth.</italic>
<volume>62</volume>
<fpage>513</fpage>–<lpage>517</lpage>. <pub-id pub-id-type="pmid">25715846</pub-id></mixed-citation>
</ref>
<ref id="B78">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jain</surname><given-names>V.</given-names></name><name><surname>Marbach</surname><given-names>J.</given-names></name><name><surname>Kimbro</surname><given-names>S.</given-names></name><name><surname>Andrade</surname><given-names>D. C.</given-names></name><name><surname>Jain</surname><given-names>A.</given-names></name><name><surname>Capozzi</surname><given-names>E.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Benefits of oxytocin administration in obstructive sleep apnea.</article-title>
<source/><italic>Am. J. Physiol. Lung Cell. Mol. Physiol.</italic>
<volume>313</volume>
<fpage>L825</fpage>–<lpage>L833</lpage>. <pub-id pub-id-type="pmid">28798255</pub-id></mixed-citation>
</ref>
<ref id="B79">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jameson</surname><given-names>H.</given-names></name><name><surname>Bateman</surname><given-names>R.</given-names></name><name><surname>Byrne</surname><given-names>P.</given-names></name><name><surname>Dyavanapalli</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Jain</surname><given-names>V.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Oxytocin neuron activation prevents hypertension that occurs with chronic intermittent hypoxia/hypercapnia in rats.</article-title>
<source/><italic>Am. J. Physiol. Heart Circ. Physiol.</italic>
<volume>310</volume>
<fpage>H1549</fpage>–<lpage>H1557</lpage>. <pub-id pub-id-type="pmid">27016581</pub-id></mixed-citation>
</ref>
<ref id="B80">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jankowski</surname><given-names>M.</given-names></name><name><surname>Bissonauth</surname><given-names>V.</given-names></name><name><surname>Gao</surname><given-names>L.</given-names></name><name><surname>Gangal</surname><given-names>M.</given-names></name><name><surname>Wang</surname><given-names>D.</given-names></name><name><surname>Danalache</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2010a</year>). <article-title>Anti-inflammatory effect of oxytocin in rat myocardial infarction.</article-title>
<source/><italic>Basic Res. Cardiol.</italic>
<volume>105</volume>
<fpage>205</fpage>–<lpage>218</lpage>. <pub-id pub-id-type="doi">10.1007/s00395-009-0076-5</pub-id>
<pub-id pub-id-type="pmid">20012748</pub-id></mixed-citation>
</ref>
<ref id="B81">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jankowski</surname><given-names>M.</given-names></name><name><surname>Wang</surname><given-names>D.</given-names></name><name><surname>Danalache</surname><given-names>B.</given-names></name><name><surname>Gangal</surname><given-names>M.</given-names></name><name><surname>Gutkowska</surname><given-names>J.</given-names></name></person-group> (<year>2010b</year>). <article-title>Cardiac oxytocin receptor blockade stimulates adverse cardiac remodeling in ovariectomized spontaneously hypertensive rats.</article-title>
<source/><italic>Am. J. Physiol. Heart Circ. Physiol.</italic>
<volume>299</volume>
<fpage>H265</fpage>–<lpage>H274</lpage>. <pub-id pub-id-type="pmid">20671291</pub-id></mixed-citation>
</ref>
<ref id="B82">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jankowski</surname><given-names>M.</given-names></name><name><surname>Broderick</surname><given-names>T. L.</given-names></name><name><surname>Gutkowska</surname><given-names>J.</given-names></name></person-group> (<year>2016</year>). <article-title>Oxytocin and cardioprotection in diabetes and obesity.</article-title>
<source/><italic>BMC Endocr. Disord.</italic>
<volume>16</volume>:<issue>34</issue>. <pub-id pub-id-type="doi">10.1186/s12902-016-0110-1</pub-id>
<pub-id pub-id-type="pmid">27268060</pub-id></mixed-citation>
</ref>
<ref id="B83">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jankowski</surname><given-names>M.</given-names></name><name><surname>Hajjar</surname><given-names>F.</given-names></name><name><surname>Kawas</surname><given-names>S. A.</given-names></name><name><surname>Mukaddam-Daher</surname><given-names>S.</given-names></name><name><surname>Hoffman</surname><given-names>G.</given-names></name><name><surname>Mccann</surname><given-names>S. M.</given-names></name><etal></etal></person-group> (<year>1998</year>). <article-title>Rat heart: a site of oxytocin production and action.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>95</volume>
<fpage>14558</fpage>–<lpage>14563</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.95.24.14558</pub-id>
<pub-id pub-id-type="pmid">9826739</pub-id></mixed-citation>
</ref>
<ref id="B84">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jankowski</surname><given-names>M.</given-names></name><name><surname>Wang</surname><given-names>D.</given-names></name><name><surname>Hajjar</surname><given-names>F.</given-names></name><name><surname>Mukaddam-Daher</surname><given-names>S.</given-names></name><name><surname>Mccann</surname><given-names>S. M.</given-names></name><name><surname>Gutkowska</surname><given-names>J.</given-names></name></person-group> (<year>2000</year>). <article-title>Oxytocin and its receptors are synthesized in the rat vasculature.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>97</volume>
<fpage>6207</fpage>–<lpage>6211</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.110137497</pub-id>
<pub-id pub-id-type="pmid">10811917</pub-id></mixed-citation>
</ref>
<ref id="B85">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Japundzic-Zigon</surname><given-names>N.</given-names></name></person-group> (<year>2013</year>). <article-title>Vasopressin and oxytocin in control of the cardiovascular system.</article-title>
<source/><italic>Curr. Neuropharmacol.</italic>
<volume>11</volume>
<fpage>218</fpage>–<lpage>230</lpage>. <pub-id pub-id-type="doi">10.2174/1570159x11311020008</pub-id>
<pub-id pub-id-type="pmid">23997756</pub-id></mixed-citation>
</ref>
<ref id="B86">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiao</surname><given-names>R.</given-names></name><name><surname>Cui</surname><given-names>D.</given-names></name><name><surname>Wang</surname><given-names>S. C.</given-names></name><name><surname>Li</surname><given-names>D.</given-names></name><name><surname>Wang</surname><given-names>Y. F.</given-names></name></person-group> (<year>2017</year>). <article-title>Interactions of the mechanosensitive channels with extracellular matrix, integrins, and cytoskeletal network in osmosensation.</article-title>
<source/><italic>Front. Mol. Neurosci.</italic>
<volume>10</volume>:<issue>96</issue>. <pub-id pub-id-type="doi">10.3389/fnmol.2017.00096</pub-id>
<pub-id pub-id-type="pmid">28424587</pub-id></mixed-citation>
</ref>
<ref id="B87">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>S.</given-names></name><name><surname>Teng</surname><given-names>X.</given-names></name><name><surname>Xiao</surname><given-names>L.</given-names></name><name><surname>Xue</surname><given-names>H.</given-names></name><name><surname>Guo</surname><given-names>Q.</given-names></name><name><surname>Duan</surname><given-names>X.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Hydrogen sulfide ameliorated L-NAME-induced hypertensive heart disease by the Akt/eNOS/NO pathway.</article-title>
<source/><italic>Exp. Biol. Med.</italic>
<volume>242</volume>
<fpage>1831</fpage>–<lpage>1841</lpage>. <pub-id pub-id-type="doi">10.1177/1535370217732325</pub-id>
<pub-id pub-id-type="pmid">28971696</pub-id></mixed-citation>
</ref>
<ref id="B88">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>Z. V.</given-names></name><name><surname>Young</surname><given-names>L. J.</given-names></name></person-group> (<year>2017</year>). <article-title>Oxytocin and vasopressin neural networks: implications for social behavioral diversity and translational neuroscience.</article-title>
<source/><italic>Neurosci. Biobehav. Rev.</italic>
<volume>76</volume>
<fpage>87</fpage>–<lpage>98</lpage>. <pub-id pub-id-type="doi">10.1016/j.neubiorev.2017.01.034</pub-id>
<pub-id pub-id-type="pmid">28434591</pub-id></mixed-citation>
</ref>
<ref id="B89">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jurek</surname><given-names>B.</given-names></name><name><surname>Neumann</surname><given-names>I. D.</given-names></name></person-group> (<year>2018</year>). <article-title>The oxytocin receptor: from intracellular signaling to behavior.</article-title>
<source/><italic>Physiol. Rev.</italic>
<volume>98</volume>
<fpage>1805</fpage>–<lpage>1908</lpage>. <pub-id pub-id-type="doi">10.1152/physrev.00031.2017</pub-id>
<pub-id pub-id-type="pmid">29897293</pub-id></mixed-citation>
</ref>
<ref id="B90">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karelina</surname><given-names>K.</given-names></name><name><surname>Stuller</surname><given-names>K. A.</given-names></name><name><surname>Jarrett</surname><given-names>B.</given-names></name><name><surname>Zhang</surname><given-names>N.</given-names></name><name><surname>Wells</surname><given-names>J.</given-names></name><name><surname>Norman</surname><given-names>G. J.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Oxytocin mediates social neuroprotection after cerebral ischemia.</article-title>
<source/><italic>Stroke</italic>
<volume>42</volume>
<fpage>3606</fpage>–<lpage>3611</lpage>. <pub-id pub-id-type="doi">10.1161/strokeaha.111.628008</pub-id>
<pub-id pub-id-type="pmid">21960564</pub-id></mixed-citation>
</ref>
<ref id="B91">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kc</surname><given-names>P.</given-names></name><name><surname>Dick</surname><given-names>T. E.</given-names></name></person-group> (<year>2010</year>). <article-title>Modulation of cardiorespiratory function mediated by the paraventricular nucleus.</article-title>
<source/><italic>Respir. Physiol. Neurobiol.</italic>
<volume>174</volume>
<fpage>55</fpage>–<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1016/j.resp.2010.08.001</pub-id>
<pub-id pub-id-type="pmid">20708107</pub-id></mixed-citation>
</ref>
<ref id="B92">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kenkel</surname><given-names>W. M.</given-names></name><name><surname>Suboc</surname><given-names>G.</given-names></name><name><surname>Carter</surname><given-names>C. S.</given-names></name></person-group> (<year>2014</year>). <article-title>Autonomic, behavioral and neuroendocrine correlates of paternal behavior in male prairie voles.</article-title>
<source/><italic>Physiol. Behav.</italic>
<volume>128</volume>
<fpage>252</fpage>–<lpage>259</lpage>. <pub-id pub-id-type="doi">10.1016/j.physbeh.2014.02.006</pub-id>
<pub-id pub-id-type="pmid">24534169</pub-id></mixed-citation>
</ref>
<ref id="B93">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>Y. S.</given-names></name><name><surname>Ahn</surname><given-names>Y.</given-names></name><name><surname>Kwon</surname><given-names>J. S.</given-names></name><name><surname>Cho</surname><given-names>Y. K.</given-names></name><name><surname>Jeong</surname><given-names>M. H.</given-names></name><name><surname>Cho</surname><given-names>J. G.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Priming of mesenchymal stem cells with oxytocin enhances the cardiac repair in ischemia/reperfusion injury.</article-title>
<source/><italic>Cells Tissues Organs</italic>
<volume>195</volume>
<fpage>428</fpage>–<lpage>442</lpage>. <pub-id pub-id-type="doi">10.1159/000329234</pub-id>
<pub-id pub-id-type="pmid">21893931</pub-id></mixed-citation>
</ref>
<ref id="B94">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>Y. S.</given-names></name><name><surname>Kwon</surname><given-names>J. S.</given-names></name><name><surname>Hong</surname><given-names>M. H.</given-names></name><name><surname>Kang</surname><given-names>W. S.</given-names></name><name><surname>Jeong</surname><given-names>H. Y.</given-names></name><name><surname>Kang</surname><given-names>H. J.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Restoration of angiogenic capacity of diabetes-insulted mesenchymal stem cells by oxytocin.</article-title>
<source/><italic>BMC Cell Biol.</italic>
<volume>14</volume>:<issue>38</issue>. <pub-id pub-id-type="doi">10.1186/1471-2121-14-38</pub-id>
<pub-id pub-id-type="pmid">24024790</pub-id></mixed-citation>
</ref>
<ref id="B95">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klein</surname><given-names>B. Y.</given-names></name><name><surname>Tamir</surname><given-names>H.</given-names></name><name><surname>Hirschberg</surname><given-names>D. L.</given-names></name><name><surname>Glickstein</surname><given-names>S. B.</given-names></name><name><surname>Ludwig</surname><given-names>R. J.</given-names></name><name><surname>Welch</surname><given-names>M. G.</given-names></name></person-group> (<year>2014</year>). <article-title>Oxytocin modulates markers of the unfolded protein response in Caco2BB gut cells.</article-title>
<source/><italic>Cell Stress Chaperones</italic>
<volume>19</volume>
<fpage>465</fpage>–<lpage>477</lpage>. <pub-id pub-id-type="doi">10.1007/s12192-013-0473-4</pub-id>
<pub-id pub-id-type="pmid">24198165</pub-id></mixed-citation>
</ref>
<ref id="B96">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klein</surname><given-names>B. Y.</given-names></name><name><surname>Tamir</surname><given-names>H.</given-names></name><name><surname>Ludwig</surname><given-names>R. J.</given-names></name><name><surname>Glickstein</surname><given-names>S. B.</given-names></name><name><surname>Welch</surname><given-names>M. G.</given-names></name></person-group> (<year>2017</year>). <article-title>Colostrum oxytocin modulates cellular stress response, inflammation, and autophagy markers in newborn rat gut villi.</article-title>
<source/><italic>Biochem. Biophys. Res. Commun.</italic>
<volume>487</volume>
<fpage>47</fpage>–<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2017.04.011</pub-id>
<pub-id pub-id-type="pmid">28389244</pub-id></mixed-citation>
</ref>
<ref id="B97">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klement</surname><given-names>J.</given-names></name><name><surname>Ott</surname><given-names>V.</given-names></name><name><surname>Rapp</surname><given-names>K.</given-names></name><name><surname>Brede</surname><given-names>S.</given-names></name><name><surname>Piccinini</surname><given-names>F.</given-names></name><name><surname>Cobelli</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Oxytocin improves beta-cell responsivity and glucose tolerance in healthy men.</article-title>
<source/><italic>Diabetes</italic>
<volume>66</volume>
<fpage>264</fpage>–<lpage>271</lpage>. <pub-id pub-id-type="doi">10.2337/db16-0569</pub-id>
<pub-id pub-id-type="pmid">27554476</pub-id></mixed-citation>
</ref>
<ref id="B98">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kobayashi</surname><given-names>H.</given-names></name><name><surname>Yasuda</surname><given-names>S.</given-names></name><name><surname>Bao</surname><given-names>N.</given-names></name><name><surname>Iwasa</surname><given-names>M.</given-names></name><name><surname>Kawamura</surname><given-names>I.</given-names></name><name><surname>Yamada</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Postinfarct treatment with oxytocin improves cardiac function and remodeling via activating cell-survival signals and angiogenesis.</article-title>
<source/><italic>J. Cardiovasc. Pharmacol.</italic>
<volume>54</volume>
<fpage>510</fpage>–<lpage>519</lpage>. <pub-id pub-id-type="doi">10.1097/fjc.0b013e3181bfac02</pub-id>
<pub-id pub-id-type="pmid">19755919</pub-id></mixed-citation>
</ref>
<ref id="B99">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koton</surname><given-names>S.</given-names></name><name><surname>Schneider</surname><given-names>A. L.</given-names></name><name><surname>Rosamond</surname><given-names>W. D.</given-names></name><name><surname>Shahar</surname><given-names>E.</given-names></name><name><surname>Sang</surname><given-names>Y.</given-names></name><name><surname>Gottesman</surname><given-names>R. F.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Stroke incidence and mortality trends in US communities, 1987 to 2011.</article-title>
<source/><italic>JAMA</italic>
<volume>312</volume>
<fpage>259</fpage>–<lpage>268</lpage>. <pub-id pub-id-type="pmid">25027141</pub-id></mixed-citation>
</ref>
<ref id="B100">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lawes</surname><given-names>C. M.</given-names></name><name><surname>Vander Hoorn</surname><given-names>S.</given-names></name><name><surname>Rodgers</surname><given-names>A.</given-names></name></person-group> (<year>2008</year>). <article-title>Global burden of blood-pressure-related disease, 2001.</article-title>
<source/><italic>Lancet</italic>
<volume>371</volume>
<fpage>1513</fpage>–<lpage>1518</lpage>. <pub-id pub-id-type="doi">10.1016/s0140-6736(08)60655-8</pub-id>
<pub-id pub-id-type="pmid">18456100</pub-id></mixed-citation>
</ref>
<ref id="B101">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>E. S.</given-names></name><name><surname>Uhm</surname><given-names>K. O.</given-names></name><name><surname>Lee</surname><given-names>Y. M.</given-names></name><name><surname>Kwon</surname><given-names>J.</given-names></name><name><surname>Park</surname><given-names>S. H.</given-names></name><name><surname>Soo</surname><given-names>K. H.</given-names></name></person-group> (<year>2008</year>). <article-title>Oxytocin stimulates glucose uptake in skeletal muscle cells through the calcium-CaMKK-AMPK pathway.</article-title>
<source/><italic>Regul. Pept.</italic>
<volume>151</volume>
<fpage>71</fpage>–<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1016/j.regpep.2008.05.001</pub-id>
<pub-id pub-id-type="pmid">18555543</pub-id></mixed-citation>
</ref>
<ref id="B102">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>H. C.</given-names></name><name><surname>Chen</surname><given-names>C. C.</given-names></name><name><surname>Tsai</surname><given-names>W. C.</given-names></name><name><surname>Lin</surname><given-names>H. T.</given-names></name><name><surname>Shiao</surname><given-names>Y. L.</given-names></name><name><surname>Sheu</surname><given-names>S. H.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Very-low-density lipoprotein of metabolic syndrome modulates gap junctions and slows cardiac conduction.</article-title>
<source/><italic>Sci. Rep.</italic>
<volume>7</volume>:<issue>12050</issue>. <pub-id pub-id-type="pmid">28935953</pub-id></mixed-citation>
</ref>
<ref id="B103">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>K. S.</given-names></name><name><surname>Kronbichler</surname><given-names>A.</given-names></name><name><surname>Eisenhut</surname><given-names>M.</given-names></name><name><surname>Lee</surname><given-names>K. H.</given-names></name><name><surname>Shin</surname><given-names>J. I.</given-names></name></person-group> (<year>2018</year>). <article-title>Cardiovascular involvement in systemic rheumatic diseases: an integrated view for the treating physicians.</article-title>
<source/><italic>Autoimmun. Rev.</italic>
<volume>17</volume>
<fpage>201</fpage>–<lpage>214</lpage>. <pub-id pub-id-type="pmid">29353099</pub-id></mixed-citation>
</ref>
<ref id="B104">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>S. K.</given-names></name><name><surname>Ryu</surname><given-names>P. D.</given-names></name><name><surname>Lee</surname><given-names>S. Y.</given-names></name></person-group> (<year>2013</year>). <article-title>Differential distributions of neuropeptides in hypothalamic paraventricular nucleus neurons projecting to the rostral ventrolateral medulla in the rat.</article-title>
<source/><italic>Neurosci. Lett.</italic>
<volume>556</volume>
<fpage>160</fpage>–<lpage>165</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2013.09.070</pub-id>
<pub-id pub-id-type="pmid">24120435</pub-id></mixed-citation>
</ref>
<ref id="B105">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lehrke</surname><given-names>M.</given-names></name><name><surname>Marx</surname><given-names>N.</given-names></name></person-group> (<year>2017</year>). <article-title>Diabetes mellitus and heart failure.</article-title>
<source/><italic>Am. J. Cardiol.</italic>
<volume>120</volume>
<fpage>S37</fpage>–<lpage>S47</lpage>.<pub-id pub-id-type="pmid">28606342</pub-id></mixed-citation>
</ref>
<ref id="B106">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leng</surname><given-names>G.</given-names></name><name><surname>Ludwig</surname><given-names>M.</given-names></name></person-group> (<year>2016</year>). <article-title>Intranasal oxytocin: myths and delusions.</article-title>
<source/><italic>Biol. Psychiatry</italic>
<volume>79</volume>
<fpage>243</fpage>–<lpage>250</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2015.05.003</pub-id>
<pub-id pub-id-type="pmid">26049207</pub-id></mixed-citation>
</ref>
<ref id="B107">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>T.</given-names></name><name><surname>Wang</surname><given-names>P.</given-names></name><name><surname>Wang</surname><given-names>S. C.</given-names></name><name><surname>Wang</surname><given-names>Y. F.</given-names></name></person-group> (<year>2017</year>). <article-title>Approaches mediating oxytocin regulation of the immune system.</article-title>
<source/><italic>Front. Immunol.</italic>
<volume>7</volume>:<issue>693</issue>. <pub-id pub-id-type="doi">10.3389/fimmu.2016.00693</pub-id>
<pub-id pub-id-type="pmid">28119696</pub-id></mixed-citation>
</ref>
<ref id="B108">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liccardi</surname><given-names>G.</given-names></name><name><surname>Bilo</surname><given-names>M.</given-names></name><name><surname>Mauro</surname><given-names>C.</given-names></name><name><surname>Salzillo</surname><given-names>A.</given-names></name><name><surname>Piccolo</surname><given-names>A.</given-names></name><name><surname>D’amato</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Oxytocin: an unexpected risk for cardiologic and broncho-obstructive effects, and allergic reactions in susceptible delivering women.</article-title>
<source/><italic>Multidiscip. Respir. Med.</italic>
<volume>8</volume>:<issue>67</issue>. <pub-id pub-id-type="pmid">24139438</pub-id></mixed-citation>
</ref>
<ref id="B109">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Light</surname><given-names>K. C.</given-names></name><name><surname>Grewen</surname><given-names>K. M.</given-names></name><name><surname>Amico</surname><given-names>J. A.</given-names></name><name><surname>Brownley</surname><given-names>K. A.</given-names></name><name><surname>West</surname><given-names>S. G.</given-names></name><name><surname>Hinderliter</surname><given-names>A. L.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>Oxytocinergic activity is linked to lower blood pressure and vascular resistance during stress in postmenopausal women on estrogen replacement.</article-title>
<source/><italic>Horm. Behav.</italic>
<volume>47</volume>
<fpage>540</fpage>–<lpage>548</lpage>. <pub-id pub-id-type="doi">10.1016/j.yhbeh.2004.12.010</pub-id>
<pub-id pub-id-type="pmid">15811355</pub-id></mixed-citation>
</ref>
<ref id="B110">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>M. C.</given-names></name><name><surname>Hsieh</surname><given-names>T. K.</given-names></name><name><surname>Liu</surname><given-names>C. A.</given-names></name><name><surname>Chu</surname><given-names>C. C.</given-names></name><name><surname>Chen</surname><given-names>J. Y.</given-names></name><name><surname>Wang</surname><given-names>J. J.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Anaphylactoid shock induced by oxytocin administration–a case report.</article-title>
<source/><italic>Acta Anaesthesiol. Taiwan.</italic>
<volume>45</volume>
<fpage>233</fpage>–<lpage>236</lpage>. <pub-id pub-id-type="pmid">18251245</pub-id></mixed-citation>
</ref>
<ref id="B111">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindahl</surname><given-names>B.</given-names></name><name><surname>Baron</surname><given-names>T.</given-names></name><name><surname>Erlinge</surname><given-names>D.</given-names></name><name><surname>Hadziosmanovic</surname><given-names>N.</given-names></name><name><surname>Nordenskjold</surname><given-names>A.</given-names></name><name><surname>Gard</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Medical therapy for secondary prevention and long-term outcome in patients with myocardial infarction with nonobstructive coronary artery disease.</article-title>
<source/><italic>Circulation</italic>
<volume>135</volume>
<fpage>1481</fpage>–<lpage>1489</lpage>. <pub-id pub-id-type="doi">10.1161/circulationaha.116.026336</pub-id>
<pub-id pub-id-type="pmid">28179398</pub-id></mixed-citation>
</ref>
<ref id="B112">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Litwiniuk</surname><given-names>A.</given-names></name><name><surname>Pijet</surname><given-names>B.</given-names></name><name><surname>Pijet-Kucicka</surname><given-names>M.</given-names></name><name><surname>Gajewska</surname><given-names>M.</given-names></name><name><surname>Pajak</surname><given-names>B.</given-names></name><name><surname>Orzechowski</surname><given-names>A.</given-names></name></person-group> (<year>2016</year>). <article-title>FOXO1 and GSK-3beta are main targets of insulin-mediated myogenesis in C2C12 muscle cells.</article-title>
<source/><italic>PLoS One</italic>
<volume>11</volume>:<issue>e0146726</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0146726</pub-id>
<pub-id pub-id-type="pmid">26785133</pub-id></mixed-citation>
</ref>
<ref id="B113">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>R.</given-names></name><name><surname>Yuan</surname><given-names>X.</given-names></name><name><surname>Chen</surname><given-names>K.</given-names></name><name><surname>Jiang</surname><given-names>Y.</given-names></name><name><surname>Zhou</surname><given-names>W.</given-names></name></person-group> (<year>2018</year>). <article-title>Perception of social interaction compresses subjective duration in an oxytocin-dependent manner.</article-title>
<source/><italic>eLife</italic>
<volume>7</volume>:<issue>e32100</issue>. <pub-id pub-id-type="pmid">29784084</pub-id></mixed-citation>
</ref>
<ref id="B114">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Llewellyn-Smith</surname><given-names>I. J.</given-names></name><name><surname>Kellett</surname><given-names>D. O.</given-names></name><name><surname>Jordan</surname><given-names>D.</given-names></name><name><surname>Browning</surname><given-names>K. N.</given-names></name><name><surname>Travagli</surname><given-names>R. A.</given-names></name></person-group> (<year>2012</year>). <article-title>Oxytocin-immunoreactive innervation of identified neurons in the rat dorsal vagal complex.</article-title>
<source/><italic>Neurogastroenterol. Motil.</italic>
<volume>24</volume>
<fpage>e136</fpage>–<lpage>146</lpage>. <pub-id pub-id-type="pmid">22188490</pub-id></mixed-citation>
</ref>
<ref id="B115">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahomed</surname><given-names>K.</given-names></name><name><surname>Wild</surname><given-names>K.</given-names></name><name><surname>Weekes</surname><given-names>C. R.</given-names></name></person-group> (<year>2018</year>). <article-title>Prostaglandin gel versus oxytocin - prelabour rupture of membranes at term - A randomised controlled trial.</article-title>
<source/><italic>Aust. N. Z. J. Obstet. Gynaecol.</italic>
<volume>58</volume>
<fpage>654</fpage>–<lpage>659</lpage>.<pub-id pub-id-type="pmid">29468633</pub-id></mixed-citation>
</ref>
<ref id="B116">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manbeck</surname><given-names>K. E.</given-names></name><name><surname>Shelley</surname><given-names>D.</given-names></name><name><surname>Schmidt</surname><given-names>C. E.</given-names></name><name><surname>Harris</surname><given-names>A. C.</given-names></name></person-group> (<year>2014</year>). <article-title>Effects of oxytocin on nicotine withdrawal in rats.</article-title>
<source/><italic>Pharmacol. Biochem. Behav.</italic>
<volume>116</volume>
<fpage>84</fpage>–<lpage>89</lpage>. <pub-id pub-id-type="doi">10.1016/j.pbb.2013.11.002</pub-id>
<pub-id pub-id-type="pmid">24239789</pub-id></mixed-citation>
</ref>
<ref id="B117">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mancini</surname><given-names>S. J.</given-names></name><name><surname>White</surname><given-names>A. D.</given-names></name><name><surname>Bijland</surname><given-names>S.</given-names></name><name><surname>Rutherford</surname><given-names>C.</given-names></name><name><surname>Graham</surname><given-names>D.</given-names></name><name><surname>Richter</surname><given-names>E. A.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Activation of AMP-activated protein kinase rapidly suppresses multiple pro-inflammatory pathways in adipocytes including IL-1 receptor-associated kinase-4 phosphorylation.</article-title>
<source/><italic>Mol. Cell. Endocrinol.</italic>
<volume>440</volume>
<fpage>44</fpage>–<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1016/j.mce.2016.11.010</pub-id>
<pub-id pub-id-type="pmid">27840174</pub-id></mixed-citation>
</ref>
<ref id="B118">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marir</surname><given-names>R.</given-names></name><name><surname>Virsolvy</surname><given-names>A.</given-names></name><name><surname>Wisniewski</surname><given-names>K.</given-names></name><name><surname>Mion</surname><given-names>J.</given-names></name><name><surname>Haddou</surname><given-names>D.</given-names></name><name><surname>Galibert</surname><given-names>E.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Pharmacological characterization of FE 201874, the first selective high affinity rat V1A vasopressin receptor agonist.</article-title>
<source/><italic>Br. J. Pharmacol.</italic>
<volume>170</volume>
<fpage>278</fpage>–<lpage>292</lpage>. <pub-id pub-id-type="doi">10.1111/bph.12249</pub-id>
<pub-id pub-id-type="pmid">23725319</pub-id></mixed-citation>
</ref>
<ref id="B119">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McLeod</surname><given-names>G.</given-names></name><name><surname>Munishankar</surname><given-names>B.</given-names></name><name><surname>Macgregor</surname><given-names>H.</given-names></name><name><surname>Murphy</surname><given-names>D. J.</given-names></name></person-group> (<year>2010</year>). <article-title>Maternal haemodynamics at elective caesarean section: a randomised comparison of oxytocin 5-unit bolus and placebo infusion with oxytocin 5-unit bolus and 30-unit infusion.</article-title>
<source/><italic>Int. J. Obstet. Anesth.</italic>
<volume>19</volume>
<fpage>155</fpage>–<lpage>160</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijoa.2009.08.005</pub-id>
<pub-id pub-id-type="pmid">20194013</pub-id></mixed-citation>
</ref>
<ref id="B120">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Menaouar</surname><given-names>A.</given-names></name><name><surname>Florian</surname><given-names>M.</given-names></name><name><surname>Wang</surname><given-names>D.</given-names></name><name><surname>Danalache</surname><given-names>B.</given-names></name><name><surname>Jankowski</surname><given-names>M.</given-names></name><name><surname>Gutkowska</surname><given-names>J.</given-names></name></person-group> (<year>2014</year>). <article-title>Anti-hypertrophic effects of oxytocin in rat ventricular myocytes.</article-title>
<source/><italic>Int. J. Cardiol.</italic>
<volume>175</volume>
<fpage>38</fpage>–<lpage>49</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijcard.2014.04.174</pub-id>
<pub-id pub-id-type="pmid">24852833</pub-id></mixed-citation>
</ref>
<ref id="B121">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meng</surname><given-names>L. B.</given-names></name><name><surname>Shan</surname><given-names>M. J.</given-names></name><name><surname>Yu</surname><given-names>Z. M.</given-names></name><name><surname>Lv</surname><given-names>J.</given-names></name><name><surname>Qi</surname><given-names>R. M.</given-names></name><name><surname>Guo</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>Chronic stress: a crucial promoter of cell apoptosis in atherosclerosis.</article-title>
<source/><italic>J. Int. Med. Res.</italic>
<pub-id pub-id-type="doi">10.1177/0300060518814606</pub-id> [Epub ahead of print]. <pub-id pub-id-type="pmid">30700193</pub-id></mixed-citation>
</ref>
<ref id="B122">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Merz</surname><given-names>T.</given-names></name><name><surname>Lukaschewski</surname><given-names>B.</given-names></name><name><surname>Wigger</surname><given-names>D.</given-names></name><name><surname>Rupprecht</surname><given-names>A.</given-names></name><name><surname>Wepler</surname><given-names>M.</given-names></name><name><surname>Groger</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Interaction of the hydrogen sulfide system with the oxytocin system in the injured mouse heart.</article-title>
<source/><italic>Intensive Care Med. Exp.</italic>
<volume>6</volume>:<issue>41</issue>. <pub-id pub-id-type="pmid">30341744</pub-id></mixed-citation>
</ref>
<ref id="B123">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>M. A.</given-names></name><name><surname>Bershad</surname><given-names>A.</given-names></name><name><surname>King</surname><given-names>A. C.</given-names></name><name><surname>Lee</surname><given-names>R.</given-names></name><name><surname>De Wit</surname><given-names>H.</given-names></name></person-group> (<year>2016</year>). <article-title>Intranasal oxytocin dampens cue-elicited cigarette craving in daily smokers: a pilot study.</article-title>
<source/><italic>Behav. Pharmacol.</italic>
<volume>27</volume>
<fpage>697</fpage>–<lpage>703</lpage>. <pub-id pub-id-type="doi">10.1097/fbp.0000000000000260</pub-id>
<pub-id pub-id-type="pmid">27661192</pub-id></mixed-citation>
</ref>
<ref id="B124">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moghimian</surname><given-names>M.</given-names></name><name><surname>Faghihi</surname><given-names>M.</given-names></name><name><surname>Karimian</surname><given-names>S. M.</given-names></name><name><surname>Imani</surname><given-names>A.</given-names></name></person-group> (<year>2012</year>). <article-title>The effect of acute stress exposure on ischemia and reperfusion injury in rat heart: role of oxytocin.</article-title>
<source/><italic>Stress</italic>
<volume>15</volume>
<fpage>385</fpage>–<lpage>392</lpage>. <pub-id pub-id-type="doi">10.3109/10253890.2011.630436</pub-id>
<pub-id pub-id-type="pmid">22044052</pub-id></mixed-citation>
</ref>
<ref id="B125">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moghimian</surname><given-names>M.</given-names></name><name><surname>Faghihi</surname><given-names>M.</given-names></name><name><surname>Karimian</surname><given-names>S. M.</given-names></name><name><surname>Imani</surname><given-names>A.</given-names></name><name><surname>Houshmand</surname><given-names>F.</given-names></name><name><surname>Azizi</surname><given-names>Y.</given-names></name></person-group> (<year>2013</year>). <article-title>Role of central oxytocin in stress-induced cardioprotection in ischemic-reperfused heart model.</article-title>
<source/><italic>J. Cardiol.</italic>
<volume>61</volume>
<fpage>79</fpage>–<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1016/j.jjcc.2012.08.021</pub-id>
<pub-id pub-id-type="pmid">23159205</pub-id></mixed-citation>
</ref>
<ref id="B126">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montgomery</surname><given-names>T. M.</given-names></name><name><surname>Pendleton</surname><given-names>E. L.</given-names></name><name><surname>Smith</surname><given-names>J. E.</given-names></name></person-group> (<year>2018</year>). <article-title>Physiological mechanisms mediating patterns of reproductive suppression and alloparental care in cooperatively breeding carnivores.</article-title>
<source/><italic>Physiol. Behav.</italic>
<volume>193</volume>(Pt A), <fpage>167</fpage>–<lpage>178</lpage>. <pub-id pub-id-type="pmid">29730040</pub-id></mixed-citation>
</ref>
<ref id="B127">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mori</surname><given-names>R.</given-names></name><name><surname>Nardin</surname><given-names>J. M.</given-names></name><name><surname>Yamamoto</surname><given-names>N.</given-names></name><name><surname>Carroli</surname><given-names>G.</given-names></name><name><surname>Weeks</surname><given-names>A.</given-names></name></person-group> (<year>2012</year>). <article-title>Umbilical vein injection for the routine management of third stage of labour.</article-title>
<source/><italic>Cochrane Database Syst. Rev.</italic>
<volume>14</volume>:<issue>CD006176</issue>.</mixed-citation>
</ref>
<ref id="B128">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morishita</surname><given-names>Y.</given-names></name><name><surname>Arima</surname><given-names>H.</given-names></name><name><surname>Hiroi</surname><given-names>M.</given-names></name><name><surname>Hayashi</surname><given-names>M.</given-names></name><name><surname>Hagiwara</surname><given-names>D.</given-names></name><name><surname>Asai</surname><given-names>N.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Poly(A) tail length of neurohypophysial hormones is shortened under endoplasmic reticulum stress.</article-title>
<source/><italic>Endocrinology</italic>
<volume>152</volume>
<fpage>4846</fpage>–<lpage>4855</lpage>. <pub-id pub-id-type="doi">10.1210/en.2011-1415</pub-id>
<pub-id pub-id-type="pmid">21971157</pub-id></mixed-citation>
</ref>
<ref id="B129">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mukaddam-Daher</surname><given-names>S.</given-names></name><name><surname>Yin</surname><given-names>Y. L.</given-names></name><name><surname>Roy</surname><given-names>J.</given-names></name><name><surname>Gutkowska</surname><given-names>J.</given-names></name><name><surname>Cardinal</surname><given-names>R.</given-names></name></person-group> (<year>2001</year>). <article-title>Negative inotropic and chronotropic effects of oxytocin.</article-title>
<source/><italic>Hypertension</italic>
<volume>38</volume>
<fpage>292</fpage>–<lpage>296</lpage>. <pub-id pub-id-type="doi">10.1161/01.hyp.38.2.292</pub-id><pub-id pub-id-type="pmid">11509492</pub-id></mixed-citation>
</ref>
<ref id="B130">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mullenix</surname><given-names>P. S.</given-names></name><name><surname>Andersen</surname><given-names>C. A.</given-names></name><name><surname>Starnes</surname><given-names>B. W.</given-names></name></person-group> (<year>2005</year>). <article-title>Atherosclerosis as inflammation.</article-title>
<source/><italic>Ann. Vasc. Surg.</italic>
<volume>19</volume>
<fpage>130</fpage>–<lpage>138</lpage>.<pub-id pub-id-type="pmid">15714382</pub-id></mixed-citation>
</ref>
<ref id="B131">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Natochin</surname><given-names>Y. V.</given-names></name><name><surname>Golosova</surname><given-names>D. V.</given-names></name><name><surname>Shakhmatova</surname><given-names>E. I.</given-names></name></person-group> (<year>2018</year>). <article-title>A new functional role of oxytocin: participation in osmoregulation.</article-title>
<source/><italic>Dokl. Biol. Sci.</italic>
<volume>479</volume>
<fpage>60</fpage>–<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1134/s0012496618020096</pub-id>
<pub-id pub-id-type="pmid">29790029</pub-id></mixed-citation>
</ref>
<ref id="B132">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nielsen</surname><given-names>S. H.</given-names></name><name><surname>Magid</surname><given-names>E.</given-names></name><name><surname>Spannow</surname><given-names>J.</given-names></name><name><surname>Christensen</surname><given-names>S.</given-names></name><name><surname>Lam</surname><given-names>H. R.</given-names></name><name><surname>Petersen</surname><given-names>J. S.</given-names></name></person-group> (<year>1997</year>). <article-title>Renal function after myocardial infarction and cardiac arrest in rats: role of ANP-induced albuminuria?</article-title>
<source/><italic>Acta Physiol. Scand.</italic>
<volume>160</volume>
<fpage>301</fpage>–<lpage>310</lpage>. <pub-id pub-id-type="doi">10.1046/j.1365-201x.1997.00162.x</pub-id>
<pub-id pub-id-type="pmid">9338510</pub-id></mixed-citation>
</ref>
<ref id="B133">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niemann</surname><given-names>B.</given-names></name><name><surname>Rohrbach</surname><given-names>S.</given-names></name><name><surname>Miller</surname><given-names>M. R.</given-names></name><name><surname>Newby</surname><given-names>D. E.</given-names></name><name><surname>Fuster</surname><given-names>V.</given-names></name><name><surname>Kovacic</surname><given-names>J. C.</given-names></name></person-group> (<year>2017</year>). <article-title>Oxidative stress and cardiovascular risk: obesity, diabetes, smoking, and pollution: part 3 of a 3-part series.</article-title>
<source/><italic>J. Am. Coll. Cardiol.</italic>
<volume>70</volume>
<fpage>230</fpage>–<lpage>251</lpage>. <pub-id pub-id-type="doi">10.1016/j.jacc.2017.05.043</pub-id>
<pub-id pub-id-type="pmid">28683970</pub-id></mixed-citation>
</ref>
<ref id="B134">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noiseux</surname><given-names>N.</given-names></name><name><surname>Borie</surname><given-names>M.</given-names></name><name><surname>Desnoyers</surname><given-names>A.</given-names></name><name><surname>Menaouar</surname><given-names>A.</given-names></name><name><surname>Stevens</surname><given-names>L. M.</given-names></name><name><surname>Mansour</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Preconditioning of stem cells by oxytocin to improve their therapeutic potential.</article-title>
<source/><italic>Endocrinology</italic>
<volume>153</volume>
<fpage>5361</fpage>–<lpage>5372</lpage>. <pub-id pub-id-type="doi">10.1210/en.2012-1402</pub-id>
<pub-id pub-id-type="pmid">23024264</pub-id></mixed-citation>
</ref>
<ref id="B135">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noller</surname><given-names>C. M.</given-names></name><name><surname>Szeto</surname><given-names>A.</given-names></name><name><surname>Mendez</surname><given-names>A. J.</given-names></name><name><surname>Llabre</surname><given-names>M. M.</given-names></name><name><surname>Gonzales</surname><given-names>J. A.</given-names></name><name><surname>Rossetti</surname><given-names>M. A.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>The influence of social environment on endocrine, cardiovascular and tissue responses in the rabbit.</article-title>
<source/><italic>Int. J. Psychophysiol.</italic>
<volume>88</volume>
<fpage>282</fpage>–<lpage>288</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijpsycho.2012.04.008</pub-id>
<pub-id pub-id-type="pmid">22546665</pub-id></mixed-citation>
</ref>
<ref id="B136">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okabe</surname><given-names>T.</given-names></name><name><surname>Goren</surname><given-names>H. J.</given-names></name><name><surname>Lederis</surname><given-names>K.</given-names></name><name><surname>Hollenberg</surname><given-names>M. D.</given-names></name></person-group> (<year>1985</year>). <article-title>Oxytocin and glucose oxidation in the rat uterus.</article-title>
<source/><italic>Regul. Pept.</italic>
<volume>10</volume>
<fpage>269</fpage>–<lpage>279</lpage>. <pub-id pub-id-type="doi">10.1016/0167-0115(85)90039-4</pub-id><pub-id pub-id-type="pmid">3890033</pub-id></mixed-citation>
</ref>
<ref id="B137">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olszewski</surname><given-names>P. K.</given-names></name><name><surname>Klockars</surname><given-names>A.</given-names></name><name><surname>Schioth</surname><given-names>H. B.</given-names></name><name><surname>Levine</surname><given-names>A. S.</given-names></name></person-group> (<year>2010</year>). <article-title>Oxytocin as feeding inhibitor: maintaining homeostasis in consummatory behavior.</article-title>
<source/><italic>Pharmacol. Biochem. Behav.</italic>
<volume>97</volume>
<fpage>47</fpage>–<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1016/j.pbb.2010.05.026</pub-id>
<pub-id pub-id-type="pmid">20595062</pub-id></mixed-citation>
</ref>
<ref id="B138">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Padol</surname><given-names>A. R.</given-names></name><name><surname>Sukumaran</surname><given-names>S. V.</given-names></name><name><surname>Sadam</surname><given-names>A.</given-names></name><name><surname>Kesavan</surname><given-names>M.</given-names></name><name><surname>Arunvikram</surname><given-names>K.</given-names></name><name><surname>Verma</surname><given-names>A. D.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Hypercholesterolemia impairs oxytocin-induced uterine contractility in late pregnant mouse.</article-title>
<source/><italic>Reproduction</italic>
<volume>153</volume>
<fpage>565</fpage>–<lpage>576</lpage>. <pub-id pub-id-type="doi">10.1530/rep-16-0446</pub-id>
<pub-id pub-id-type="pmid">28400465</pub-id></mixed-citation>
</ref>
<ref id="B139">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paquin</surname><given-names>J.</given-names></name><name><surname>Danalache</surname><given-names>B. A.</given-names></name><name><surname>Jankowski</surname><given-names>M.</given-names></name><name><surname>Mccann</surname><given-names>S. M.</given-names></name><name><surname>Gutkowska</surname><given-names>J.</given-names></name></person-group> (<year>2002</year>). <article-title>Oxytocin induces differentiation of P19 embryonic stem cells to cardiomyocytes.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>99</volume>
<fpage>9550</fpage>–<lpage>9555</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.152302499</pub-id>
<pub-id pub-id-type="pmid">12093924</pub-id></mixed-citation>
</ref>
<ref id="B140">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>N.</given-names></name><name><surname>Radeos</surname><given-names>M.</given-names></name></person-group> (<year>2018</year>). <article-title>Severe delayed postpartum hemorrhage after cesarean section.</article-title>
<source/><italic>J. Emerg. Med.</italic>
<volume>55</volume>
<fpage>408</fpage>–<lpage>410</lpage>.<pub-id pub-id-type="pmid">29753568</pub-id></mixed-citation>
</ref>
<ref id="B141">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patrick</surname><given-names>R. P.</given-names></name><name><surname>Ames</surname><given-names>B. N.</given-names></name></person-group> (<year>2014</year>). <article-title>Vitamin D hormone regulates serotonin synthesis. Part 1: relevance for autism.</article-title>
<source/><italic>FASEB J.</italic>
<volume>28</volume>
<fpage>2398</fpage>–<lpage>2413</lpage>. <pub-id pub-id-type="doi">10.1096/fj.13-246546</pub-id>
<pub-id pub-id-type="pmid">24558199</pub-id></mixed-citation>
</ref>
<ref id="B142">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peller</surname><given-names>M.</given-names></name><name><surname>Lodzinski</surname><given-names>P.</given-names></name><name><surname>Ozieranski</surname><given-names>K.</given-names></name><name><surname>Tyminska</surname><given-names>A.</given-names></name><name><surname>Balsam</surname><given-names>P.</given-names></name><name><surname>Kajurek</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>The influence of the atrial fibrillation episode duration on the endothelial function in patients treated with pulmonary veins isolation.</article-title>
<source/><italic>Adv. Clin. Exp. Med.</italic>
<volume>26</volume>
<fpage>109</fpage>–<lpage>113</lpage>. <pub-id pub-id-type="doi">10.17219/acem/66995</pub-id>
<pub-id pub-id-type="pmid">28397441</pub-id></mixed-citation>
</ref>
<ref id="B143">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peters</surname><given-names>S. T.</given-names></name><name><surname>Bowen</surname><given-names>M. T.</given-names></name><name><surname>Bohrer</surname><given-names>K.</given-names></name><name><surname>Mcgregor</surname><given-names>I. S.</given-names></name><name><surname>Neumann</surname><given-names>I. D.</given-names></name></person-group> (<year>2017</year>). <article-title>Oxytocin inhibits ethanol consumption and ethanol-induced dopamine release in the nucleus accumbens.</article-title>
<source/><italic>Addict. Biol.</italic>
<volume>22</volume>
<fpage>702</fpage>–<lpage>711</lpage>. <pub-id pub-id-type="doi">10.1111/adb.12362</pub-id>
<pub-id pub-id-type="pmid">26810371</pub-id></mixed-citation>
</ref>
<ref id="B144">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petersson</surname><given-names>M.</given-names></name><name><surname>Uvnas-Moberg</surname><given-names>K.</given-names></name></person-group> (<year>2008</year>). <article-title>Postnatal oxytocin treatment of spontaneously hypertensive male rats decreases blood pressure and body weight in adulthood.</article-title>
<source/><italic>Neurosci. Lett.</italic>
<volume>440</volume>
<fpage>166</fpage>–<lpage>169</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2008.05.091</pub-id>
<pub-id pub-id-type="pmid">18562099</pub-id></mixed-citation>
</ref>
<ref id="B145">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petty</surname><given-names>M. A.</given-names></name><name><surname>Lang</surname><given-names>R. E.</given-names></name><name><surname>Unger</surname><given-names>T.</given-names></name><name><surname>Ganten</surname><given-names>D.</given-names></name></person-group> (<year>1985</year>). <article-title>The cardiovascular effects of oxytocin in conscious male rats.</article-title>
<source/><italic>Eur. J. Pharmacol.</italic>
<volume>112</volume>
<fpage>203</fpage>–<lpage>210</lpage>. <pub-id pub-id-type="doi">10.1016/0014-2999(85)90497-2</pub-id><pub-id pub-id-type="pmid">4029259</pub-id></mixed-citation>
</ref>
<ref id="B146">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phie</surname><given-names>J.</given-names></name><name><surname>Haleagrahara</surname><given-names>N.</given-names></name><name><surname>Newton</surname><given-names>P.</given-names></name><name><surname>Constantinoiu</surname><given-names>C.</given-names></name><name><surname>Sarnyai</surname><given-names>Z.</given-names></name><name><surname>Chilton</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Prolonged subcutaneous administration of oxytocin accelerates angiotensin II-induced hypertension and renal damage in male rats.</article-title>
<source/><italic>PLoS One</italic>
<volume>10</volume>:<issue>e0138048</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0138048</pub-id>
<pub-id pub-id-type="pmid">26393919</pub-id></mixed-citation>
</ref>
<ref id="B147">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pimentel</surname><given-names>V. M.</given-names></name><name><surname>Arabkhazaeli</surname><given-names>M.</given-names></name><name><surname>Moon</surname><given-names>J. Y.</given-names></name><name><surname>Wang</surname><given-names>A.</given-names></name><name><surname>Kapedani</surname><given-names>A.</given-names></name><name><surname>Bernstein</surname><given-names>P. S.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Induction of labor using one dose versus multiple doses of misoprostol: a randomized controlled trial.</article-title>
<source/><italic>Am. J. Obstet. Gynecol.</italic>
<volume>218</volume>
<fpage>614.e1</fpage>–<lpage>614.e8</lpage>.<pub-id pub-id-type="pmid">29614276</pub-id></mixed-citation>
</ref>
<ref id="B148">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plante</surname><given-names>E.</given-names></name><name><surname>Menaouar</surname><given-names>A.</given-names></name><name><surname>Danalache</surname><given-names>B. A.</given-names></name><name><surname>Yip</surname><given-names>D.</given-names></name><name><surname>Broderick</surname><given-names>T. L.</given-names></name><name><surname>Chiasson</surname><given-names>J. L.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Oxytocin treatment prevents the cardiomyopathy observed in obese diabetic male db/db mice.</article-title>
<source/><italic>Endocrinology</italic>
<volume>156</volume>
<fpage>1416</fpage>–<lpage>1428</lpage>. <pub-id pub-id-type="doi">10.1210/en.2014-1718</pub-id>
<pub-id pub-id-type="pmid">25562615</pub-id></mixed-citation>
</ref>
<ref id="B149">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pohl</surname><given-names>O.</given-names></name><name><surname>Chollet</surname><given-names>A.</given-names></name><name><surname>Kim</surname><given-names>S. H.</given-names></name><name><surname>Riaposova</surname><given-names>L.</given-names></name><name><surname>Spezia</surname><given-names>F.</given-names></name><name><surname>Gervais</surname><given-names>F.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>OBE022, an oral and selective prostaglandin F2alpha receptor antagonist as an effective and safe modality for the treatment of preterm labor.</article-title>
<source/><italic>J. Pharmacol. Exp. Ther.</italic>
<volume>366</volume>
<fpage>349</fpage>–<lpage>364</lpage>. <pub-id pub-id-type="doi">10.1124/jpet.118.247668</pub-id>
<pub-id pub-id-type="pmid">29777040</pub-id></mixed-citation>
</ref>
<ref id="B150">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Polshekan</surname><given-names>M.</given-names></name><name><surname>Jamialahmadi</surname><given-names>K.</given-names></name><name><surname>Khori</surname><given-names>V.</given-names></name><name><surname>Alizadeh</surname><given-names>A. M.</given-names></name><name><surname>Saeidi</surname><given-names>M.</given-names></name><name><surname>Ghayour-Mobarhan</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>RISK pathway is involved in oxytocin postconditioning in isolated rat heart.</article-title>
<source/><italic>Peptides</italic>
<volume>86</volume>
<fpage>55</fpage>–<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1016/j.peptides.2016.10.001</pub-id>
<pub-id pub-id-type="pmid">27717750</pub-id></mixed-citation>
</ref>
<ref id="B151">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Polshekan</surname><given-names>M.</given-names></name><name><surname>Khori</surname><given-names>V.</given-names></name><name><surname>Alizadeh</surname><given-names>A. M.</given-names></name><name><surname>Ghayour-Mobarhan</surname><given-names>M.</given-names></name><name><surname>Saeidi</surname><given-names>M.</given-names></name><name><surname>Jand</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>The SAFE pathway is involved in the postconditioning mechanism of oxytocin in isolated rat heart.</article-title>
<source/><italic>Peptides</italic>
<volume>111</volume>
<fpage>142</fpage>–<lpage>151</lpage>. <pub-id pub-id-type="doi">10.1016/j.peptides.2018.04.002</pub-id>
<pub-id pub-id-type="pmid">29635063</pub-id></mixed-citation>
</ref>
<ref id="B152">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Price</surname><given-names>C. L.</given-names></name><name><surname>Knight</surname><given-names>S. C.</given-names></name></person-group> (<year>2007</year>). <article-title>Advanced glycation: a novel outlook on atherosclerosis.</article-title>
<source/><italic>Curr. Pharm. Des.</italic>
<volume>13</volume>
<fpage>3681</fpage>–<lpage>3687</lpage>. <pub-id pub-id-type="doi">10.2174/138161207783018608</pub-id>
<pub-id pub-id-type="pmid">18220806</pub-id></mixed-citation>
</ref>
<ref id="B153">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qian</surname><given-names>W.</given-names></name><name><surname>Zhu</surname><given-names>T.</given-names></name><name><surname>Tang</surname><given-names>B.</given-names></name><name><surname>Yu</surname><given-names>S.</given-names></name><name><surname>Hu</surname><given-names>H.</given-names></name><name><surname>Sun</surname><given-names>W.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Decreased circulating levels of oxytocin in obesity and newly diagnosed type 2 diabetic patients.</article-title>
<source/><italic>J. Clin. Endocrinol. Metab.</italic>
<volume>99</volume>
<fpage>4683</fpage>–<lpage>4689</lpage>. <pub-id pub-id-type="doi">10.1210/jc.2014-2206</pub-id>
<pub-id pub-id-type="pmid">25233153</pub-id></mixed-citation>
</ref>
<ref id="B154">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qiu</surname><given-names>Z.</given-names></name><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Fan</surname><given-names>F.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Wu</surname><given-names>C.</given-names></name><name><surname>Ye</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Rosuvastatin-attenuated heart failure in aged spontaneously hypertensive rats via PKCalpha/beta2 signal pathway.</article-title>
<source/><italic>J. Cell. Mol. Med.</italic>
<volume>16</volume>
<fpage>3052</fpage>–<lpage>3061</lpage>. <pub-id pub-id-type="doi">10.1111/j.1582-4934.2012.01632.x</pub-id>
<pub-id pub-id-type="pmid">22970977</pub-id></mixed-citation>
</ref>
<ref id="B155">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quinones-Jenab</surname><given-names>V.</given-names></name><name><surname>Jenab</surname><given-names>S.</given-names></name><name><surname>Ogawa</surname><given-names>S.</given-names></name><name><surname>Adan</surname><given-names>R. A.</given-names></name><name><surname>Burbach</surname><given-names>J. P.</given-names></name><name><surname>Pfaff</surname><given-names>D. W.</given-names></name></person-group> (<year>1997</year>). <article-title>Effects of estrogen on oxytocin receptor messenger ribonucleic acid expression in the uterus, pituitary, and forebrain of the female rat.</article-title>
<source/><italic>Neuroendocrinology</italic>
<volume>65</volume>
<fpage>9</fpage>–<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1159/000127160</pub-id>
<pub-id pub-id-type="pmid">9032770</pub-id></mixed-citation>
</ref>
<ref id="B156">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quintana</surname><given-names>D. S.</given-names></name><name><surname>Dieset</surname><given-names>I.</given-names></name><name><surname>Elvsashagen</surname><given-names>T.</given-names></name><name><surname>Westlye</surname><given-names>L. T.</given-names></name><name><surname>Andreassen</surname><given-names>O. A.</given-names></name></person-group> (<year>2017</year>). <article-title>Oxytocin system dysfunction as a common mechanism underlying metabolic syndrome and psychiatric symptoms in schizophrenia and bipolar disorders.</article-title>
<source/><italic>Front. Neuroendocrinol.</italic>
<volume>45</volume>
<fpage>1</fpage>–<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1016/j.yfrne.2016.12.004</pub-id>
<pub-id pub-id-type="pmid">28049009</pub-id></mixed-citation>
</ref>
<ref id="B157">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quintana</surname><given-names>D. S.</given-names></name><name><surname>Kemp</surname><given-names>A. H.</given-names></name><name><surname>Alvares</surname><given-names>G. A.</given-names></name><name><surname>Guastella</surname><given-names>A. J.</given-names></name></person-group> (<year>2013</year>). <article-title>A role for autonomic cardiac control in the effects of oxytocin on social behavior and psychiatric illness.</article-title>
<source/><italic>Front. Neurosci.</italic>
<volume>7</volume>:<issue>48</issue>. <pub-id pub-id-type="doi">10.3389/fnins.2013.00048</pub-id>
<pub-id pub-id-type="pmid">23565075</pub-id></mixed-citation>
</ref>
<ref id="B158">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rabow</surname><given-names>S.</given-names></name><name><surname>Hjorth</surname><given-names>U.</given-names></name><name><surname>Schonbeck</surname><given-names>S.</given-names></name><name><surname>Olofsson</surname><given-names>P.</given-names></name></person-group> (<year>2018</year>). <article-title>Effects of oxytocin and anaesthesia on vascular tone in pregnant women: a randomised double-blind placebo-controlled study using non-invasive pulse wave analysis.</article-title>
<source/><italic>BMC Pregnancy Childbirth</italic>
<volume>18</volume>:<issue>453</issue>. <pub-id pub-id-type="doi">10.1186/s12884-018-2029-1</pub-id>
<pub-id pub-id-type="pmid">30466402</pub-id></mixed-citation>
</ref>
<ref id="B159">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rahman</surname><given-names>M. S.</given-names></name><name><surname>Woollard</surname><given-names>K.</given-names></name></person-group> (<year>2017</year>). <article-title>Atherosclerosis.</article-title>
<source/><italic>Adv. Exp. Med. Biol.</italic>
<volume>1003</volume>
<fpage>121</fpage>–<lpage>144</lpage>.<pub-id pub-id-type="pmid">28667557</pub-id></mixed-citation>
</ref>
<ref id="B160">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raphael</surname><given-names>J.</given-names></name><name><surname>Gozal</surname><given-names>Y.</given-names></name><name><surname>Navot</surname><given-names>N.</given-names></name><name><surname>Zuo</surname><given-names>Z.</given-names></name></person-group> (<year>2015</year>). <article-title>Activation of adenosine triphosphate-regulated potassium channels during reperfusion restores isoflurane postconditioning-induced cardiac protection in acutely hyperglycemic rabbits.</article-title>
<source/><italic>Anesthesiology</italic>
<volume>122</volume>
<fpage>1299</fpage>–<lpage>1311</lpage>. <pub-id pub-id-type="doi">10.1097/aln.0000000000000648</pub-id>
<pub-id pub-id-type="pmid">25812079</pub-id></mixed-citation>
</ref>
<ref id="B161">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rapsomaniki</surname><given-names>E.</given-names></name><name><surname>Timmis</surname><given-names>A.</given-names></name><name><surname>George</surname><given-names>J.</given-names></name><name><surname>Pujades-Rodriguez</surname><given-names>M.</given-names></name><name><surname>Shah</surname><given-names>A. D.</given-names></name><name><surname>Denaxas</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1.25 million people.</article-title>
<source/><italic>Lancet</italic>
<volume>383</volume>
<fpage>1899</fpage>–<lpage>1911</lpage>. <pub-id pub-id-type="doi">10.1016/s0140-6736(14)60685-1</pub-id>
<pub-id pub-id-type="pmid">24881994</pub-id></mixed-citation>
</ref>
<ref id="B162">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reed</surname><given-names>S. C.</given-names></name><name><surname>Haney</surname><given-names>M.</given-names></name><name><surname>Manubay</surname><given-names>J.</given-names></name><name><surname>Campagna</surname><given-names>B. R.</given-names></name><name><surname>Reed</surname><given-names>B.</given-names></name><name><surname>Foltin</surname><given-names>R. W.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>Sex differences in stress reactivity after intranasal oxytocin in recreational cannabis users.</article-title>
<source/><italic>Pharmacol. Biochem. Behav.</italic>
<volume>176</volume>
<fpage>72</fpage>–<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1016/j.pbb.2018.11.008</pub-id>
<pub-id pub-id-type="pmid">30521833</pub-id></mixed-citation>
</ref>
<ref id="B163">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rettori</surname><given-names>E.</given-names></name><name><surname>De Laurentiis</surname><given-names>A.</given-names></name><name><surname>Dees</surname><given-names>W. L.</given-names></name><name><surname>Endruhn</surname><given-names>A.</given-names></name><name><surname>Rettori</surname><given-names>V.</given-names></name></person-group> (<year>2014</year>). <article-title>Host neuro- immuno-endocrine responses in periodontal disease.</article-title>
<source/><italic>Curr. Pharm. Des.</italic>
<volume>20</volume>
<fpage>4749</fpage>–<lpage>4759</lpage>. <pub-id pub-id-type="doi">10.2174/1381612820666140130204043</pub-id>
<pub-id pub-id-type="pmid">24588827</pub-id></mixed-citation>
</ref>
<ref id="B164">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rimoldi</surname><given-names>V.</given-names></name><name><surname>Reversi</surname><given-names>A.</given-names></name><name><surname>Taverna</surname><given-names>E.</given-names></name><name><surname>Rosa</surname><given-names>P.</given-names></name><name><surname>Francolini</surname><given-names>M.</given-names></name><name><surname>Cassoni</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>2003</year>). <article-title>Oxytocin receptor elicits different EGFR/MAPK activation patterns depending on its localization in caveolin-1 enriched domains.</article-title>
<source/><italic>Oncogene</italic>
<volume>22</volume>
<fpage>6054</fpage>–<lpage>6060</lpage>. <pub-id pub-id-type="doi">10.1038/sj.onc.1206612</pub-id>
<pub-id pub-id-type="pmid">12955084</pub-id></mixed-citation>
</ref>
<ref id="B165">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodriguez-Iturbe</surname><given-names>B.</given-names></name><name><surname>Pons</surname><given-names>H.</given-names></name><name><surname>Johnson</surname><given-names>R. J.</given-names></name></person-group> (<year>2017</year>). <article-title>Role of the immune system in hypertension.</article-title>
<source/><italic>Physiol. Rev.</italic>
<volume>97</volume>
<fpage>1127</fpage>–<lpage>1164</lpage>.<pub-id pub-id-type="pmid">28566539</pub-id></mixed-citation>
</ref>
<ref id="B166">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roy</surname><given-names>R. K.</given-names></name><name><surname>Augustine</surname><given-names>R. A.</given-names></name><name><surname>Brown</surname><given-names>C. H.</given-names></name><name><surname>Schwenke</surname><given-names>D. O.</given-names></name></person-group> (<year>2018</year>). <article-title>Activation of oxytocin neurons in the paraventricular nucleus drives cardiac sympathetic nerve activation following myocardial infarction in rats.</article-title>
<source/><italic>Commun. Biol.</italic>
<volume>1</volume>:<issue>160</issue>. <pub-id pub-id-type="pmid">30320228</pub-id></mixed-citation>
</ref>
<ref id="B167">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saccone</surname><given-names>G.</given-names></name><name><surname>Ciardulli</surname><given-names>A.</given-names></name><name><surname>Baxter</surname><given-names>J. K.</given-names></name><name><surname>Quinones</surname><given-names>J. N.</given-names></name><name><surname>Diven</surname><given-names>L. C.</given-names></name><name><surname>Pinar</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Discontinuing oxytocin infusion in the active phase of labor: a systematic review and meta-analysis.</article-title>
<source/><italic>Obstet. Gynecol.</italic>
<volume>130</volume>
<fpage>1090</fpage>–<lpage>1096</lpage>. <pub-id pub-id-type="doi">10.1097/aog.0000000000002325</pub-id>
<pub-id pub-id-type="pmid">29016497</pub-id></mixed-citation>
</ref>
<ref id="B168">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sack</surname><given-names>M.</given-names></name><name><surname>Spieler</surname><given-names>D.</given-names></name><name><surname>Wizelman</surname><given-names>L.</given-names></name><name><surname>Epple</surname><given-names>G.</given-names></name><name><surname>Stich</surname><given-names>J.</given-names></name><name><surname>Zaba</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Intranasal oxytocin reduces provoked symptoms in female patients with posttraumatic stress disorder despite exerting sympathomimetic and positive chronotropic effects in a randomized controlled trial.</article-title>
<source/><italic>BMC Med.</italic>
<volume>15</volume>:<issue>40</issue>. <pub-id pub-id-type="doi">10.1186/s12916-017-0801-</pub-id>
<pub-id pub-id-type="pmid">28209155</pub-id></mixed-citation>
</ref>
<ref id="B169">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanin</surname><given-names>V.</given-names></name><name><surname>Pfetsch</surname><given-names>V.</given-names></name><name><surname>Koenig</surname><given-names>W.</given-names></name></person-group> (<year>2017</year>). <article-title>Dyslipidemias and cardiovascular prevention: tailoring treatment according to lipid phenotype.</article-title>
<source/><italic>Curr. Cardiol. Rep.</italic>
<volume>19</volume>:<issue>61</issue>. <pub-id pub-id-type="pmid">28528455</pub-id></mixed-citation>
</ref>
<ref id="B170">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schinzari</surname><given-names>F.</given-names></name><name><surname>Tesauro</surname><given-names>M.</given-names></name><name><surname>Cardillo</surname><given-names>C.</given-names></name></person-group> (<year>2017</year>). <article-title>Endothelial and perivascular adipose tissue abnormalities in obesity-related vascular dysfunction: novel targets for treatment.</article-title>
<source/><italic>J. Cardiovasc. Pharmacol.</italic>
<volume>69</volume>
<fpage>360</fpage>–<lpage>368</lpage>. <pub-id pub-id-type="pmid">28141700</pub-id></mixed-citation>
</ref>
<ref id="B171">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schuh</surname><given-names>A. K.</given-names></name><name><surname>Sheybani</surname><given-names>B.</given-names></name><name><surname>Jortzik</surname><given-names>E.</given-names></name><name><surname>Niemann</surname><given-names>B.</given-names></name><name><surname>Wilhelm</surname><given-names>J.</given-names></name><name><surname>Boening</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Redox status of patients before cardiac surgery.</article-title>
<source/><italic>Redox Rep.</italic>
<volume>23</volume>
<fpage>83</fpage>–<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1080/13510002.2017.1418620</pub-id>
<pub-id pub-id-type="pmid">29257712</pub-id></mixed-citation>
</ref>
<ref id="B172">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seckl</surname><given-names>J. R.</given-names></name><name><surname>Johnson</surname><given-names>M.</given-names></name><name><surname>Shakespear</surname><given-names>C.</given-names></name><name><surname>Lightman</surname><given-names>S. L.</given-names></name></person-group> (<year>1988</year>). <article-title>Endogenous opioids inhibit oxytocin release during nicotine-stimulated secretion of vasopressin in man.</article-title>
<source/><italic>Clin. Endocrinol.</italic>
<volume>28</volume>
<fpage>509</fpage>–<lpage>514</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2265.1988.tb03685.x</pub-id>
<pub-id pub-id-type="pmid">3214943</pub-id></mixed-citation>
</ref>
<ref id="B173">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seidl</surname><given-names>M. D.</given-names></name><name><surname>Stein</surname><given-names>J.</given-names></name><name><surname>Hamer</surname><given-names>S.</given-names></name><name><surname>Pluteanu</surname><given-names>F.</given-names></name><name><surname>Scholz</surname><given-names>B.</given-names></name><name><surname>Wardelmann</surname><given-names>E.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Characterization of the genetic program linked to the development of atrial fibrillation in CREM-IbDeltaC-X mice.</article-title>
<source/><italic>Circ. Arrhythm. Electrophysiol.</italic>
<volume>10</volume>:<issue>e005075</issue>. <pub-id pub-id-type="pmid">28784605</pub-id></mixed-citation>
</ref>
<ref id="B174">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shioi</surname><given-names>T.</given-names></name><name><surname>Kang</surname><given-names>P. M.</given-names></name><name><surname>Douglas</surname><given-names>P. S.</given-names></name><name><surname>Hampe</surname><given-names>J.</given-names></name><name><surname>Yballe</surname><given-names>C. M.</given-names></name><name><surname>Lawitts</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2000</year>). <article-title>The conserved phosphoinositide 3-kinase pathway determines heart size in mice.</article-title>
<source/><italic>EMBO J.</italic>
<volume>19</volume>
<fpage>2537</fpage>–<lpage>2548</lpage>. <pub-id pub-id-type="doi">10.1093/emboj/19.11.2537</pub-id>
<pub-id pub-id-type="pmid">10835352</pub-id></mixed-citation>
</ref>
<ref id="B175">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soares</surname><given-names>T. J.</given-names></name><name><surname>Coimbra</surname><given-names>T. M.</given-names></name><name><surname>Martins</surname><given-names>A. R.</given-names></name><name><surname>Pereira</surname><given-names>A. G.</given-names></name><name><surname>Carnio</surname><given-names>E. C.</given-names></name><name><surname>Branco</surname><given-names>L. G.</given-names></name><etal></etal></person-group> (<year>1999</year>). <article-title>Atrial natriuretic peptide and oxytocin induce natriuresis by release of cGMP.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>96</volume>
<fpage>278</fpage>–<lpage>283</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.96.1.278</pub-id>
<pub-id pub-id-type="pmid">9874809</pub-id></mixed-citation>
</ref>
<ref id="B176">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>Z.</given-names></name><name><surname>Albers</surname><given-names>H. E.</given-names></name></person-group> (<year>2017</year>). <article-title>Cross-talk among oxytocin and arginine-vasopressin receptors: relevance for basic and clinical studies of the brain and periphery.</article-title>
<source/><italic>Front. Neuroendocrinol.</italic>
<volume>51</volume>
<fpage>14</fpage>–<lpage>24</lpage>. <pub-id pub-id-type="pmid">29054552</pub-id></mixed-citation>
</ref>
<ref id="B177">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stevenson</surname><given-names>J. R.</given-names></name><name><surname>Wenner</surname><given-names>S. M.</given-names></name><name><surname>Freestone</surname><given-names>D. M.</given-names></name><name><surname>Romaine</surname><given-names>C. C.</given-names></name><name><surname>Parian</surname><given-names>M. C.</given-names></name><name><surname>Christian</surname><given-names>S. M.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Oxytocin reduces alcohol consumption in prairie voles.</article-title>
<source/><italic>Physiol. Behav.</italic>
<volume>179</volume>
<fpage>411</fpage>–<lpage>421</lpage>. <pub-id pub-id-type="doi">10.1016/j.physbeh.2017.07.021</pub-id>
<pub-id pub-id-type="pmid">28716609</pub-id></mixed-citation>
</ref>
<ref id="B178">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sumi</surname><given-names>S.</given-names></name><name><surname>Kobayashi</surname><given-names>H.</given-names></name><name><surname>Yasuda</surname><given-names>S.</given-names></name><name><surname>Iwasa</surname><given-names>M.</given-names></name><name><surname>Yamaki</surname><given-names>T.</given-names></name><name><surname>Yamada</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Postconditioning effect of granulocyte colony-stimulating factor is mediated through activation of risk pathway and opening of the mitochondrial KATP channels.</article-title>
<source/><italic>Am. J. Physiol. Heart Circ. Physiol.</italic>
<volume>299</volume>
<fpage>H1174</fpage>–<lpage>H1182</lpage>. <pub-id pub-id-type="pmid">20693399</pub-id></mixed-citation>
</ref>
<ref id="B179">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>J.</given-names></name><name><surname>Lu</surname><given-names>Y.</given-names></name><name><surname>Huang</surname><given-names>Y.</given-names></name><name><surname>Wugeti</surname><given-names>N.</given-names></name></person-group> (<year>2015</year>). <article-title>Unilateral vagus nerve stimulation improves ventricular autonomic nerve distribution and functional imbalance in a canine heart failure model.</article-title>
<source/><italic>Int. J. Clin. Exp. Med.</italic>
<volume>8</volume>
<fpage>9334</fpage>–<lpage>9340</lpage>. <pub-id pub-id-type="pmid">26309593</pub-id></mixed-citation>
</ref>
<ref id="B180">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sunaga</surname><given-names>D.</given-names></name><name><surname>Tanno</surname><given-names>M.</given-names></name><name><surname>Kuno</surname><given-names>A.</given-names></name><name><surname>Ishikawa</surname><given-names>S.</given-names></name><name><surname>Ogasawara</surname><given-names>M.</given-names></name><name><surname>Yano</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Accelerated recovery of mitochondrial membrane potential by GSK-3beta inactivation affords cardiomyocytes protection from oxidant-induced necrosis.</article-title>
<source/><italic>PLoS One</italic>
<volume>9</volume>:<issue>e112529</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0112529</pub-id>
<pub-id pub-id-type="pmid">25390651</pub-id></mixed-citation>
</ref>
<ref id="B181">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suva</surname><given-names>J.</given-names></name><name><surname>Caisova</surname><given-names>D.</given-names></name><name><surname>Stajner</surname><given-names>A.</given-names></name></person-group> (<year>1980</year>). <article-title>Modification of fat and carbohydrate metabolism by neurohypophyseal hormones. III. Effect of oxytocin on non-esterified fatty acid, glucose, triglyceride and cholesterol levels in rat serum.</article-title>
<source/><italic>Endokrinologie</italic>
<volume>76</volume>
<fpage>333</fpage>–<lpage>339</lpage>. <pub-id pub-id-type="pmid">7472291</pub-id></mixed-citation>
</ref>
<ref id="B182">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Svanstrom</surname><given-names>M. C.</given-names></name><name><surname>Biber</surname><given-names>B.</given-names></name><name><surname>Hanes</surname><given-names>M.</given-names></name><name><surname>Johansson</surname><given-names>G.</given-names></name><name><surname>Naslund</surname><given-names>U.</given-names></name><name><surname>Balfors</surname><given-names>E. M.</given-names></name></person-group> (<year>2008</year>). <article-title>Signs of myocardial ischaemia after injection of oxytocin: a randomized double-blind comparison of oxytocin and methylergometrine during Caesarean section.</article-title>
<source/><italic>Br. J. Anaesth.</italic>
<volume>100</volume>
<fpage>683</fpage>–<lpage>689</lpage>. <pub-id pub-id-type="doi">10.1093/bja/aen071</pub-id>
<pub-id pub-id-type="pmid">18385263</pub-id></mixed-citation>
</ref>
<ref id="B183">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swanson</surname><given-names>L. W.</given-names></name><name><surname>Hartman</surname><given-names>B. K.</given-names></name></person-group> (<year>1980</year>). <article-title>Biochemical specificity in central pathways related to peripheral and intracerebral homeostatic functions.</article-title>
<source/><italic>Neurosci. Lett.</italic>
<volume>16</volume>
<fpage>55</fpage>–<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1016/0304-3940(80)90100-7</pub-id>
<pub-id pub-id-type="pmid">6189002</pub-id></mixed-citation>
</ref>
<ref id="B184">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szeto</surname><given-names>A.</given-names></name><name><surname>Rossetti</surname><given-names>M. A.</given-names></name><name><surname>Mendez</surname><given-names>A. J.</given-names></name><name><surname>Noller</surname><given-names>C. M.</given-names></name><name><surname>Herderick</surname><given-names>E. E.</given-names></name><name><surname>Gonzales</surname><given-names>J. A.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Oxytocin administration attenuates atherosclerosis and inflammation in Watanabe Heritable Hyperlipidemic rabbits.</article-title>
<source/><italic>Psychoneuroendocrinology</italic>
<volume>38</volume>
<fpage>685</fpage>–<lpage>693</lpage>. <pub-id pub-id-type="doi">10.1016/j.psyneuen.2012.08.009</pub-id>
<pub-id pub-id-type="pmid">22998949</pub-id></mixed-citation>
</ref>
<ref id="B185">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takayanagi</surname><given-names>Y.</given-names></name><name><surname>Kasahara</surname><given-names>Y.</given-names></name><name><surname>Onaka</surname><given-names>T.</given-names></name><name><surname>Takahashi</surname><given-names>N.</given-names></name><name><surname>Kawada</surname><given-names>T.</given-names></name><name><surname>Nishimori</surname><given-names>K.</given-names></name></person-group> (<year>2008</year>). <article-title>Oxytocin receptor-deficient mice developed late-onset obesity.</article-title>
<source/><italic>Neuroreport</italic>
<volume>19</volume>
<fpage>951</fpage>–<lpage>955</lpage>. <pub-id pub-id-type="doi">10.1097/wnr.0b013e3283021ca9</pub-id>
<pub-id pub-id-type="pmid">18520999</pub-id></mixed-citation>
</ref>
<ref id="B186">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanwar</surname><given-names>V.</given-names></name><name><surname>Gorr</surname><given-names>M. W.</given-names></name><name><surname>Velten</surname><given-names>M.</given-names></name><name><surname>Eichenseer</surname><given-names>C. M.</given-names></name><name><surname>Long</surname><given-names>V. P.</given-names><suffix>III</suffix></name><name><surname>Bonilla</surname><given-names>I. M.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>In utero particulate matter exposure produces heart failure, electrical remodeling, and epigenetic changes at adulthood.</article-title>
<source/><italic>J. Am. Heart Assoc.</italic>
<volume>6</volume>:<issue>e005796</issue>. <pub-id pub-id-type="pmid">28400369</pub-id></mixed-citation>
</ref>
<ref id="B187">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tracy</surname><given-names>L. M.</given-names></name><name><surname>Gibson</surname><given-names>S. J.</given-names></name><name><surname>Labuschagne</surname><given-names>I.</given-names></name><name><surname>Georgiou-Karistianis</surname><given-names>N.</given-names></name><name><surname>Giummarra</surname><given-names>M. J.</given-names></name></person-group> (<year>2018</year>). <article-title>Intranasal oxytocin reduces heart rate variability during a mental arithmetic task: a randomised, double-blind, placebo-controlled cross-over study.</article-title>
<source/><italic>Prog. Neuropsychopharmacol. Biol. Psychiatry</italic>
<volume>81</volume>
<fpage>408</fpage>–<lpage>415</lpage>. <pub-id pub-id-type="doi">10.1016/j.pnpbp.2017.08.016</pub-id>
<pub-id pub-id-type="pmid">28844717</pub-id></mixed-citation>
</ref>
<ref id="B188">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vardavas</surname><given-names>C. I.</given-names></name><name><surname>Panagiotakos</surname><given-names>D. B.</given-names></name></person-group> (<year>2009</year>). <article-title>The causal relationship between passive smoking and inflammation on the development of cardiovascular disease: a review of the evidence.</article-title>
<source/><italic>Inflamm. Allergy Drug Targets</italic>
<volume>8</volume>
<fpage>328</fpage>–<lpage>333</lpage>. <pub-id pub-id-type="doi">10.2174/1871528110908050328</pub-id>
<pub-id pub-id-type="pmid">20025578</pub-id></mixed-citation>
</ref>
<ref id="B189">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vargas-Martinez</surname><given-names>F.</given-names></name><name><surname>Schanler</surname><given-names>R. J.</given-names></name><name><surname>Abrams</surname><given-names>S. A.</given-names></name><name><surname>Hawthorne</surname><given-names>K. M.</given-names></name><name><surname>Landers</surname><given-names>S.</given-names></name><name><surname>Guzman-Barcenas</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Oxytocin, a main breastfeeding hormone, prevents hypertension acquired in utero: a therapeutics preview.</article-title>
<source/><italic>Biochim. Biophys. Acta</italic>
<volume>1861</volume>
<fpage>3071</fpage>–<lpage>3084</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbagen.2016.09.020</pub-id>
<pub-id pub-id-type="pmid">27658996</pub-id></mixed-citation>
</ref>
<ref id="B190">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Veening</surname><given-names>J. G.</given-names></name><name><surname>Olivier</surname><given-names>B.</given-names></name></person-group> (<year>2013</year>). <article-title>Intranasal administration of oxytocin: behavioral and clinical effects, a review.</article-title>
<source/><italic>Neurosci. Biobehav. Rev.</italic>
<volume>37</volume>
<fpage>1445</fpage>–<lpage>1465</lpage>. <pub-id pub-id-type="doi">10.1016/j.neubiorev.2013.04.012</pub-id>
<pub-id pub-id-type="pmid">23648680</pub-id></mixed-citation>
</ref>
<ref id="B191">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Viero</surname><given-names>C.</given-names></name><name><surname>Shibuya</surname><given-names>I.</given-names></name><name><surname>Kitamura</surname><given-names>N.</given-names></name><name><surname>Verkhratsky</surname><given-names>A.</given-names></name><name><surname>Fujihara</surname><given-names>H.</given-names></name><name><surname>Katoh</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>REVIEW: oxytocin: crossing the bridge between basic science and pharmacotherapy.</article-title>
<source/><italic>CNS Neurosci. Ther.</italic>
<volume>16</volume>
<fpage>e138</fpage>–<lpage>e156</lpage>. <pub-id pub-id-type="doi">10.1111/j.1755-5949.2010.00185.x</pub-id>
<pub-id pub-id-type="pmid">20626426</pub-id></mixed-citation>
</ref>
<ref id="B192">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vilahur</surname><given-names>G.</given-names></name><name><surname>Casani</surname><given-names>L.</given-names></name><name><surname>Pena</surname><given-names>E.</given-names></name><name><surname>Juan-Babot</surname><given-names>O.</given-names></name><name><surname>Mendieta</surname><given-names>G.</given-names></name><name><surname>Crespo</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>HMG-CoA reductase inhibition prior reperfusion improves reparative fibrosis post-myocardial infarction in a preclinical experimental model.</article-title>
<source/><italic>Int. J. Cardiol.</italic>
<volume>175</volume>
<fpage>528</fpage>–<lpage>538</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijcard.2014.06.040</pub-id>
<pub-id pub-id-type="pmid">25023790</pub-id></mixed-citation>
</ref>
<ref id="B193">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>C.</given-names></name><name><surname>Fujita</surname><given-names>T.</given-names></name><name><surname>Kumamoto</surname><given-names>E.</given-names></name></person-group> (<year>2018</year>). <article-title>Orexin B modulates spontaneous excitatory and inhibitory transmission in lamina II neurons of adult rat spinal cord.</article-title>
<source/><italic>Neuroscience</italic>
<volume>383</volume>
<fpage>114</fpage>–<lpage>128</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2018.04.048</pub-id>
<pub-id pub-id-type="pmid">29752983</pub-id></mixed-citation>
</ref>
<ref id="B194">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>S. C.</given-names></name><name><surname>Meng</surname><given-names>D.</given-names></name><name><surname>Yang</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Jia</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>P.</given-names></name><name><surname>Wang</surname><given-names>Y.-F.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Pathological basis of cardiac arrhythmias: vicious cycle of immune-metabolic dysregulation.</article-title>
<source/><italic>Cardiovasc. Disord. Med.</italic>
<volume>3</volume>
<fpage>1</fpage>–<lpage>7</lpage>.</mixed-citation>
</ref>
<ref id="B195">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>F.</given-names></name><name><surname>Yang</surname><given-names>J.</given-names></name><name><surname>Sun</surname><given-names>J.</given-names></name><name><surname>Dong</surname><given-names>Y.</given-names></name><name><surname>Zhao</surname><given-names>H.</given-names></name><name><surname>Shi</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Testosterone replacement attenuates mitochondrial damage in a rat model of myocardial infarction.</article-title>
<source/><italic>J. Endocrinol.</italic>
<volume>225</volume>
<fpage>101</fpage>–<lpage>111</lpage>. <pub-id pub-id-type="doi">10.1530/joe-14-0638</pub-id>
<pub-id pub-id-type="pmid">25770118</pub-id></mixed-citation>
</ref>
<ref id="B196">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>P.</given-names></name><name><surname>Yang</surname><given-names>H. P.</given-names></name><name><surname>Tian</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>S. C.</given-names></name><name><surname>Zhang</surname><given-names>F.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Oxytocin-secreting system: a major part of the neuroendocrine center regulating immunologic activity.</article-title>
<source/><italic>J. Neuroimmunol.</italic>
<volume>289</volume>
<fpage>152</fpage>–<lpage>161</lpage>. <pub-id pub-id-type="doi">10.1016/j.jneuroim.2015.11.001</pub-id>
<pub-id pub-id-type="pmid">26616885</pub-id></mixed-citation>
</ref>
<ref id="B197">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>P.</given-names></name><name><surname>DeFea</surname><given-names>K. A.</given-names></name></person-group> (<year>2006</year>). <article-title>Protease-activated receptor-2 simultaneously directs beta-arrestin-1-dependent inhibition and Galphaq-dependent activation of phosphatidylinositol 3-kinase.</article-title>
<source/><italic>Biochemistry</italic>
<volume>45</volume>
<fpage>9374</fpage>–<lpage>9385</lpage>. <pub-id pub-id-type="doi">10.1021/bi0602617</pub-id>
<pub-id pub-id-type="pmid">16878972</pub-id></mixed-citation>
</ref>
<ref id="B198">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>P.</given-names></name><name><surname>Jiang</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Shyy</surname><given-names>J. Y.</given-names></name><name><surname>Defea</surname><given-names>K. A.</given-names></name></person-group> (<year>2010</year>). <article-title>Beta-arrestin inhibits CAMKKbeta-dependent AMPK activation downstream of protease-activated-receptor-2.</article-title>
<source/><italic>BMC Biochem.</italic>
<volume>11</volume>:<issue>36</issue>. <pub-id pub-id-type="doi">10.1186/1471-2091-11-36</pub-id>
<pub-id pub-id-type="pmid">20858278</pub-id></mixed-citation>
</ref>
<ref id="B199">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>S.</given-names></name><name><surname>Binder</surname><given-names>P.</given-names></name><name><surname>Fang</surname><given-names>Q.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>Xiao</surname><given-names>W.</given-names></name><name><surname>Liu</surname><given-names>W.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Endoplasmic reticulum stress in the heart: insights into mechanisms and drug targets.</article-title>
<source/><italic>Br. J. Pharmacol.</italic>
<volume>175</volume>
<fpage>1293</fpage>–<lpage>1304</lpage>.<pub-id pub-id-type="pmid">28548229</pub-id></mixed-citation>
</ref>
<ref id="B200">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y.-F.</given-names></name></person-group> (<year>2016</year>). <article-title>Center role of the oxytocin-secreting system in neuroendocrine-immune network revisited.</article-title>
<source/><italic>J. Clin. Exp. Neuroimmunol.</italic>
<volume>1</volume>:<issue>102</issue>.</mixed-citation>
</ref>
<ref id="B201">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y. F.</given-names></name><name><surname>Hatton</surname><given-names>G. I.</given-names></name></person-group> (<year>2006</year>). <article-title>Mechanisms underlying oxytocin-induced excitation of supraoptic neurons: prostaglandin mediation of actin polymerization.</article-title>
<source/><italic>J. Neurophysiol.</italic>
<volume>95</volume>
<fpage>3933</fpage>–<lpage>3947</lpage>. <pub-id pub-id-type="doi">10.1152/jn.01267.2005</pub-id>
<pub-id pub-id-type="pmid">16554501</pub-id></mixed-citation>
</ref>
<ref id="B202">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y. F.</given-names></name><name><surname>Hatton</surname><given-names>G. I.</given-names></name></person-group> (<year>2007a</year>). <article-title>Dominant role of betagamma subunits of G-proteins in oxytocin-evoked burst firing.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>27</volume>
<fpage>1902</fpage>–<lpage>1912</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.5346-06.2007</pub-id>
<pub-id pub-id-type="pmid">17314286</pub-id></mixed-citation>
</ref>
<ref id="B203">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y. F.</given-names></name><name><surname>Hatton</surname><given-names>G. I.</given-names></name></person-group> (<year>2007b</year>). <article-title>Interaction of extracellular signal-regulated protein kinase 1/2 with actin cytoskeleton in supraoptic oxytocin neurons and astrocytes: role in burst firing.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>27</volume>
<fpage>13822</fpage>–<lpage>13834</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.4119-07.2007</pub-id>
<pub-id pub-id-type="pmid">18077694</pub-id></mixed-citation>
</ref>
<ref id="B204">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname><given-names>S.</given-names></name><name><surname>Wei</surname><given-names>F. Y.</given-names></name><name><surname>Matsunaga</surname><given-names>T.</given-names></name><name><surname>Matsunaga</surname><given-names>N.</given-names></name><name><surname>Kaitsuka</surname><given-names>T.</given-names></name><name><surname>Tomizawa</surname><given-names>K.</given-names></name></person-group> (<year>2016</year>). <article-title>Oxytocin protects against stress-induced cell death in murine pancreatic beta-cells.</article-title>
<source/><italic>Sci. Rep.</italic>
<volume>6</volume>:<issue>25185</issue>. <pub-id pub-id-type="pmid">27143105</pub-id></mixed-citation>
</ref>
<ref id="B205">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weissman</surname><given-names>A.</given-names></name><name><surname>Tobia</surname><given-names>R. S.</given-names></name><name><surname>Burke</surname><given-names>Y. Z.</given-names></name><name><surname>Maxymovski</surname><given-names>O.</given-names></name><name><surname>Drugan</surname><given-names>A.</given-names></name></person-group> (<year>2017</year>). <article-title>The effects of oxytocin and atosiban on the modulation of heart rate in pregnant women.</article-title>
<source/><italic>J. Matern. Fetal Neonatal Med.</italic>
<volume>30</volume>
<fpage>329</fpage>–<lpage>333</lpage>. <pub-id pub-id-type="doi">10.3109/14767058.2016.1172564</pub-id>
<pub-id pub-id-type="pmid">27030149</pub-id></mixed-citation>
</ref>
<ref id="B206">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whayne</surname><given-names>T. F.</given-names><suffix>Jr.</suffix></name><name><surname>Saha</surname><given-names>S. P.</given-names></name></person-group> (<year>2019</year>). <article-title>Genetic risk, adherence to a healthy lifestyle, and ischemic heart disease.</article-title>
<source/><italic>Curr. Cardiol. Rep.</italic>
<volume>21</volume>:<issue>1</issue>.</mixed-citation>
</ref>
<ref id="B207">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wronska</surname><given-names>D.</given-names></name><name><surname>Kania</surname><given-names>B. F.</given-names></name><name><surname>Blachuta</surname><given-names>M.</given-names></name></person-group> (<year>2017</year>). <article-title>Direct effect of hypothalamic neuropeptides on the release of catecholamines by adrenal medulla in sheep - study ex vivo.</article-title>
<source/><italic>Pol. J. Vet. Sci.</italic>
<volume>20</volume>
<fpage>339</fpage>–<lpage>346</lpage>. <pub-id pub-id-type="doi">10.1515/pjvs-2017-0041</pub-id>
<pub-id pub-id-type="pmid">28865224</pub-id></mixed-citation>
</ref>
<ref id="B208">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wsol</surname><given-names>A.</given-names></name><name><surname>Cudnoch-Je Drzejewska</surname><given-names>A.</given-names></name><name><surname>Szczepanska-Sadowska</surname><given-names>E.</given-names></name><name><surname>Kowalewski</surname><given-names>S.</given-names></name><name><surname>Dobruch</surname><given-names>J.</given-names></name></person-group> (<year>2009</year>). <article-title>Central oxytocin modulation of acute stress-induced cardiovascular responses after myocardial infarction in the rat.</article-title>
<source/><italic>Stress</italic>
<volume>12</volume>
<fpage>517</fpage>–<lpage>525</lpage>. <pub-id pub-id-type="doi">10.3109/10253890802687688</pub-id>
<pub-id pub-id-type="pmid">20102320</pub-id></mixed-citation>
</ref>
<ref id="B209">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wsol</surname><given-names>A.</given-names></name><name><surname>Kasarello</surname><given-names>K.</given-names></name><name><surname>Kuch</surname><given-names>M.</given-names></name><name><surname>Gala</surname><given-names>K.</given-names></name><name><surname>Cudnoch-Jedrzejewska</surname><given-names>A.</given-names></name></person-group> (<year>2016</year>). <article-title>Increased activity of the intracardiac oxytocinergic system in the development of postinfarction heart failure.</article-title>
<source/><italic>Biomed Res. Int.</italic>
<volume>2016</volume>:<issue>3652068</issue>. <pub-id pub-id-type="pmid">27957495</pub-id></mixed-citation>
</ref>
<ref id="B210">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wsol</surname><given-names>A.</given-names></name><name><surname>Szczepanska-Sadowska</surname><given-names>E.</given-names></name><name><surname>Kowalewski</surname><given-names>S.</given-names></name><name><surname>Puchalska</surname><given-names>L.</given-names></name><name><surname>Cudnoch-Jedrzejewska</surname><given-names>A.</given-names></name></person-group> (<year>2014</year>). <article-title>Oxytocin differently regulates pressor responses to stress in WKY and SHR rats: the role of central oxytocin and V1a receptors.</article-title>
<source/><italic>Stress</italic>
<volume>17</volume>
<fpage>117</fpage>–<lpage>125</lpage>. <pub-id pub-id-type="doi">10.3109/10253890.2013.872620</pub-id>
<pub-id pub-id-type="pmid">24308490</pub-id></mixed-citation>
</ref>
<ref id="B211">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>S.</given-names></name><name><surname>Lu</surname><given-names>Q.</given-names></name><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Ding</surname><given-names>Y.</given-names></name><name><surname>Ma</surname><given-names>Z.</given-names></name><name><surname>Mao</surname><given-names>X.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Binding of FUN14 domain containing 1 with inositol 1,4,5-trisphosphate receptor in mitochondria-associated endoplasmic reticulum membranes maintains mitochondrial dynamics and function in hearts in vivo.</article-title>
<source/><italic>Circulation</italic>
<volume>136</volume>
<fpage>2248</fpage>–<lpage>2266</lpage>. <pub-id pub-id-type="doi">10.1161/circulationaha.117.030235</pub-id>
<pub-id pub-id-type="pmid">28942427</pub-id></mixed-citation>
</ref>
<ref id="B212">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>J. Q.</given-names></name><name><surname>Murphy</surname><given-names>S. L.</given-names></name><name><surname>Kochanek</surname><given-names>K. D.</given-names></name><name><surname>Bastian</surname><given-names>B. A.</given-names></name></person-group> (<year>2016</year>). <article-title>Deaths: final data for 2013.</article-title>
<source/><italic>Natl. Vital Stat. Rep.</italic>
<volume>64</volume>
<fpage>1</fpage>–<lpage>119</lpage>.<pub-id pub-id-type="pmid">26905861</pub-id></mixed-citation>
</ref>
<ref id="B213">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>F.</given-names></name><name><surname>Yu</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>T.</given-names></name><name><surname>Wu</surname><given-names>J.</given-names></name><name><surname>Zhao</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Exogenous H2S regulates endoplasmic reticulum-mitochondria cross-talk to inhibit apoptotic pathways in STZ-induced type I diabetes.</article-title>
<source/><italic>Am. J. Physiol. Endocrinol. Metab.</italic>
<volume>312</volume>
<fpage>E190</fpage>–<lpage>E203</lpage>. <pub-id pub-id-type="pmid">27998959</pub-id></mixed-citation>
</ref>
<ref id="B214">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>J.</given-names></name><name><surname>Cao</surname><given-names>R. Y.</given-names></name><name><surname>Gao</surname><given-names>R.</given-names></name><name><surname>Mi</surname><given-names>Q.</given-names></name><name><surname>Dai</surname><given-names>Q.</given-names></name><name><surname>Zhu</surname><given-names>F.</given-names></name></person-group> (<year>2017</year>). <article-title>Physical exercise is a potential “Medicine” for atherosclerosis.</article-title>
<source/><italic>Adv. Exp. Med. Biol.</italic>
<volume>999</volume>
<fpage>269</fpage>–<lpage>286</lpage>. <pub-id pub-id-type="doi">10.1007/978-981-10-4307-9_15</pub-id>
<pub-id pub-id-type="pmid">29022268</pub-id></mixed-citation>
</ref>
<ref id="B215">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>H. P.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Han</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>S. C.</given-names></name></person-group> (<year>2013</year>). <article-title>Nonsocial functions of hypothalamic oxytocin.</article-title>
<source/><italic>ISRN Neurosci.</italic>
<volume>2013</volume>:<issue>179272</issue>. <pub-id pub-id-type="pmid">24967304</pub-id></mixed-citation>
</ref>
<ref id="B216">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yano</surname><given-names>T.</given-names></name><name><surname>Shimoshige</surname><given-names>S.</given-names></name><name><surname>Miki</surname><given-names>T.</given-names></name><name><surname>Tanno</surname><given-names>M.</given-names></name><name><surname>Mochizuki</surname><given-names>A.</given-names></name><name><surname>Fujito</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Clinical impact of myocardial mTORC1 activation in nonischemic dilated cardiomyopathy.</article-title>
<source/><italic>J. Mol. Cell. Cardiol.</italic>
<volume>91</volume>
<fpage>6</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.yjmcc.2015.12.022</pub-id>
<pub-id pub-id-type="pmid">26739211</pub-id></mixed-citation>
</ref>
<ref id="B217">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ybarra</surname><given-names>N.</given-names></name><name><surname>Del Castillo</surname><given-names>J. R.</given-names></name><name><surname>Troncy</surname><given-names>E.</given-names></name></person-group> (<year>2011</year>). <article-title>Involvement of the nitric oxide-soluble guanylyl cyclase pathway in the oxytocin-mediated differentiation of porcine bone marrow stem cells into cardiomyocytes.</article-title>
<source/><italic>Nitric Oxide</italic>
<volume>24</volume>
<fpage>25</fpage>–<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1016/j.niox.2010.09.008</pub-id>
<pub-id pub-id-type="pmid">20934529</pub-id></mixed-citation>
</ref>
<ref id="B218">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yee</surname><given-names>J. R.</given-names></name><name><surname>Kenkel</surname><given-names>W. M.</given-names></name><name><surname>Frijling</surname><given-names>J. L.</given-names></name><name><surname>Dodhia</surname><given-names>S.</given-names></name><name><surname>Onishi</surname><given-names>K. G.</given-names></name><name><surname>Tovar</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Oxytocin promotes functional coupling between paraventricular nucleus and both sympathetic and parasympathetic cardioregulatory nuclei.</article-title>
<source/><italic>Horm. Behav.</italic>
<volume>80</volume>
<fpage>82</fpage>–<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1016/j.yhbeh.2016.01.010</pub-id>
<pub-id pub-id-type="pmid">26836772</pub-id></mixed-citation>
</ref>
<ref id="B219">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ying</surname><given-names>L.</given-names></name><name><surname>Becard</surname><given-names>M.</given-names></name><name><surname>Lyell</surname><given-names>D.</given-names></name><name><surname>Han</surname><given-names>X.</given-names></name><name><surname>Shortliffe</surname><given-names>L.</given-names></name><name><surname>Husted</surname><given-names>C. I.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>The transient receptor potential vanilloid 4 channel modulates uterine tone during pregnancy.</article-title>
<source/><italic>Sci. Transl. Med.</italic>
<volume>7</volume>:<issue>319ra204</issue>. <pub-id pub-id-type="doi">10.1126/scitranslmed.aad0376</pub-id>
<pub-id pub-id-type="pmid">26702092</pub-id></mixed-citation>
</ref>
<ref id="B220">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>You</surname><given-names>X.</given-names></name><name><surname>Chen</surname><given-names>Z.</given-names></name><name><surname>Zhao</surname><given-names>H.</given-names></name><name><surname>Xu</surname><given-names>C.</given-names></name><name><surname>Liu</surname><given-names>W.</given-names></name><name><surname>Sun</surname><given-names>Q.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Endogenous hydrogen sulfide contributes to uterine quiescence during pregnancy.</article-title>
<source/><italic>Reproduction</italic>
<volume>153</volume>
<fpage>535</fpage>–<lpage>543</lpage>. <pub-id pub-id-type="doi">10.1530/rep-16-0549</pub-id>
<pub-id pub-id-type="pmid">28188160</pub-id></mixed-citation>
</ref>
<ref id="B221">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yudkin</surname><given-names>J. S.</given-names></name></person-group> (<year>2003</year>). <article-title>Adipose tissue, insulin action and vascular disease: inflammatory signals.</article-title>
<source/><italic>Int. J. Obes. Relat. Metab. Disord.</italic>
<volume>27</volume>(Suppl. 3), <fpage>S25</fpage>–<lpage>S28</lpage>.<pub-id pub-id-type="pmid">14704740</pub-id></mixed-citation>
</ref>
<ref id="B222">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yue</surname><given-names>C.</given-names></name><name><surname>Sanborn</surname><given-names>B. M.</given-names></name></person-group> (<year>2001</year>). <article-title>KN-93 inhibition of G protein signaling is independent of the ability of Ca2+/calmodulin-dependent protein kinase II to phosphorylate phospholipase Cbeta3 on 537-Ser.</article-title>
<source/><italic>Mol. Cell. Endocrinol.</italic>
<volume>175</volume>
<fpage>149</fpage>–<lpage>156</lpage>. <pub-id pub-id-type="doi">10.1016/s0303-7207(01)00383-5</pub-id>
<pub-id pub-id-type="pmid">11325525</pub-id></mixed-citation>
</ref>
<ref id="B223">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zafirovic</surname><given-names>S.</given-names></name><name><surname>Obradovic</surname><given-names>M.</given-names></name><name><surname>Sudar-Milovanovic</surname><given-names>E.</given-names></name><name><surname>Jovanovic</surname><given-names>A.</given-names></name><name><surname>Stanimirovic</surname><given-names>J.</given-names></name><name><surname>Stewart</surname><given-names>A. J.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>17beta-Estradiol protects against the effects of a high fat diet on cardiac glucose, lipid and nitric oxide metabolism in rats.</article-title>
<source/><italic>Mol. Cell. Endocrinol.</italic>
<volume>446</volume>
<fpage>12</fpage>–<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1016/j.mce.2017.02.001</pub-id>
<pub-id pub-id-type="pmid">28163099</pub-id></mixed-citation>
</ref>
<ref id="B224">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Wu</surname><given-names>C.</given-names></name><name><surname>Chen</surname><given-names>Q.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Xu</surname><given-names>Z.</given-names></name><name><surname>Wu</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Treatment of obesity and diabetes using oxytocin or analogs in patients and mouse models.</article-title>
<source/><italic>PLoS One</italic>
<volume>8</volume>:<issue>e61477</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0061477</pub-id>
<pub-id pub-id-type="pmid">23700406</pub-id></mixed-citation>
</ref>
<ref id="B225">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>H. M.</given-names></name><name><surname>Qiu</surname><given-names>Y.</given-names></name><name><surname>Ye</surname><given-names>X.</given-names></name><name><surname>Hemida</surname><given-names>M. G.</given-names></name><name><surname>Hanson</surname><given-names>P.</given-names></name><name><surname>Yang</surname><given-names>D.</given-names></name></person-group> (<year>2014</year>). <article-title>P58(IPK) inhibits coxsackievirus-induced apoptosis via the PI3K/Akt pathway requiring activation of ATF6a and subsequent upregulation of mitofusin 2.</article-title>
<source/><italic>Cell. Microbiol.</italic>
<volume>16</volume>
<fpage>411</fpage>–<lpage>424</lpage>. <pub-id pub-id-type="doi">10.1111/cmi.12229</pub-id>
<pub-id pub-id-type="pmid">24134518</pub-id></mixed-citation>
</ref>
<ref id="B226">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Guo</surname><given-names>H.</given-names></name><name><surname>Yuan</surname><given-names>F.</given-names></name><name><surname>Hong</surname><given-names>Z. C.</given-names></name><name><surname>Tian</surname><given-names>Y. M.</given-names></name><name><surname>Zhang</surname><given-names>X. J.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Limb remote ischemia per-conditioning protects the heart against ischemia-reperfusion injury through the opioid system in rats.</article-title>
<source/><italic>Can. J. Physiol. Pharmacol.</italic>
<volume>96</volume>
<fpage>68</fpage>–<lpage>75</lpage>. <pub-id pub-id-type="doi">10.1139/cjpp-2016-0585</pub-id>
<pub-id pub-id-type="pmid">28763627</pub-id></mixed-citation>
</ref>
<ref id="B227">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhong</surname><given-names>M.</given-names></name><name><surname>Parish</surname><given-names>B.</given-names></name><name><surname>Murtazina</surname><given-names>D. A.</given-names></name><name><surname>Ku</surname><given-names>C. Y.</given-names></name><name><surname>Sanborn</surname><given-names>B. M.</given-names></name></person-group> (<year>2007</year>). <article-title>Amino acids in the COOH-terminal region of the oxytocin receptor third intracellular domain are important for receptor function.</article-title>
<source/><italic>Am. J. Physiol. Endocrinol. Metab.</italic>
<volume>292</volume>
<fpage>E977</fpage>–<lpage>E984</lpage>. <pub-id pub-id-type="pmid">17148753</pub-id></mixed-citation>
</ref>
<ref id="B228">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhong</surname><given-names>M.</given-names></name><name><surname>Yang</surname><given-names>M.</given-names></name><name><surname>Sanborn</surname><given-names>B. M.</given-names></name></person-group> (<year>2003</year>). <article-title>Extracellular signal-regulated kinase 1/2 activation by myometrial oxytocin receptor involves Galpha(q)Gbetagamma and epidermal growth factor receptor tyrosine kinase activation.</article-title>
<source/><italic>Endocrinology</italic>
<volume>144</volume>
<fpage>2947</fpage>–<lpage>2956</lpage>. <pub-id pub-id-type="doi">10.1210/en.2002-221039</pub-id>
<pub-id pub-id-type="pmid">12810550</pub-id></mixed-citation>
</ref>
<ref id="B229">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>M.</given-names></name><name><surname>Bao</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Pan</surname><given-names>Y.</given-names></name><name><surname>Shu</surname><given-names>L.</given-names></name><name><surname>Xia</surname><given-names>Z.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Deficiency of adipocyte fatty-acid-binding protein alleviates myocardial ischaemia/reperfusion injury and diabetes-induced cardiac dysfunction.</article-title>
<source/><italic>Clin. Sci.</italic>
<volume>129</volume>
<fpage>547</fpage>–<lpage>559</lpage>. <pub-id pub-id-type="doi">10.1042/cs20150073</pub-id>
<pub-id pub-id-type="pmid">26186740</pub-id></mixed-citation>
</ref>
<ref id="B230">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Xie</surname><given-names>Y.</given-names></name></person-group> (<year>2017</year>). <article-title>Regulation of angiogenic behaviors by oxytocin receptor through Gli1-indcued transcription of HIF-1alpha in human umbilical vein endothelial cells.</article-title>
<source/><italic>Biomed. Pharmacother.</italic>
<volume>90</volume>
<fpage>928</fpage>–<lpage>934</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopha.2017.04.021</pub-id>
<pub-id pub-id-type="pmid">28445928</pub-id></mixed-citation>
</ref>
<ref id="B231">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zimmerman</surname><given-names>E. A.</given-names></name><name><surname>Nilaver</surname><given-names>G.</given-names></name><name><surname>Hou-Yu</surname><given-names>A.</given-names></name><name><surname>Silverman</surname><given-names>A. J.</given-names></name></person-group> (<year>1984</year>). <article-title>Vasopressinergic and oxytocinergic pathways in the central nervous system.</article-title>
<source/><italic>Fed. Proc.</italic>
<volume>43</volume>
<fpage>91</fpage>–<lpage>96</lpage>.<pub-id pub-id-type="pmid">6690342</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>